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PrefaCe
Synthetic glucocorticoids such as dexamethasone are frequently used to enhance 
pulmonary development in preterm ventilator-dependent infants. In contrast to the 
short-term benefit on survival and lung maturation, early glucocorticoid exposure 
has been shown to adversely affect neurodevelopmental processes. Both human 
and animals studies have reported acute and long-lasting impairment in response 
to neonatal dexamethasone treatment. In rodent studies, this treatment is even 
reported to result in shortening of the lifespan. These findings have led to the 
question whether the benefits of this treatment outweigh its costs.
Therefore, the objective of the studies described in this thesis is to investigate 
using an animal model: 1) the short- and long-term consequences of neonatal 
synthetic glucocorticoid treatment and 2) the possibility to prevent these effects 
using pharmacological and behavioural intervention strategies. 
We report that systemic glucocorticoid treatment acutely affects brain 
development by suppressing cell proliferation and glial activity. These acute 
effects on the brain can be partially prevented by central glucocorticoid receptor 
antagonist pre-treatment. Accordingly, central administration of the antagonist 
might serve as a protective strategy against the adverse neurodevelopmental 
effects of dexamethasone treatment. 
Although glucocorticoid exposure clearly affects the developmental trajectory, 
the long-lasting consequences of this treatment were not as detrimental as 
previously reported. We suggest that daily handling of the neonate, which was an 
inevitable component of our experimental design and leads to enhanced levels 
of maternal care towards the offspring, may compensate for the adverse effects 
of glucocorticoid exposure.
We conclude that the impact of neonatal glucocorticoid exposure highly 
depends on interactions with other components of the early environment and is 
therefore susceptible to pharmacological and behavioural intervention strategies.
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IntroductIon
1It is well documented that early-life experiences are involved in shaping later-life phenotypes. Both human and animal studies have reported the impact of 
(adverse) early experiences on the development of the stress system, and its 
consequences for the development of stress-related disorders. The aim of 
the research described in this thesis is to explore the acute and long-lasting 
consequences of two distinct types of postnatal experience, varying substantially 
in nature and severity. The impact of both very subtle differences in maternal 
environment as well as of exposure to synthetic glucocorticoids during the early 
postnatal period was investigated. Furthermore, two potential intervention 
strategies will be introduced to prevent the frequently reported adverse effects of 
glucocorticoid-induced disruption of normal development and brain maturation.
In this introductory chapter, an overview is given of important concepts for the 
study of developmental programming. Additionally, several animal models used 
in experiments described in this thesis will be introduced.
1. DeveloPmental Programming
Early perinatal life represents a critical developmental period. Not only the quality 
of embryonic environment (1), also early postnatal experiences have long-lasting 
consequences for emotional and cognitive development and functioning in later-
life. Exposure to early adversity such as maternal stress during pregnancy, abuse 
or exposure to extreme poverty has been shown to increase the vulnerability to 
develop psychopathology in later-life. 
The term ‘developmental programming’ derives from the concept of 
‘developmental origin of adult disease’ introduced by Barker and colleagues 
and was based on a vast amount of epidemiological research documenting 
the relationship between low birth weight and an increased risk of developing 
metabolic and cardiovascular disorders (2-4). These findings led to what is currently 
known as the Barker Hypothesis (5). This concept has been since extended and is 
now frequently studied in the context of the hypothalamic-pituitary-adrenal (HPA) 
axis (6-10). Programming of the stress system is achieved through the actions of 
environmental cues acting at a specific time during development, resulting in 
permanent alterations in the functioning of the HPA axis (6-10). 
Both preclinical and clinical evidence suggests that this phenomenon has 
relevance for the etiology of mental disorders triggered by stressful life events, 
including depression and post-traumatic stress disorder (9-12).
2. DiSruPtion of normal DeveloPment
2.1 human studies
Because of ethical considerations, the direct impact of stress on development cannot 
be investigated in humans. Therefore progress in this field relies on retrospective 
reports and correlational studies. There are however some experiments of nature 
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in which the impact of prenatal (intrauterine growth restriction, low birth weight) 
and postnatal (low socioeconomic status, maltreatment) adversity can be studied.
A series of studies have convincingly shown that exposure to early adverse 
events, such as childhood abuse, results in an increased risk to develop psychiatric 
dysfunctions (11-14). A dose-response relationship has been described between 
the number of experienced childhood adversities and mental health score in 
later-life (i.e. probability of lifetime depressive disorders) (15, 16). Besides these 
severe forms of adversity such as emotional neglect and abuse, there is also 
evidence that milder forms of adversity are associated with increased risk for stress 
related-pathologies. For instance, early-life socioeconomic disadvantage (17) but 
also subtle differences in parenting style (18-20) appear to affect health status 
of the individual in later-life. Therefore, there is no doubt that early adversity 
plays a crucial role in programming the development of a range of physical and 
psychiatric disorders which is likely to be mediated (at least partially) via the 
effects of early adversity on the functioning of the HPA axis. Several studies have 
shown the association between early-life adversity and enduring sensitization of 
the responsiveness of the HPA axis in humans. For instance, alterations in basal as 
well as stress-induced HPA axis activity at different life stages have been reported 
in human subjects exposed to adversity in early-life (13, 14, 21, 22). 
2.2 animal studies
In contrast to human studies, animal studies allow the development of experimental 
models where individuals are submitted to acute or chronic adversity and the 
resulting outcome on brain and behaviour can be investigated. Experimental 
early-life manipulations can be largely subdivided in prenatal and postnatal 
manipulations. Prenatal manipulations involve stress during pregnancy, maternal 
synthetic glucocorticoid exposure, or nutrient restriction. For a review on the 
impact of prenatal manipulations, we refer to previous literature (23-26).
Postnatal manipulations frequently involve manipulating or depriving the 
infant from maternal behaviour.
2.2.1 Handling
In the 1950’s, it was discovered that exposing rat pups to daily handling sessions, 
which consisted of brief periods of separation from the dam (< 15 min) between 
postnatal day (pnd) 1 and 21, had a surprising and unexpected outcome (27). 
Levine, and others, found that handling induced long-lasting changes in adult 
phenotype such as HPA axis hypo-responsiveness (28-30), reduced emotionality 
(29), and increased cognitive performance (31) when compared to rats raised in 
undisturbed laboratory conditions, i.e. non handled. However, the use of such 
‘undisturbed’ control groups was recognized to be problematic later; see reviews 
(32-34). Because the handling procedure was considered at that time to be a 
stressful experience, these findings challenged the dominant theory stating that 
early-life stress invariably contributes to the development of ‘emotional instability’. 
Instead, the findings from Levine demonstrated that, in some instances (e.g. via 
handling), exposure to ‘moderate stress’ in early-life appeared to be beneficial for 
12
IntroductIon
1the infant by promoting a greater ability of the organism to adapt to psychological and physiological stressors in adulthood (27). This same principle also serves as 
the basis for the stress inoculation-induced resilience theory developed several 
years later (35-39).
à In chapter 5 of this thesis the beneficial effects of neonatal handling will be 
used as a potential rescue strategy to compensate for the adverse effects of 
neonatal synthetic glucocorticoid exposure.
2.2.2 Maternal separation
Over the years new paradigms were introduced in an attempt to also study the 
mechanisms underlying developmental programming following exposure to more 
‘adverse’ experiences (40). Maternal separation consists of prolonged periods 
of maternal absence ranging from 1h to 24h. The reported effects of maternal 
separation appear to be more controversial compared to the effects of handling, 
in part because of the substantial variety in different experimental procedures 
across different laboratories in terms of duration, frequency, age of onset of the 
separation, gender and the choice of control group (41-43). Nevertheless, maternal 
separation appeared to ‘program’ the functioning of the HPA axis. As expected, 
this manipulation was reported to yield a more severe outcome, opposing the 
effects of handling, including HPA hyper-responsiveness following stress (40), 
increased emotionality (44), and impaired cognitive performance (28). For an 
extensive review of the consequences of postnatal manipulations, see: (28, 45).
3. maternal meDiation hyPotheSiS
The use of the handling model in rodents raised an important question: how 
can short episodes of maternal absence result in such profound and enduring 
effects on adult stress-phenotype? The ‘maternal mediation hypothesis’ was 
proposed for the fist time as part of the mechanism underlying the lasting 
effects of handling by Smotherman and Bell (46). This theory postulates that the 
outcome of postnatal manipulations (such as handling and maternal separation) is 
mediated by changes in maternal behaviour directed towards the offspring upon 
reunion after a given period of mother-infant separation (47). It was observed 
that brief (15 min) episodes of handling resulted in increased levels of maternal 
care upon reunion between mother and offspring, sometimes reported to remain 
higher throughout the entire day (48). Longer periods (4 h) of maternal separation 
yielded an increase in active maternal care only directly after reunion of the dam 
with the pups but not at any other time point, leading overall to differences in the 
amount/quality of maternal care received by handled versus maternally separated 
pups (48). This suggests that the amount and quality of maternal care, at least in 
part, mediates effects of handling and maternal separation on functioning of the 
HPA axis in the offspring.
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However, certain findings challenged this theory. For instance, Macri and 
co-workers (32) reported inconsistencies in the maternal mediation hypothesis. 
They showed an overall increase in maternal care following both handling and 
maternal separation. Their findings revealed that directly following maternal 
separation dams increase their care to such an extent that they fully compensate 
for the separation time and reach a level comparable to dams of handled pups. 
Since handled and maternally separated offspring display significantly different 
endocrine and behavioural stress responses in later-life, it was concluded that 
maternal care cannot be the only mediator driving the effects of the postnatal 
manipulations (32, 33).
4. naturally oCCurring variation in maternal 
Care
4.1 rodent studies
The most compelling set of evidence for the importance of the amount and 
quality of maternal care on the development of the stress-regulating system 
came from studies performed by Meaney and colleagues (49). Employing a non-
invasive naturalistic approach, they studied the impact of naturally occurring 
variation in maternal care on the development of the HPA axis in rodents. This 
model is based on extreme differences among lactating rats in the frequency of 
licking and grooming (LG) they provide to their pups. It shows that variation in the 
amount of maternal LG, a form of tactile stimulation, modulates the development 
of the structure and function of the neural circuitry underlying stress regulation, 
emotionality, and cognitive processes (49-54). Reminiscent of the outcome of 
handling, offspring of high, relative to low LG dams, show decreased behavioural 
and endocrine responsiveness to stress, reduced emotionality, and enhanced 
performance in tests of spatial learning (49, 51, 54). These effects are largely 
reversed with cross-fostering, in which the biological offspring of a high LG 
mother is cross-fostered to a low LG mother or vice versa. This suggests that 
variation in maternal care transfers phenotypic differences to the offspring in a 
non-genetic way (55).
à This model is based on the assumption that maternal care is equally distributed 
over individual pups sharing a litter, such that each individual develops a similar 
phenotype later in life. In chapter 2 of this thesis this assumption is tested. We 
hypothesize that the distribution of maternal care directed towards individual 
pups within a litter is homogenous and therefore results in a uniform ‘stress 
phenotype’ in later-life.
4.2 human studies
As with animal models, the mediating role of the mother (or another caregiver) 
in the regulation of the HPA axis of the infant has also been demonstrated in 
humans (56). Several studies show that when children are exposed to adequate 
14
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1care, they display diminished cortisol responsiveness, an increased threshold to evoke a cortisol response to various stressors (56), and a better cortisol recovery 
after stress (i.e. enhanced glucocorticoid negative feedback) (57). This is explained 
by suggesting that children, under high care-giving conditions, anticipate that a 
caregiver will protect them and therefore they feel able to cope with a threatening 
situation (56). Additionally, it has been reported that subtle differences in parenting 
style are associated with the degree of antisocial behaviour in adolescents (19). 
Moreover, differences in within-family parenting style appear to be associated with 
variation in antisocial behaviour and depressive symptoms in the offspring (18).
5. ePigenetiC Programming of the hPa axiS
The neuro-endocrine (49), behavioural (51, 58, 59), and cognitive alterations (50, 
52) observed in response to naturally-occurring variations in maternal care (60) are 
suggested to be the consequence of alterations in HPA axis activity, hippocampal 
glucocorticoid receptor (GR) expression  and synaptic plasticity.
A major breakthrough in the field of developmental programming came with 
the discovery of epigenetic modifications in the promoter area of the GR gene, 
revealing a mechanism underlying these environmentally driven effects on later-
life stress phenotype. It was shown that increased levels of maternal LG during the 
first week of life alter the methylation pattern of the GR gene in the hippocampus 
of the offspring (61). These changes persist into adulthood and alter the 
expression of the GR throughout life via modification of the chromatin structure. 
Cross fostering of the offspring (from a high to a low LG dam or vice versa) shows 
a complete reversal of methylation patterns, demonstrating that DNA can be 
structurally modified (without alterations to sequence) through environmental 
influences, thus leading to changes in gene expression (61, 62). 
The significance of these findings in the field of psychiatry is unclear but 
recent studies in humans revealed that epigenetic programming of the HPA 
axis via changes in DNA methylation of GR may occur in human infants born to 
mothers whom experienced depression during pregnancy (63). Additionally, there 
are indications of epigenetic regulation of GR in the brains of individuals with a 
history of adverse childhood experiences whom committed suicide following a 
stressful life event (64).
6. reSilienCe
Traditionally, research in the field of developmental programming has focused 
on the detrimental consequences of stress and far less on the ability to develop 
resilience to stress or stress-related diseases. Recent findings are challenging 
this view and suggest that the outcome of early experience is not necessarily 
deterministic and cannot be perceived as good or bad. 
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6.1 resilience through matching environments
From an evolutionary perspective, biological mechanisms leading to ‘programming’ 
effects are generally meant to be adaptive and not necessarily a substrate for 
diseases. This is the basis of the ‘predictive adaptation plasticity hypothesis’ (65-69). 
This theory is based on the concept that a developing organism responds to cues 
(e.g. maternal care) in its environment by changing certain aspects of its homeostatic 
regulation (e.g. HPA axis) in order to produce a phenotype that is highly adapted to 
its current and anticipated future environment. This concept led to the idea that a 
high degree of ‘mismatch’ between the early- and later-life environments accounts 
for an increased risk to develop diseases in adulthood (66-69). There is much 
evidence to support this view in the field of metabolic and cardiovascular disorders 
(67, 70). However in psychiatric research, the validity of this concept is uncertain. 
Recent evidence from animal studies however suggests that the concept of 
‘mismatch’ can also apply to the development of individual differences in stress 
sensitivity. It was recently shown that the outcome of early experiences on stress-
related parameters is dependent on later-life environmental context (50, 52). 
Specifically, it was reported that adult offspring of low LG mothers (considered 
as a form of adversity) show indeed the expected poor cognitive performance 
in a low-stress context. However, in a high-stress context their performance was 
better compared to animals that had received high levels of maternal LG, which in 
turn were impaired under the same stressful conditions (50, 52). Additionally early 
deprivation of maternal care (a severe form of adversity) has been reported to result 
in impaired cognition under low stress but enhanced performance under high 
stress conditions (71). These findings suggest that the influence of environmental 
experiences during development might serve as a basis for resilience to stressful 
challenges in later life.
6.2 intervention
Interventions, when made at a specific time during development, can mediate the 
developmental programming of a certain phenotype, as is shown by studies on 
infants raised in orphanages. These infants have been reported to show changes 
in cognitive performance (72) and neuronal function in the hippocampus, when 
compared to never-institutionalized children (73). However, these deleterious 
effects appear to be reversible when intervention occurs within a certain time 
window. Placement of institutionalized infants in foster families significantly 
improves long-term learning and memory performance, with earlier intervention 
leading to better outcome (74).
The impact of interventions has also been described in animal studies. It has 
been reported that the cognitive impairment in animals either receiving low levels 
of maternal LG (75) or being exposed to prolonged periods of maternal separation 
(76) in early-life can be reversed by exposing them in the peri-pubertal period 
to environmental enrichment, an effect that might be mediated via structural 
changes in the hippocampus (77). These findings indicate that even ‘adversely’ 
programmed individuals can be ‘rescued’ by environmental interventions.
16
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1à In chapters 3 and 5 two intervention strategies to overcome the frequently reported adverse effects of neonatal glucocorticoid exposure will be described
7. the StreSS hyPo-reSPonSive PerioD
The outcome of early-life experiences largely depends on the timing, frequency 
and duration an individual is exposed to particular environmental experiences 
(78-81). For instance, the timing of handling and 24h maternal separation is 
crucial for the outcome on adult phenotype, with handling effects being more 
profound if performed during the early postnatal period as compared to later in 
the postnatal period (78, 80). This is important since the early postnatal period 
coincides with onset of the stress hypo-responsive period (SHRP). The SHRP 
begins several days after birth and terminates around pnd 14 in rodents (28, 45). 
This period is characterized by very low basal corticosterone (CORT) levels and 
a reduced ability to show an increase in circulating CORT levels in response to 
mild stressors that are capable of triggering a profound glucocorticoid response 
in the adult animal (82). While during the SHRP the neonate’s pituitary-adrenal 
axis is mostly hypo-responsive (83), the central component of the HPA axis does 
respond to stressors as is revealed by activation of hypothalamic paraventricular 
(PVN) neurons (84). This hypo-responsiveness of the adrenals is time and stressor 
specific because more severe stressors have been shown to induce a substantial 
CORT response (85, 86).
Interestingly, the presence of the mother is highly important in maintaining 
the SHRP (87, 88). Maternal presence in rodents - resulting in active maternal 
care and feeding - is suggested to actively regulate the responsiveness of the 
neonate’s HPA axis during the SHRP (82, 89). Adrenocorticotropic hormone 
(ACTH) and CORT levels slowly increase if pups are separated from the mother, 
reaching peak levels after 8 h (90-92). The SHRP is disrupted and an adrenal 
CORT response is more easily activated after exposure to mild stressors and 
exogenous ACTH administration (91, 93, 94). When certain aspects of maternal 
behaviour are reinstated during separation, by stroking and feeding of the pups, 
the effects evoked by separation can be reversed (95)(see figure 1). Therefore 
maternal presence serves to ‘buffer’ the impact of stressors on the neonate. 
There is accumulating evidence that a human analogue to the rodent stress 
hyporesponsive period exists, emerging in infancy and lasting throughout most 
of childhood (56).
7.1 Social buffering and attachment learning
The importance of the SHRP and the role of the mother were also illustrated 
in the context of attachment learning. During the first days of life, rodent pups 
strongly depend on the mother for survival. They must learn to approach her and 
exhibit certain behaviours to elicit nursing behaviour from the mother. Since pups 
do not see or hear during the early postnatal period, attachment to the mother 
is based on odour learning, supported by a circuitry involving the olfactory bulb 
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and locus coeruleus. Pups readily learn to approach the mother based on her 
smell. Additionally, they learn to approach artificial odours when paired with 
positive stimuli such as stroking and warmth, and during the very early postnatal 
period even to negative stimuli such as a shock, indicating that the neonate is 
programmed for attachment rather than avoidance (96). 
Interestingly, this attachment learning only occurs under low CORT conditions. 
When the neonate reaches the end of the SHRP, and mild stimuli start to elicit 
a rise in CORT levels, the buffering role of the mother becomes important for 
maintaining attachment learning. A novel odour paired with a shock will not result 
in a rise in CORT in presence of the mother, and the pup will learn to approach 
this odour. However if conditioning takes place in absence of the mother, the pup 
will display increased CORT levels in response to the shock, which will activate 
the amygdala, and will result in a shift from odour preference to odour avoidance. 
Older rodents (weaning age and older), having a mature HPA axis, will always show 
aversion to odours paired with negative stimuli since they elicit a rise in CORT 
Figure 1. Stress-induced HPA axis activity of an adult, neonate and maternally-deprived 
neonate rat. During the SHRP the neonate rat shows a central response to stressors, which is 
not translated to a corticosterone response. The SHRP is characterized by hyporesponsiveness 
of the adrenals to stress resulting in low and stable levels of circulating corticosterone which is 
unbound because corticosteroid binding globulin is virtually absent at that age. Also on other 
levels of the HPA axis there are differences in sensitivity and reactivity compared to an adult 
animal. Interestingly, the HPA axis of a maternally-deprived neonate is responsive to stressors, 
showing some resemblance to that of an adult animal and therefore suggesting premature 
maturation of the stress pathways. However, when certain aspects of the maternal behaviour 
repertoire are reinstated (by stroking and/or feeding the neonate) during deprivation, several 
deprivation-induced alterations can be reversed. The size and thickness of symbols and lines 
represent the magnitude of responsiveness. - depicts suppression of stress-induced activity. 
PVN: paraventricular nucleus of the hypothalamus; CRH: corticotropin-releasing hormone, 
ACTH: adrenocorticotropic hormone, CORT: corticosterone.
18
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1levels and subsequently activate the amygdala-fear pathway. Activation of this avoidance learning is obviously an important survival strategy for animals that can 
no longer depend on their caregiver and have to face the challenges of the world 
outside the nest (96, 97). However, when this fear pathway is triggered during the 
very early ‘sensitive’ postnatal period, due to prematurely elevated CORT levels, 
there will be long-term consequences for functioning of the amygdala and related 
pathways with a bias to enhanced activation (Daskakalis et al., submitted).
8. gluCoCortiCoiDS During DeveloPment
The purpose of the SHRP might be to protect the rapidly developing brain from 
the impact of high levels of glucocorticoids. Appropriate levels of glucocorticoids 
are necessary for normal development (88, 98, 99). However, not only exposure 
to high levels of glucocorticoids is disadvantageous, also very low or absent 
glucocorticoid levels adversely affect development. During normal pregnancy the 
activity of the maternal HPA axis is dramatically changed, leading to increased 
circulating glucocorticoid and ACTH levels (100). 
The impact of glucocorticoids during development is frequently studied in the 
context of lung development. Glucocorticoid receptors (GR) are expressed in most 
foetal tissue and mediate the glucocorticoid action that is essential for survival. GR 
null mice die several hours after birth because of insufficient lung development 
and respiratory failure (101). Additionally, animals devoid of the actions of 
glucocorticoids suffer perinatally from abnormal pulmonary development due to 
hyper-proliferation and can be rescued by (prenatal) glucocorticoid treatment, a 
treatment that is obviously ineffective in GR null mice (102, 103).
In prematurely born infants, who frequently display underdeveloped lungs 
at birth, glucocorticoid treatment can enhance lung maturation (104, 105) by 
stimulating differentiation of epithelial cells (106). Exogenous glucocorticoid 
administration during normal development however leads to hypo-proliferation, 
as well as pulmonary epithelial maturation (107). It appears that glucocorticoid 
exposure enhances maturation/differentiation at the expense of growth/
proliferation, as is reviewed by Bolt (108). These effects can be either beneficial 
or detrimental depending on the developmental context.
8.1 Synthetic glucocorticoid treatment for prematurity associated respiratory 
distress syndrome
The initial, and accidental, discovery that antenatal glucocorticoid treatment was 
associated with accelerated lung maturation (109) led to a first controlled study 
showing that this treatment prevented respiratory distress syndrome in prematurely 
born infants (110). Since this important publication numerous reports of randomised 
controlled trials have been published on this topic (111). Several major health 
organisations started to recommend the use of antenatal glucocorticoids to reduce 
the incidence of respiratory distress syndrome (112-114).
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Also the postnatal administration of glucocorticoids to attenuate pulmonary 
inflammation contributing to the pathogenesis of bronchopulmonary dysplasia 
became common practice (115). By the end of the 1990’s glucocorticoid use 
peaked at around 25% (postnatal) and 60-75 % (antenatal) of all preterm infants 
(116, 117). However, besides acute beneficial effects leading to reduced mortality 
and bronchopulmonary dysplasia, there was growing evidence that repeated 
courses of antenatal (118) and also early postnatal glucocorticoid treatment (119) 
led to adverse neurodevelopmental effects. Its image of ‘magic bullet’ changed 
into ‘misguided rocket’ (120)(see table 1).
Although long-term follow up studies are scarce (because treated subjects are 
still relatively young), there are now several reports on the ‘long-lasting’ outcome 
of neonatal glucocorticoid treatment showing alterations in cardiovascular, 
endocrine, immune, motor and cognitive functioning (121-124). Meta-analyses 
on the lasting effects of this treatment are unfortunately not yet available.
8.2 impact of neonatal glucocorticoid treatment: rodent studies
To elucidate the neurobiological mechanism underlying the neurodevelopmental 
side effects reported in human preterm infants, the consequences of neonatal 
glucocorticoid treatment have been investigated using animal models. The use 
of rats is especially interesting since rodent pups are born prematurely by nature. 
The growth spurt of the brain during early postnatal development in rat pups 
shows similarities with that of human babies during the last trimester of gestation, 
see Box 1 (137). Since neonatal glucocorticoid treatment is usually administered 
between 26 and 33 weeks postmenstrual age (last trimester) in the neonatal 
nursery, the neonate rat pup can be used to study the neurodevelopmental 
impact of glucocorticoid treatment in the premature infant. 
Over the last decade many studies were published on the impact of neonatal 
dexamethasone treatment in rats. Among the numerous findings were reports on 
altered social behaviour in adolescence and adulthood (142), impaired spatial 
learning (144) and hippocampal synaptic plasticity (144, 145), altered endocrine 
Table1.Adverse side effects of glucocorticoid treatment in preterm infants.
Effect Reference
Growth Reduced somatic growth (125-129) 
Reduced head circumference (129) 
Reduced gray matter growth (130) 
Motor Impaired motor performance (131)
Endocrine Suppressed HPA activity (123, 132-134)
Metabolic Hyperglycaemia (119, 126, 127, 129, 135, 136) 
Immune Altered Th1-Th2 balance (123) 
Gastrointestinal Perforation (119, 126) 
Cardiovascular Hypertension (119, 126, 129, 135, 136) 
Cognition IQ (124, 129) 
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responsiveness to stress (141, 146, 147) and a significant shortening of the lifespan 
(143, 148, 149). This reduction in lifespan has been associated with heart and 
kidney failure (143, 149-152). Additionally, immune function has been reported to 
be affected by neonatal glucocorticoid exposure (153, 154). For an overview of 
findings in rodents, see table 2.
à In chapters 3, 4 and 5 of this thesis the acute and long-lasting impact of 
neonatal dexamethasone treatment in rats will be described. Additionally, two 
intervention strategies to overcome the frequently reported adverse effects will 
be introduced.
9. SCoPe of the theSiS
It is well documented that early-life experiences have an impact on development 
and aging. The aim of the research described in this thesis is to explore the short- 
and long-term consequences of two distinct types of early postnatal experiences: 
box 1. Relevance of treatment design for human clinical situation.
Extrapolating findings from animal studies to humans can only be done 
with great caution. Although there is much variation between species in the 
complexity of the mature brain and in the timing of neurodevelopmental 
processes in relation to the timing of birth, there are great similarities between 
rodents and humans in the sequence of events during brain development. 
The human brain shows a growth spurt during the last trimester of pregnancy 
that peaks around birth. In rodents, this growth spurt takes place during the 
first 10 postnatal days. This suggests that the developmental stage of a rodent 
brain on postnatal day 1 corresponds to a human brain at the start of the 
third trimester of pregnancy (137), i.e. a premature infants’ brain. Therefore, 
exposing rodents to glucocorticoids during the first postnatal days can be 
used as a model to study the neurodevelopmental impact of glucocorticoid 
treatment in the preterm infant.
Clinical protocols show much variation in timing of treatment initiation 
(due to timing of preterm birth), duration (1-42 days), as well as cumulative 
dose (0.2-14 mg/kg) of postnatal dexamethasone treatment. Dosage starts 
however frequently at 0.5 mg/kg (138, 139). With the current design, a 3-day 
course of dexamethasone treatment (0.5, 0.3, 0.1 mg/kg), we aimed to deliver 
a relevant treatment in terms of dosage and timing/duration. Although the 
cumulative dose seems relatively low, the finding that the rodent is relatively 
corticosteroid-sensitive compared to man (140), might explain why such severe 
developmental alterations have been reported in rats using a similar dosage 
regimen (141-144).
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1) very subtle variations in maternal environment, and 2) exposure to synthetic 
glucocorticoids. Since the outcome of neonatal glucocorticoid exposure has been 
reported to be detrimental, we additionally investigated the possibility to reverse 
these frequently reported adverse effects of glucocorticoid exposure by both 
pharmacological and behavioural intervention.
Table2.Effects of neonatal glucocorticoid treatment in rodents.
Effect Drug Time(days) Reference
Development
Body weight ↓ D 1-3 / 1-5 / 3-6 / 4 (142, 145, 146, 155, 156) 
Brain weight ↓ D 4 / 3-6 / 7 (147, 155-157) 
Cell proliferation ↓ HC 1-4 / 1-7 (158-160)
Adrenal Weight ↓ D 1-5 (146)
Eye opening ↑ D 3-6 (147, 156) 
Socialbehaviour
Social play ↓ C,D 1-4 (161)
↑ D 1-3 (142) 
Submission ↑ C 3-5 (162)
↓ D 1-3 (142) 
Sexual performance = C 1-2 (161)
↑ D 1-3 (142) 
↓ C 1-3 (163)
LearningandMemory
Water maze ↓ D 4 / 7 /1-3 (144, 155, 157, 164) 
Hippocampal 
synaptic plasticity
↓ D 1-3 (144, 145, 165) 
Passive avoidance = D 1-3 (145, 156)
Anxiety
Elevated plus maze = D 1-3 (142) 
Closed arms ↑ D 3-6 (156) 
AdultHPAaxis
Basal CORT = D 1-3 /1-5 (141, 146) 
Stress-induced CORT Novelty:↓ D 1-3 (141)
Conditioned fear: = D 1-3 (141) 
LPS challenge: ↓ D 1-3 (153) 
Crowding: ↑ D 3-6 (156) 
Restraint: ↓ D 1-5 (146) 
ACTH-induced CORT = D 1-3 (141) 
Lifespan
Survival ↓ D 1-3 (143)
C: corticosterone, HC: hydrocortisone, D: dexamethasone
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1Within-litter differences in maternal careTo investigate the consequences of experiencing subtle differences in maternal 
environment we used an adjusted model of naturally occurring variations in 
maternal care allowing the study of individual within-litter differences in maternal 
licking and grooming in Wistar rats. Endocrine responsiveness to an acute novelty 
stressor was investigated in adolescence and adulthood.
Hypothesis: Maternal care is equally distributed across littermates, resulting in 
the development of a uniform stress phenotype within the litter.
neonatal synthetic glucocorticoid exposure
To investigate the impact of neonatal exposure to synthetic glucocorticoids, 
newborn Long Evans rats were injected with dexamethasone. We investigated 
the consequences of this treatment in early-life, adulthood, middle age and 
senescence using behavioural and molecular techniques. Additionally, we tested 
the rescuing potential of behavioural and pharmacological intervention strategies.
Hypotheses:
1. Neonatal dexamethasone treatment acutely affects brain development
2. Neonatal dexamethasone treatment results in long-lasting alterations in 
endocrine and behavioural reactivity
3. These effects can be prevented by 
I. blocking central GR activation prior to dexamethasone exposure
II. handling of the neonate during the first 3 weeks of life
10. outline of the theSiS
Chapter 2 describes an adjustment of the original maternal care model as 
described in section 4.1 which allows the study of individual within-litter differences 
in maternal care. We report that besides differences in maternal care between 
litters, differences within the litter exist. Furthermore, these subtle differences 
in early maternal environment have long-lasting effects on the offspring’s stress 
phenotype, although in a gender-dependent manner. 
Chapter 3 describes the acute central effects of neonatal dexamethasone 
treatment. We report that hippocampal cell proliferation is acutely, but transiently 
reduced. The number of astrocytes is reduced one week post-treatment, an effect 
that can be fully prevented by central GR antagonist pre-treatment, which is 
proposed as a potential intervention strategy to prevent certain dexamethasone-
induced changes in the developing brain.
Chapter 4 describes the long-term effects of neonatal exposure to 
dexamethasone using several behavioural paradigms. We report that although 
neonatal dexamethasone treatment leads to developmental alterations, the 
frequently reported adverse effects on adult phenotype were not observed. It is 
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suggested that handling of the infant during the postnatal period mediates - and 
potentially overrides - the outcome of neonatal dexamethasone exposure.
In chapter5 this hypothesis is further investigated with the goal to examine 
the potential of neonatal handling to reverse adverse effects induced by neonatal 
dexamethasone treatment. We report that the effects of dexamethasone 
treatment interact with those of neonatal handling in shaping the adult endocrine 
and behavioural phenotype. 
In chapter6 all experimental findings are summarized and the relevance of 
their interactions in shaping the adult phenotype is discussed.
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CHAPTER 2
abStraCt
Previous studies have shown that naturally-occurring variation in maternal care 
during the first week of life predicts stress responsiveness, cognitive performance 
and emotionality in adult offspring. These findings are based on the assumption 
that maternal care is distributed equally across pups sharing a litter, such that each 
individual pup inevitably develops a similar phenotype later in life. Therefore, the 
current study tests the hypothesis that the distribution of maternal care directed 
towards individual pups within a litter is homogenous and therefore results in a 
uniform ‘stress phenotype’ in later-life among individuals within a given nest. 
Maternal care directed towards individual pups was observed for 5 h/day during 
the first week of life. Each pup was daily labeled and weighted, and examined at 
adolescence and adulthood for its endocrine responsiveness to a novelty stressor 
using an open field test. Blood samples were collected for analyses of basal and 
stress-induced corticosterone (CORT) levels. Our data show that: 1) distribution 
of maternal care is unequal within the litter, 2) males receive higher levels of 
maternal care than females, and 3) basal and stress-induced CORT levels were 
negatively correlated with the amount of maternal care received.
These findings reveal the impact of individual pup-oriented maternal care on 
the development of individual differences in stress responsiveness in later life and 
can help provide more insight into how very subtle early-life experiences within 
the family unit promote vulnerability or resilience throughout the lifespan.
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introDuCtion
Both human epidemiological data and animal studies have consistently shown that 
adverse early-life events are associated with alterations in stress responsiveness as 
well as impaired cognitive and emotional development (1-6) which may increase 
the susceptibility to a wide array of both mental and physiological disorders later 
in life (7-13). The mechanisms underlying these long-term effects of early-life 
environmental adversity are largely unknown, but are thought to involve alterations 
in mother-infant interaction. Therefore, amount and/or quality of maternal care 
are seen as mediating factors for the effects of early environmental adversity on 
the development of the offspring. 
Previous studies using a rodent model of naturally-occurring variation in 
maternal care indeed have shown a strong mediating effect of maternal care on 
the offspring’s stress responsiveness, emotional and cognitive development (4, 
14, 15). This model is based on individual differences among lactating rats in 
the frequency of maternal licking and grooming (LG) they provide to their pups 
and has shown that as adults, offspring raised by mothers that naturally display 
high levels of LG show decreased behavioural and endocrine responsiveness to 
acute stress compared with offspring of mothers that naturally show lower levels 
of LG (14, 15). Cross-fostering studies, in which the biological offspring of a high 
LG mother is cross-fostered to a low LG mother or vice versa, show that this 
procedure completely reverses the phenotype of the offspring (16), suggesting 
that maternal care transfers differences in stress responsiveness to the offspring 
in a non-genetic way. 
In addition to stress responsiveness, development of emotionality and 
cognitive performance in the adult offspring also depends on the amount and 
quality of maternal care received during early-life. Offspring of high LG mothers 
showed substantially reduced behavioural fearfulness in response to novelty 
compared with offspring of low LG mothers (15). Additionally, relative to offspring 
of low LG mothers, offspring of high LG mothers showed greater hippocampal 
dendritic (and spine) complexity, synaptogenesis and synaptic plasticity, which 
are associated with enhanced long-term potentiation (LTP), spatial learning and 
memory function (4, 17, 18).
Interestingly, due to methodological considerations, the association between 
maternal care during early-life and phenotype of the offspring in later-life is 
based solely on maternal phenotype (i.e. high vs. low LG dam) and not on what 
is experienced by individual pups within the nest. However, recent studies have 
suggested that pups from the same litter (assumed to have received the same 
amount of maternal LG) display substantial variation in behavioural phenotype later 
in life (19). Additionally, we previously reported that a 24 hour maternal deprivation 
results in the amplification of individual differences in stress responsiveness, rather 
than having a generalized outcome (20). What makes some individuals more 
vulnerable or resilient to the impairing effects of maternal deprivation is largely 
unknown; however we propose that this phenomenon might be mediated by 
differences in individual mother-infant interactions during early life. 
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This study, using the Wistar rat as a model, provides a detailed description of 
the amount and quality of maternal care received by each individual pup within 
the litter during the first week of life. Secondly, we investigated whether variation 
in maternal care within the litter correlates to phenotypic differences in stress 
responsiveness in the offspring later in life, thus complementing previous studies 
on variation in maternal care across litters. 
methoDS
animals
20 female Wistar rats (6 weeks, 200 g) and 10 male Wistar rats (6 weeks, 250 g) 
obtained from Harlan (Horst, the Netherlands) were used as breeders. After a 
habituation period of one week, two females were mated with one male in type 
4 polycarbonate cages (59x38x20cm) containing sawdust bedding and tissues. 
Food (RM3, Special Diet Services, Witham, Essex, UK) and water (8 ml 25% HCl 
/10 L tap water) were provided ad libitum. Animals were maintained on a 11-h 
light : 13-h dark cycle with light on at 08.30h, in a temperature (21+/- 2°C) and 
humidity (55 +/- 5%) controlled room. After breeding, pregnant females were 
individually housed in Plexiglass cages (55x30x44cm) that were customized to 
allow a clear view of all activity within the cage, despite the presence of sawdust 
bedding and tissues. Females were checked daily for presence of pups. If pups 
were present, the day of birth for that particular litter was defined as postnatal day 
0 (pnd 0). On pnd 1, litters were culled to 8 pups (4 males and 4 females). Cages 
were not cleaned until pnd 10 and after that once weekly. After weaning (pnd 21), 
offspring was housed in same-sex, same-litter groups in type 4 polycarbonate 
cages (59x38x20cm) until time of testing. 
Animal experiments were approved by the Local Committee for Animal 
Health, Ethics and Research of Leiden University and carried out in accordance 
with European Communities Council Directive (86/609/EEC). 
marking
In order to discriminate between individual pups within the litter, all pups were 
daily marked using a non toxic, odourless surgical marker (Codman, via Johnson 
& Johnson, Amersfoort, the Netherlands). The marking of the pups always took 
place between 08.30h and 10.30h in the morning. The procedure took about 
7 min per litter and consisted of removing all the pups from the mother and 
marking them gently one by one after recording their body weight. A schematic 
of the marking system is depicted in Fig 1. Upon completion of the marking 
procedure, all pups were immediately returned to their mother.
maternal behaviour
The maternal behaviour of each dam was observed and scored for five 60 
minutes periods per day during the first 7 days post partum using a procedure 
as described by Champagne and colleagues (21). Observations were performed 
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at three periods during the light phase (10:00, 13:00, 17:00) and two periods 
during the dark phase (07:00 and 20:00) of the cycle. Within each 60 min 
observation period the behaviour of each mother was scored every 3 minutes 
(20 observations per period, 100 observations per day, 700 observations for 
the first 7 days postpartum, see Fig 2). The following maternal behaviours were 
scored: a) frequency of licking and grooming (LG) of the pups (whole body LG 
and anogenital LG), b) frequency of arched back nursing/blanket nursing/passive 
nursing, c) mother away from nest/no maternal contact. The data were analyzed as 
the percentage of observations in which animals displayed one of the behaviours 
described above. Furthermore, for every maternal behaviour scored, it was noted 
to which pup(s) it was directed. The data for these individual observations were 
analyzed as the percentage of observations in which each pup received one of 
the maternal behaviours described above. The total percentage of LG received 
by individual pups was used to categorize them. For each litter a LG ‘family mean 
score’ was calculated and pups that displayed a LG score of at least 1 standard 
deviation above or below the family mean were selected as high and low LG 
pups, respectively. 
endocrine responsiveness to novelty stress
Selected high and low LG animals (n = 13) were tested for their responsiveness 
to acute novelty stress in adolescence (pnd 28) and adulthood (4,5 months). All 
animals were individually housed two days prior to testing (to reduce the effect 
of testing-order within the cage) and returned to their home cage directly after 
testing. The novelty stressor consisted of 10 min exposure to a black circular open 
Fig 1.Marking system used to discriminate between individual littermates. Black areas 
indicate body parts that were marked. M = male, F = female.
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field apparatus (diameter: 90 cm, height: 40 cm) in a dimly lit room (approximately 
30 lux floor level). Two animals were tested at the same time and in the same 
testing room using two separate open field setups. All testing took place between 
09.00 and 13.00h, and each test apparatus was cleaned thoroughly between 
animals using 70% ethanol.
blood sampling for endocrine measurement
Blood samples were obtained from the tail vein, by a small incision with a razorblade 
at three different time points: a) basal, one day before novelty exposure, b) 10 
min after onset of novelty stress, i.e. directly after termination of stressor, and c) 
30 min after onset of novelty stress, i.e. 20 min after termination of stressor. Blood 
was collected in small EDTA coated tubes (Microvette CB 300 K2E, Sarstedt, 
Numbrecht, Germany). Plasma was obtained by 15 min centrifugation at 13000 
rpm at 4°C and subsequently stored at -20°C until further analysis.
Plasma corticosterone determination
Plasma corticosterone (CORT) concentrations were measured in-duplo using 
radioimmunoassay (RIA) kits containing 125Iodine labelled CORT (MP Biomedicals, 
Asse-Regelem, Belgium). All samples were analysed in one session to exclude 
inter-assay variability.
Data analysis
Statistics were performed using SPSS for Windows (version 14.0; SPSS, Chicago, 
IL). One-way ANOVA was performed to determine significant differences between 
high and low LG animals, and between males and females. Graphs were plotted 
using Prism Graph Pad software.
reSultS
maternal licking and grooming
Distribution of maternal LG received by individual pups in each of the 7  litters 
(with appropriate litter composition) studied is depicted in figure 3 and shows 
Fig 2. Observation schedule. 
Adapted from: Champagne et 
al, 2008. P1: postnatal day 1, 
P2 : postnatal day 2, etc.
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Fig3.Distribution of maternal licking and grooming (LG) received by individual pups for 
each litter (1-7). Shown is percentage of observations (pnd 1-7) during which each individual 
pup received maternal LG. Male pups are indicated with ♂, female pups are indicated with 
♀. Selected high (n = 9) and low LG (n = 4) offspring within the litter (that displayed a LG 
percentage of at least 1 standard deviation above or below the family mean, respectively) 
are indicated with enlarged symbols.
Inset:Total percentage of LG displayed by each mother. 
that maternal LG is unequally distributed among pups within the litter and that 
particular pups clearly received higher levels of LG compared to their littermates. 
However there is variation in the amount of inequality between different litters. 
Mothers from litters 1, 2, 5, and 6 appear to distribute their care more equally 
compared to mothers from litters 3, 4, and 7, which show a more heterogeneous 
distribution of LG. 
gender preference
Additionally, we report that mothers show a preference for male over female 
offspring (F = 4.31; p < 0.05; n = 55; Fig 4). In the current study, 6 out of 7 
mothers spend significantly more time providing LG to male compared to female 
offspring.
endocrine responsiveness to novelty stress
Endocrine response to novelty stress, both at adolescence and adulthood was 
investigated in animals receiving either high or low levels of maternal LG during 
the first week of life (see Fig 5).
Both basal and stress-induced CORT levels in adolescent animals are associated 
with individual differences in maternal LG received during early-life. Thus, animals 
that received high levels of maternal LG within litter show significantly lower basal 
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(F = 5.09; p < 0.05) as well as stress-induced (10 min and 30 min after onset; F = 
4.93; p < 0.05; F = 5.56; p < 0.05 respectively) CORT levels when compared to 
animals that received low levels of maternal LG (Fig 6a).
Similar to what is observed in adolescence; the amount of maternal LG received 
in infancy also appears to predict CORT levels in adulthood. Animals that received 
high levels of maternal LG within litter show significantly lower stress-induced (10 
min and 30 min after onset; F = 61,99; p < 0.001; F = 14,05; p < 0.01 respectively) 
CORT levels when compared to animals that received low levels of maternal LG 
(Fig 6b). Due to technical issues, we are unable to show basal CORT levels of the 
animals in adulthood.
DiSCuSSion
The present study provides a detailed description of the naturally-occurring 
variation in maternal care received by individual pups within a litter over the first 
week of life. The hypothesis was tested that maternal care is equally distributed 
among individual pups within the litter and therefore results in a uniform stress 
phenotype across littermates. We report that: 1) maternal care was unequally 
distributed among individual littermates, leading to the occurrence of high and 
Fig 4. Percentage (mean ± SEM) of 
maternal licking and grooming (LG) 
received by male (light grey) and female 
(dark grey) offspring. In 6 out of 7 litters 
(86%), males (n = 31) received higher 
levels of maternal LG compared to 
females (n = 24). * = p < 0.05.
Fig 5. Percentage of licking and 
grooming (LG) received during the first 
7 days postpartum for selected high and 
low LG pups taken from distinct litters. 
Male pups are indicated with ♂, female 
pups are indicated with ♀. The selected 
high and low offspring significantly 
differ in the mean percentage of LG 
(p < 0.001). Horizontal lines indicate 
the group mean. Mean ± SEM high LG 
group (n = 9: 8 males, 1 female) = 0.83 
± 0.09 and mean ± SEM low LG group (n 
= 4: all female) = 0.11 ± 0.07.
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low LG offspring within a given litter; 2) LG was biased towards male offspring, 
leading to the fact that most high LG pups were of the male gender; 3) within-
litter differences in maternal LG were negatively correlated with basal and 
stress-induced plasma CORT levels in adolescence and adulthood, although in a 
gender-dependent manner.
individual differences in mother-infant interaction
The present study demonstrates that maternal care is not equally distributed 
across individual pups sharing a litter, meaning that the mother consistently spends 
more time caring for certain pups compared to others. However, in previous 
maternal care studies the behaviour of the mother was observed regardless of 
which pup the behaviour was directed at (4, 14, 15). In studies using this ‘whole 
litter’ paradigm it has been assumed that all pups sharing a litter receive the 
same amount of care, leading to the hypothesis that all individual littermates 
inevitably develop a similar phenotype in adulthood, although substantial 
variation in adult behavioural phenotype has been reported between littermates 
(19). A more recent study showed that individual differences in maternal LG were 
correlated with hippocampal synaptic plasticity and glucocorticoid receptor 
mRNA expression (22). These findings suggest that very subtle differences in non-
shared maternal LG (up to 10 fold smaller than previously reported differences in 
LG used to characterize maternal behaviour directed towards the whole litter (21)) 
appear to have comparable predictive value for later-life phenotypic outcome. 
Although further studies are warranted to understand these observations, the 
findings suggest that results from whole litter observations should be carefully 
interpreted.
Fig 6. Plasma corticosterone 
(CORT) levels of rats 
characterised as high or low 
LG within the litter, expressed 
as mean ± SEM. * p < 0.05; ** 
p < 0.01. Selected high (n = 
9) and low LG (n = 4) animals 
were tested for their endocrine 
responsiveness to acute novelty 
stress in (A) adolescence (age 
pnd 28) and (B) adulthood (age 
4.5 months). CORT levels were 
significantly more elevated in 
low LG compared to high LG 
offspring at 10 min (CORT10) 
and 30 min (CORT30) after onset 
of acute stress. Due to technical 
issues, we are unable to show 
basal CORT levels of the animals 
at adulthood; therefore in figure 
6B only stress-induced CORT 
levels are displayed.
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underestimation of individual differences in lg
We showed that the amount of maternal LG is associated with basal and stress-
induced CORT levels during adolescence and adulthood. This is reminiscent of 
previous studies using whole litter observations that have also shown the impact of 
naturally-occurring variation in maternal LG on endocrine response to acute stress 
(14, 23). The present study shows that even more subtle naturally-occurring within-
litter differences in mother-infant interaction are associated with variation in stress 
responsiveness. However, the differences we observed using this paradigm might 
be too subtle to reveal significant interactions between LG received in infancy and 
behavioural responses to novelty stress in adulthood (data not shown); an effect 
that has been reported using the whole litter paradigm (15, 16). 
Wistar dams display overall relatively low levels of maternal care compared to 
Long Evans dams that are frequently used for studies on the effects of maternal 
LG (21). Therefore the average levels of LG (i.e. 6%) displayed by Wistar dams in 
our study would be equivalent to levels displayed by low LG Long Evans dams. In 
our study, we observed that Wistar dams on average delivered 40 LG events over 
the 7 day observation period (700 observations). From the pup’s perspective, this 
might represent on average 5 LG events per individual pup. Such scores might 
appear too low to reliably categorize individual littermates as low or high LG 
offspring. We acknowledge that this represents a limitation of our experimental 
approach, which leads to an underestimation of the occurrence of pup-directed 
LG events. In the future, this issue can be resolved by increasing the amount 
of observations per day to achieve a more reliable representation of the actual 
differences in non-shared maternal LG. 
gender preference
It is noteworthy that for most of the litters studied, dams displayed a strong gender 
preference for male over female offspring. Such a preference of the mother for 
male pups has been shown before (24, 25) and is proposed to be regulated by 
testosterone, pheromones, and urinary odour (26, 27). As a consequence, this 
gender preference resulted in a bias in the distribution of males and females 
over the selected low (exclusively females) and high LG (almost exclusively 
males) groups. Since glucocorticoid levels and corticosteroid binding globulin 
levels in the blood are modulated by fluctuations in sex hormone levels (28) the 
association between early-life maternal LG and later-life HPA axis activity has to 
be carefully interpreted. However, we report an association between neonatal 
LG and glucocorticoid levels as early as pnd 28, when the regulatory role 
of sex hormones on HPA axis functioning is assumed to be low compared to 
that in adulthood (29). Gender differences in endocrine responsiveness on pnd 
28 have been shown in some (30, 31) but not all (32) studies. Because of the 
small sample size, we were unable to reveal a within-gender effect of maternal 
LG on glucocorticoid levels. Future studies using a higher number of animals 
and including ovariectomized female offspring could reveal the exact role of 
gender-dependent within-litter differences in maternal LG during early-life on the 
development of stress phenotype in later-life. 
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introduction of early handling
In order to score individual LG, a daily marking procedure was used to label 
and identify individual littermates. Such a procedure inevitably introduces a 
substantial amount of handling. This implies that besides studying the impact of 
subtle differences in maternal care within the litter, we have to take into account 
the well-known effects of handling (33-36). The daily handling/marking procedure 
potentially altered maternal care directed towards the offspring. However we 
believe that this bias is distributed to a similar extent to all litters. Furthermore, 
since we observed a substantial amount of variation between littermates in terms 
of stress responsiveness, we suggest that non-shared experiences in LG rather 
than the shared experience of handling/marking mediate the effects observed 
here. This scenario is not unprecedented and has been previously proposed by 
Macri and co-workers for variation in shared maternal care (37, 38).
early-life experiences within the family unit promote development of individ-
ual differences 
It is well-known that the quality of early family environment can serve as a 
major source of vulnerability in later life. After both human and animal studies 
have reported that early-life adversity is associated with alterations in stress 
responsiveness (39, 40) which may increase the risk for developing various 
disorders later in life (41, 42), it has now been assumed that this effect is at least 
partly mediated by parental influence on the development of the stress-regulating 
system (43-45). Subtle differences in parenting style could lead to dysregulation 
of HPA responsiveness, which subsequently could promote the development of 
illness (46-48). Human studies have reported that parenting style not only varies 
between families but also within the family. These non-shared factors, such as 
variation in individual parent-child interaction might have higher predictive power 
for the development of stress-related pathologies in later-life compared to the 
shared family environment (49, 50). 
The present study is to our knowledge the first to report the impact of within-
family differences in parenting in rodents on the development of individual 
differences in stress responsiveness in later life and can help to provide more 
insight into how very subtle early-life experiences within the family unit promote 
vulnerability or resilience throughout the lifespan.
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CHAPTER 3
abStraCt
Dexamethasone (DEX), a synthetic glucocorticoid, is widely used to wean 
preterm infants from the ventilator. Despite the important short-term benefit 
on lung function, there is growing concern about the long-term outcome of 
this treatment, since follow-up studies of preterm infants have shown pervasive 
adverse neurodevelopmental effects.
Since the mechanism underlying these neurodevelopmental impairments is 
largely unknown, the aim of the present study was (i) to investigate the acute 
effects of neonatal DEX treatment on the developing brain; and (ii) to block the 
effects of DEX in the brain by central administration of the glucocorticoid receptor 
(GR) antagonist mifepristone. 
Long Evans rat pups were injected subcutaneously with tapering doses of DEX 
or saline (SAL) on postnatal days (pnd) 1, 2 and 3. Separate groups received 
intracerebroventricular injections with mifepristone prior to DEX treatment. 
On pnd 4 and 10 pups were sacrificed and brains collected for analysis of cell 
proliferation (Ki67) and gliosis (GFAP). 
We report that neonatal DEX treatment reduced hippocampal cell proliferation 
on pnd 4 and caused a significant reduction in the number and density of astrocytes 
within various brain areas on pnd 10. These effects could be partially prevented 
by GR antagonist pre-treatment. These findings represent a proof of principle for 
the use of central GR antagonist pre-treatment as a potential intervention strategy 
to block postnatal DEX-induced alterations in brain development and function.
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introDuCtion
Preterm birth is the leading cause of perinatal morbidity and mortality in developed 
countries (1). Although the prevalence of preterm birth has increased over time, 
survival rates are going up significantly because of technological advances (2). 
However, preterm infants are still at increased risk for neurodevelopmental 
impairments and other complications compared to their term counterparts. With 
most organs being immature in the preterm, lung development especially suffers 
from prematurity and is frequently associated with morbidity such as respiratory 
distress syndrome (RDS) and bronchopulmonary dysplasia (BPD). Glucocorticoids 
(GC) are the drug of choice to accelerate lung maturation and wean infants 
from the ventilator. Several studies have indeed shown beneficial effects of GC 
treatment (3) on acceleration of lung maturation and a decreased incidence and 
severity of BPD. However others fail to do so or show only modest effects (4).
Moreover, follow-up studies of prematurely born infants treated with GC have 
shown pervasive adverse neurodevelopmental effects (5, 6). Randomized placebo-
controlled trials have shown that GC treatment leads to an increased incidence of 
cerebral palsy resulting in a higher level of neurodevelopmental impairment (5), 
poor motor skills and lower IQ scores compared to control preterm infants (7). 
Imaging studies have further revealed a significant reduction in total brain and 
cerebellar volume at term age in GC-treated premature infants when compared 
to non-treated preterm infants and control term infants (8, 9). 
These alterations in cerebral volume might structurally underlie the cognitive 
and motor impairments reported in GC-treated infants. Therefore, there have 
been growing concerns as to whether the short-term benefits of GC treatment 
outweigh the adverse side effects leading to neurodevelopmental impairment 
(10). Supporting the evidence from human studies, data from rodent studies have 
now demonstrated that neonatal GC treatment results in long-lasting alterations 
in cognitive performance and hippocampal function (11-14), social behaviour 
(15), stress responsiveness (16, 17) and eventually may even lead to a significant 
shortening of the lifespan (14, 18). 
Here, we aim to investigate the acute impact of neonatal GC treatment on the 
developing brain in rats. We describe its effects on markers for glial activation and 
cell proliferation at two different time points after administration, 24 hours and 7 
days post-treatment respectively. Additionally we propose a potential intervention 
strategy to block the acute effects of GC treatment on the developing brain.
methoDS
animals
Adult female and male Long Evans rats from our breeding population were 
used as breeders. Two females were mated with one male for 10 days in type 4 
polycarbonate cages (59x38x20cm) containing sawdust bedding and tissues. Food 
(RM3, Special Diet Services, Witham, Essex, UK) and water (8 ml 25% HCl /10 L tap 
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water) were provided ad libitum. Animals were maintained on a 11-h light : 13-h 
dark cycle with lights on at 08.30h, in a temperature (21± 2°C) and humidity (55 ± 
5%) controlled room. After breeding, pregnant females were housed individually. 
Females were checked daily for presence of pups. If pups were present, the day 
of birth for that particular litter was defined as postnatal day 0 (pnd 0). On pnd 1, 
litters consisting of 8-12 pups with an appropriate gender distribution (40-60 % 
male) were selected. If a litter did not meet these criteria, the litter was excluded 
from the study; no culling was performed. Cages were not cleaned until time of 
sacrifice. Animal experiments were approved by the Local Committee for Animal 
Health, Ethics and Research of Leiden University and carried out in accordance 
with European Communities Council Directive (86/609/EEC). 
Drug treatment
Pups were randomly assigned to one of six treatment groups (see table 1) according 
to a within-litter design. Males and females were equally distributed over the 
treatment groups. Pups in the DEX groups were subcutaneously (SC) injected with 
dexamethasone-21-phosphate (Sigma Aldrich, Zwijndrecht, The Netherlands) on 
pnd 1 (0,5 µg/g body weight), pnd 2 (0,3 µg/g) and pnd 3 (0,1 µg/g). Pups in the 
SAL groups were injected with equivalent volumes of sterile and pyrogen free 
saline (SAL). Groups 3-6 received bilateral intracerebroventricular (ICV) injections 
with either vehicle (VEH: 0.4% Tween 80 (Sigma) in SAL) or the GR antagonist 
mifepristone (50 ng/µl VEH, Corcept Therapeutics, Menlo Park, USA) 30 minutes 
prior to DEX/SAL administration. Since mifepristone was administered bilaterally, 
the total dose per day was 100 ng dissolved in 2 µl VEH (1 µl per hemisphere). 
ICV injections were performed according to (19) reaching a success rate of > 90%. 
Custom made syringes and needles were used for both SC and ICV injections 
(Hamilton, Germany). All pups were daily marked using a non-toxic, odourless 
marker in order to distinguish the littermates assigned to different treatment 
groups. Daily marking was essential since marks did not last long due to maternal 
licking and grooming of the pups.
Table 1. Description of experimental groups. 
Group SC ICV N
1 SAL - 11
2 DEX - 10
3 SAL VEH 11
4 DEX VEH 11
5 SAL MIF 12
6 DEX MIF 13
SC: subcutaneous, ICV: intracerebroventricular, SAL: saline, DEX: dexamethasone, VEH: vehicle, 
MIF: mifepristone.
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Procedure
Pnd 1-3: The daily procedure consisted of removing all pups from the nest 
followed by transfer to an adjacent room, where the cage was placed on a heating 
pad. If applicable, first the VEH/mifepristone ICV injection was given. Then body 
weights (BW) were recorded, followed by marking of the pups and administration 
of the SC injection. After the procedure (which took ~ 35 minutes per litter) all 
pups were immediately returned to the home cage.
Pnd 4-10: The daily procedure consisted of removing all pups from the nest 
followed by transfer to an adjacent room. BWs were recorded, followed by 
marking of the pups. After the procedure (which took ~ 8 minutes per litter) all 
pups were immediately returned to the home cage. Besides these manipulations 
(between 9.00 and 13.00h) litters were left undisturbed.
tissue preparation
To determine effects of neonatal DEX treatment on glial activity and cell 
proliferation, pups were sacrificed on pnd 4 or 10 (24h and 7 days post-
treatment respectively). On the day of sacrifice animals were anesthetized by 
an intraperitoneal injection with pentobarbital sodium salt (Nembutal, A.U.V., 
Cuijk, The Netherlands; 1 ml/kg BW) and perfused transcardially with 0.9% saline 
followed by 4% paraformaldehyde (PFA) in phosphate buffer (PB, 0.1M, pH 7.4). 
Brains were post-fixed overnight in the skull at 4°C. The next day they were 
carefully removed from the skull, washed and cryoprotected by equilibration in 
a buffered 30% sucrose solution. Afterwards brains were snap frozen in ice-cold 
isopentane and stored at -80°C until further processing.
Brains were sectioned coronally (30 μm) using a cryostat and collected and 
stored in an antifreeze solution (30% ethylene glycol, 20% glycerol, 0.02 M 
Na2HPO4, 6.6 mM NaH2PO4) at -20°C until further processing.
immunohistochemistry
Free-floating immunohistochemistry for Glial Fibrillary Acidic Protein (GFAP, 
polyclonal rabbit anti-GFAP, DAKO, 1:1000) was used to determine glial activity 
in the corpus callosum (CC) and dentate gyrus (DG). The primary antibody was 
amplified by biotinylated goat anti-rabbit (Santa Cruz, 1:1500), and avidin-
biotin enzyme complex (ABC-Kit, Elite Vectastain, Brunschwig Chemie, 1:200). 
Chromogen development was done with diaminobenzidine (DAB; 0.05% in 0.1M 
PBS, 0.06% H2O2), after which sections were carefully mounted on Superfrost Plus 
slides (Menzel-Gläser, Germany).
Immunohistochemistry for Ki-67 (polyclonal rabbit anti-Ki67; Novocastra, 
1:2000) was used to determine cell proliferation in the DG of the hippocampus 
as described before (Oomen et al., 2010). The primary antibody was amplified by 
biotinylated goat anti-rabbit (Vector Laboratories, 1:200), avidin-biotin enzyme 
complex (Elite Vectastain ABC kit, Brunschwig Chemie, 1:1000) and tyramide 
(1:500; 0.01% H2O2). Subsequent
 chromogen development was done with 
diaminobenzidine (20 mg/100 ml Tris buffer, 0.01% H2O2).
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Stereological quantification
For quantification of the number of GFAP positive cells and density of GFAP 
staining in CC and hilus of the DG, pictures from these brain areas were taken 
using a light microscope (Leica DM6000B). Photoshop (Adobe) was used to 
convert pictures to grayscale. Grayscale pictures were then analyzed with 
ImageJ (Version 1.41) for optical density of GFAP (correcting for corresponding 
background optical density) and for quantification of GFAP positive cells. Pictures 
showing substantial tissue damage were removed from the analysis. On average, 
3 sections per animal were used for CC quantification and 7 for DG quantification. 
Due to technical limitations it was not possible to discriminate between individual 
astrocytes in the pnd 4 sections. Therefore, for this time point only optical density 
measurements are shown. However, in the pnd 10 sections both the number of 
GFAP positive cells and optical density of GFAP were measured.
For quantification of Ki67 positive cells in the DG of the hippocampus, a 
stereological quantification procedure was performed in every 6th coronal section 
along the rostrocaudal axis, i.e. a total of 8 sections per animal. Total numbers 
of Ki67 positive cells were quantified by systematic random sampling performed 
with the Stereo Investigator system (MicroBrightField, Germany). As Optical 
Fractionator settings for sampling of pnd 10 sections a grid size of 125 x 125 µm 
and a counting frame of 30 x 30 µm were used, which resulted in an average count 
of 300 markers per animal. For analysis of pnd 4 sections a grid size of 75 x 75 
µm and a counting frame of 30 x 30 µm were used, which resulted in an average 
count of 200 markers per animal. DG surface area and volume was determined 
according to Cavalieri’s principle using the Stereo Investigator system.
Data analysis
All statistics were performed using SPSS 17.0 for Windows. Data are presented 
as mean ± SEM. Since the data did not show a significant effect of gender, 
data from males and females were pooled. Due to the limited capacity of our 
immunohistochemistry setup, analysis of the samples occurred over multiple 
experimental runs. To correct for inter-run variation we normalized all output 
against the mean of either the SAL or the VEH SAL samples in the relevant run. 
This way, for each experimental group, the difference with its relevant control 
group (either SAL or VEH SAL) is shown in percentages.
Differences between SAL and DEX were analyzed using T-test. Differences 
between the ICV treated groups were analyzed using two-way ANOVA with ICV 
treatment (VEH or mifepristone) and peripheral SC treatment (SAL or DEX) as 
between-subjects factors.
Body weight data were analyzed using Repeated Measures ANOVA with ‘pnd’ 
as within-subjects effect and ‘treatment’ as between-subjects effect.
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reSultS
body weight pnd 1-10
Neonatal DEX treatment significantly reduces BW gain during the early postnatal 
period (p < 0.001; fig. 1A). This reduction is not normalized by central mifepristone 
pre-treatment (fig. 1B).
Fig1.Body weight on pnd 1-10 of SAL and DEX treated animals without (A) or with (B) ICV 
treatment. DEX treatment significantly reduced body weight; this effect is not prevented by 
central mifepristone pre-treatment. ** p < .001
glial activity pnd 4
24h post treatment, DEX treatment did not affect optical density of GFAP 
expression in the CC (fig. 2A). Also in the ICV treated groups (fig. 2B) there are no 
significant differences between treatment groups. However, there is a tendency 
towards reduction of GFAP expression in DEX compared to SAL treated groups (p 
= 0.072). Interestingly, mifepristone pre-treatment appears to result in a slight (not 
statistically significant) increase in GFAP expression compared to VEH treatment (p 
= 0.096). No significant interaction between the SC and ICV treatment was found.
In the hilus of the hippocampus, no main effects of, or interaction between, SC 
and ICV treatment were observed (fig. 2C & D).
glial number and activity pnd 10
Although we did not observe an acute effect of DEX treatment (under basal, 
non-ICV conditions) on GFAP expression, 1 week post treatment DEX resulted in 
reductions in both density of GFAP expression (p = 0.023, data not shown) and 
number of GFAP positive cells in the CC (p = 0.003; fig. 3A). In the hilus, DEX 
treatment resulted in a trend towards reduced density (p = 0.068, data not shown) 
and significantly reduced the number of GFAP positive cells (p = 0.002; fig. 3B).
In the ICV treated groups, we observed a significant interaction between SC 
and ICV treatment in CC (p = 0.001) indicating that the observed reduction in the 
VEH DEX group is fully normalized by central mifepristone pre-treatment (fig. 3C). 
There is a trend towards an interaction between SC and ICV treatment in the hilus 
(p = 0.080, fig. 3D). Due to enhanced variation these interactions do not reach 
statistical significance in the optical density measurements (data not shown).
57
Fig2. Optical density of Glial Fibrillary Acidic Protein (GFAP) staining in Corpus Callosum 
(A and B) and hilus of the hippocampus (C and D) 24h post treatment, i.e. on pnd 4.
Fig3. Number of Glial Fibrillary Acidic Protein (GFAP) positive cells in the Corpus Callosum 
(A and C) and Hilus of the hippocampus (B and D) 7 days post treatment, i.e. on pnd 10 in 
SAL and DEX treated animals with (C and D) or without (A and B) ICV treatment. ** in A and 
B: DEX compared to SAL p < .01. ** in C: interaction between SC and ICV treatment p < .01.
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Cell proliferation pnd 4
DEX treatment significantly reduced the total number of proliferating cells in the 
DG of the hippocampus 24h post treatment (p = 0.007, fig. 4A) as well as the 
volume of the DG (p = 0.001, fig. 4B). Additionally, after correction for differences in 
volume (total number of Ki67+ cells/DG volume) we observed a trend (p = 0.10, fig. 
4C) towards a reduction in density of proliferating cells in the DG in the DEX group. 
In the ICV treated groups, DEX also significantly reduced the total number 
of proliferating cells in the DG of the hippocampus (p < 0.001, fig. 5A) and the 
volume of the DG (p = 0.001, fig. 5B). These reductions were not normalized 
by central mifepristone pre-treatment. Additionally, the density of proliferating 
cells was lower in all DEX treated groups (p = 0.016, fig. 5C). Although the 
interaction between ICV and SC treatment does not reach statistical significance 
there appears to be a tendency towards normalization by central mifepristone 
pre-treatment (fig. 5C).
Cell proliferation pnd 10
Seven days post treatment the reduction in total number of proliferating cells in 
the DG (as was observed 24h post treatment) is normalized in the DEX treated 
group towards control (SAL) levels (fig. 6A). Although the volume of the DG 
appears smaller in the DEX group (fig. 6B), and the density of proliferating cells 
higher (fig. 6C), these effects do not reach statistical significance. 
Also in the ICV treated groups, group differences that were observed 24h post 
treatment had normalized to control levels 1 week post treatment (fig. 7A, B & C).
Fig 4. Total number of Ki67 
positive cells in (A), volume of (B) 
and density of Ki67 positive cells 
(C) in the dentate gyrus of the 
hippocampus 24h post treatment, 
i.e. on pnd 4 in SAL and DEX 
treated animals. ** p < .01.
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Fig 5. Total number of Ki67 
positive cells in (A), volume of (B) 
and density of Ki67 positive cells 
(C) in the dentate gyrus of the 
hippocampus 24h post treatment, 
i.e. on pnd 4 in SAL and DEX 
treated animals with ICV pre-
treatment. ** DEX vs SAL p < .01; * 
DEX vs SAL p < .05.
Fig 6. Total number of Ki67 
positive cells in (A), volume of 
(B) and density of Ki67 positive 
cells (C) in the dentate gyrus of 
the hippocampus 7 days post 
treatment, i.e. on pnd 10 in SAL 
and DEX treated animals.
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DiSCuSSion
We report that neonatal DEX treatment had differential effects on GFAP expression 
24h and 7 days post treatment which could be (partially) prevented by central GR 
antagonist pre-treatment. Additionally, we report that neonatal DEX treatment 
acutely reduced DG cell proliferation and volume. These effects had normalized 
1 week post treatment, and were not affected by central GR antagonist pre-
treatment. These findings indicate that neonatal DEX treatment exerts acute and 
delayed as well as transient effects on the developing brain. Additionally, central 
anti-glucocorticoid pre-treatment may serve as a potential early intervention 
strategy, partially normalizing DEX-induced changes in the developing brain.
Differential effects of Dex on glial number and activity
The effect of DEX on GFAP expression was two-fold. First, the density of GFAP 
expression tended to be acutely reduced in the CC by DEX treatment in animals 
that received ICV injections, whereas DEX treatment did not acutely affect GFAP 
expression in non-ICV injected animals. Interestingly, the overall expression of 
GFAP was higher in the ICV injected groups as compared to the non-ICV injected 
groups (data not shown). A diffuse glial scar comprising reactive astrocytes is 
likely to form in response to 3 consecutive days of bilateral ICV injections (20, 21). 
This reactive gliosis tended to be responsive to DEX treatment. GCs have been 
reported before to regulate the number of GFAP positive astrocytes (22), the 
production of GFAP in astrocytes (23) and their differentiation (24). Additionally, 
Fig 7. Total number of Ki67 
positive cells in (A), volume of 
(B) and density of Ki67 positive 
cells (C) in the dentate gyrus of 
the hippocampus 7 days post 
treatment, i.e. on pnd 10 in SAL 
and DEX treated animals with ICV 
pre-treatment.
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steroid hormones have been shown to reduce reactive gliosis upon injury (25, 26). 
Since the glial scar has characteristics leading to inhibition of neuronal growth and 
regeneration (27), strategies to reduce these characteristics are used as treatment 
for brain injury (28). It has been reported that the gliosis-reducing effect of steroid 
hormones is associated with enhanced functional recovery after injury (25) and 
can therefore be considered a beneficial effect. 
Secondly, DEX treatment led to a significant reduction in the number of 
GFAP positive cells 7 days post treatment, both in animals with and without ICV 
treatment, which could be fully restored by central GR antagonist pre-treatment. 
Several studies have shown GC-induced reductions in GFAP expression both in 
terms of RNA or protein levels (23, 29, 30) and number of GFAP positive cells (22). 
Unfortunately we were not able to quantify cell numbers on pnd 4. Therefore we 
cannot rule out whether an acute DEX-induced reduction in glial cell number on 
day 4 was maintained until day 10, or whether this effect developed progressively 
during maturation of the brain. 
Whereas the gliosis-suppressing effect of DEX could have a beneficial 
effect, the reduction in cell number, present in all DEX treated animals, 
appears detrimental considering the supportive role of astrocytes in the brain 
especially during development (31). Huang and colleagues have reported a 
delayed maturation of astrocytes in CC after GC treatment, leading to a delayed 
tightening of the blood-brain barrier, which is suggested to have detrimental 
effects on CNS development (30). Additionally, GC exposure leads to delayed 
myelination of callosal fibers (32) and disturbances in long-term maintenance of 
myelin (33). These disturbances led to decreased conduction velocity potentially 
affecting information processing and cognitive performance (34). A reduction 
in astrocyte number during development is likely to mediate and/or contribute 
to this phenomenon and might underlie the frequently reported cognitive 
impairments after neonatal synthetic GC exposure (7, 12).
Dex temporarily suppresses hippocampal cell proliferation
We report that neonatal exposure to DEX acutely reduced DG cell proliferation, 
an effect that had normalized by pnd 10. The inhibitory effect of this GC on 
cell proliferation has been shown frequently, with some studies reporting a 
transient nature (35, 36) and others showing lasting effects of early GC or stress 
treatment (14, 37). The current findings are in line with previous findings from 
Tauber and colleagues showing that early exposure to DEX resulted in reduced 
cell proliferation in the newborn marmoset (38) which was restored to control 
levels at 2 year of age (39) indicating that the decreased proliferation rate in the 
newborn is transient.
From these, and the current findings it should not be concluded that perinatal 
GC treatment does not have long-lasting consequences and that its use can be 
considered safe. In rodents, the development of the hippocampus, especially the 
DG, happens largely during the early postnatal period (40-43). It is believed that 
the extensive plasticity that characterizes normal early development is necessary to 
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set the stage for proper adult functioning of the hippocampus, especially in terms 
of adult neurogenesis (43-45). This indicates that, even a temporary reduction in 
cell proliferation during a developmental stage that is normally characterized by 
high levels of proliferation, can exert long-lasting effects on the functioning of 
the hippocampus and other connected brain structures. These alterations could 
contribute to the frequently reported cognitive impairments in both animals and 
humans neonatally exposed to synthetic GCs (7, 12).
mifepristone and anti-progesterone activity in proliferation
One of the aims of this study was to investigate the possibility to prevent 
DEX-induced alterations in the developing brain by blocking the GR during 
DEX treatment. We report that the DEX-induced reduction in glial cell number 
observed on pnd 10 was fully normalized by central mifepristone pre-treatment. 
However, the substantial reduction in hippocampal cell proliferation, observed 
on pnd 4 was not prevented by mifepristone pre-treatment. Blocking the GC-
induced reduction in cell proliferation by mifepristone was expected to induce 
a proliferation-enhancing effect (14, 35, 38, 46) by promoting the protective 
function of the mineralocorticoid receptor (MR) (47). However, we did not observe 
this effect in the current study. 
The role of mifepristone in cell proliferation is however multidimensional. 
Besides blocking GR mediated effects and enhancing the role of MR (altogether 
enhancing proliferation), mifepristone also has intrinsic anti-proliferative effects 
(48). These effects are likely the result of its anti-progesterone activity (49). Since 
we did not observe anti-proliferative effects in the MIF SAL animals or investigate 
the role of progesterone activity in this experiment, we cannot conclude that 
progesterone receptor-mediated effects overruled those mediated via GR. 
Altogether, these findings suggest that in future studies, the possibility of blocking 
DEX-induced, GR-dependent effects should be investigated using a selective GR 
antagonist.
factors mediating function of gr ligands
There are additional factors that mediate the outcome of treatment with GR 
ligands. Under certain conditions mifepristone can exert effects similar to those 
induced by DEX (50) and act as a full GR agonist with respect to GR-mediated 
transrepression (51). Therefore, DEX-induced alterations depending on GR-
mediated transrepression are less prone to be prevented by mifepristone pre-
treatment.
Additionally, alterations in GR density determine the degree of (ant)agonistic 
activity of GR ligands in transrepression as well as the efficacy and potency 
of DEX (52). GR expression is known to be affected by neonatal GC exposure 
(53) and since these effects appear rather acute (within days) (54), differences 
in central GR density between the treatment groups may develop during the 3 
days of drug treatment. This variation might lead to group-specific alterations in 
the behaviour of the GR ligands (both agonist and antagonist) in terms of GR-
mediated transrepression.
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The finding that not all DEX-induced effects can be normalized using GR 
antagonist pre-treatment could also indicate that DEX exerts it function partially 
via another receptor or mechanism. For example, it has been suggested that 
DEX, despite a substantially higher affinity for GR, binds to MR as well (55-57). 
Since the blood-brain barrier is not fully developed in the neonate (58, 59) GCs 
may readily enter the brain (60, 61) at these life stages, where they may be able to 
target central MR in addition to GR, which are both expressed in the developing 
brain (61, 62). Certain DEX-induced alterations can be counteracted if there is 
sufficient MR activation (63).
The daily procedure of removing pups from the nest followed by handling 
and injections can be considered an experience disrupting the neonate’s stress 
hyporesponsive period, potentially leading to an inappropriate rise in endogenous 
GC levels (64, 65). This potential rise in corticosterone can be modulated by DEX 
(66) and mifepristone leading to a complex interplay between endogenous and 
exogenous (anti-) glucocorticoids, resulting in differential MR activation profiles in 
the different experimental groups.
ConCluDing remarkS
The aim of this study was to investigate the possibility to block DEX-induced changes 
on the developing brain using GR antagonist pre-treatment. To summarize, DEX 
treatment exerts acute, delayed as well as transient effects, which might contribute 
to the frequently reported long-term functional alterations reported following 
neonatal GC treatment. DEX-induced alterations can be partially prevented by 
central mifepristone pre-treatment. Therefore we suggest that these findings 
represent a proof of principle for the use of central GR antagonist pre-treatment 
as a potential intervention strategy to block DEX-induced alterations. It has to 
be noted however, that there is only partial normalization and that the route of 
mifepristone administration is relatively invasive, resulting in an additional impact 
(reactive gliosis) on the developing brain. Future studies are therefore needed 
to investigate alternative routes of administration (such as intrathecal therapy) to 
determine the clinical potential of this intervention strategy.
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CHAPTER 4
abStraCt
Exposure to increased glucocorticoid levels during development is known to have 
enduring consequences for brain function and behaviour throughout the lifespan. 
Perinatal dexamethasone administration, a common treatment for prematurity-
associated respiratory disorders and an example of such enhanced glucocorticoid 
exposure, has been shown to result in adverse side effects on the developing 
nervous system, leading to long-lasting alterations in endocrine and behavioural 
phenotype. 
In the current study we investigated the development of these alterations in 
male Long Evans rats. Rat pups were injected with dexamethasone or saline on 
postnatal days 1, 2 and 3. In experiment I, body weight, eye opening and fur 
development were measured during the postnatal period. In adulthood animals 
were tested for spatial learning, stress responsiveness, and contextual fear 
conditioning. 
Dexamethasone treatment resulted in growth retardation, an altered pattern 
of fur development and accelerated eye opening. However, we did not observe 
alterations in behavioural and endocrine phenotype in adulthood. Therefore, we 
investigated a potential interaction of the effects of dexamethasone treatment 
with those of neonatal handling, which was an inevitable component of our 
experimental design. Thus, we included in experiment II an untreated non-
handled control group. We report that these non-handled controls displayed 
reduced pre-pulse inhibition, motor performance and spatial learning in addition 
to a prolonged endocrine stress response, compared to handled animals (both 
saline and dexamethasone-treated). 
We conclude that neonatal handling resulted in profound phenotypic alterations 
throughout the lifespan, potentially protecting against dexamethasone-induced 
alterations.
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introDuCtion
Perinatal life represents a critical period during which an individual is highly 
susceptible to environmental influences. Adverse infant experiences have been 
shown to induce profound and long-lasting effects on adult brain function and 
behaviour (1, 2) that may increase vulnerability for disease development (3-5). These 
enduring effects of early experiences may be associated with a long-lasting impact 
on the functioning of the hypothalamic-pituitary-adrenal (HPA) axis (3, 4, 6-8). 
During normal early development, the brain appears to be protected from 
exposure to high levels of endogenous glucocorticoids, since the neonate displays 
a strongly reduced adrenocortical response to mild stressors, a phenomenon 
reported in rodents (9-11) and humans (6). This stress hypo-responsive period 
(SHRP) can only be disrupted when the organism is either exposed to extremely 
stressful (life threatening) events or when the caregiver is absent. In absence 
of the mother, corticosterone levels slowly increase and the neonate becomes 
responsive to mild stressors that would not result in HPA axis activation in her 
presence (11-13). Emergence from the SHRP, and subsequent exposure to elevated 
levels of glucocorticoids has profound programming effects on development and 
is important for shaping the adult phenotype (14-16). 
Exposure to exogenous glucocorticoids such as dexamethasone (DEX) can 
be considered a model for inappropriate glucocorticoid secretion. Interestingly, 
DEX administration is a common treatment for prematurity-associated respiratory 
disorders and supposedly a life saving treatment (17). However, as can be 
expected from neonatal glucocorticoid exposure, this treatment has profound 
side effects on the developing nervous system, leading to long-lasting alterations 
in brain function and behaviour both in humans (18) and animals (19). DEX-treated 
rodents show spatial learning impairments, altered endocrine responsiveness to 
acute stress and a significantly shortened lifespan (19-21).
In the current study we investigated the development of these alterations 
in cognitive performance and endocrine stress responsiveness after neonatal 
glucocorticoid treatment in a rodent model, which is described in experiment I. 
Interestingly we did not observe the previously reported detrimental effects of 
neonatal glucocorticoid exposure on adult phenotype. We suggest that neonatal 
handling, as an inevitable component of the experimental design, might serve as a 
factor protecting against the adverse effects of neonatal glucocorticoid exposure. 
This hypothesis was tested in experiment II, using untreated non-handled animals 
as an additional control group.
materialS anD methoDS
animals
Adult Long Evans rats from our breeding population were used as breeders. Two 
females were mated with one male for 10 days in type 4 polycarbonate cages 
(59x38x20cm) containing sawdust bedding and tissues. Food (RM3, Special Diet 
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Services, Witham, Essex, UK) and water (8  ml 25% HCl /10  L tap water) were 
provided ad libitum. Animals were maintained on a 11-h light : 13-h dark cycle with 
lights on at 08.30h, in a temperature (21± 2°C) and humidity (55 ± 5%) controlled 
room. After breeding, pregnant females were individually housed. Females were 
checked daily for presence of pups. If pups were present, the day of birth for that 
particular litter was defined as postnatal day 0 (pnd 0). On pnd 1, litters were 
culled to 8 pups (4 male and 4 female). Cages were cleaned at pnd 10 and after 
weaning once weekly. Animal experiments were approved by the Local Committee 
for Animal Health, Ethics and Research of Leiden University and carried out in 
accordance with European Communities Council Directive (86/609/EEC). 
experimental Design
Experiment I: To investigate the consequences of neonatal DEX treatment on 
development and adult phenotype we studied saline (SAL) and DEX treated 
offspring according to the schedule depicted in fig. 1.
Fig1.Timeline experiment I. PND: postnatal day.
Fig2.Timeline experiment II.
Experiment II: To investigate whether the effects of neonatal handling, induced by 
daily marking and weighing of the offspring, might have protected against DEX-
induced alterations, we extended the experiment with an untreated non-handled 
(UNT NH) control group. Animals from litters born at the same time in the same 
breeding colony as the SAL and DEX animals, were included for this purpose at the 
age of 6 months. These animals were raised and housed under similar conditions 
as the SAL H and DEX H animals, except for drug administration and daily handling 
during the postnatal period. They were not subjected to the two behavioural tests 
in experiment I, and thus kept undisturbed except for a weekly cage cleaning. SAL 
and DEX treated animals will, in experiment II, be referred to as SAL H and DEX H. 
Animals were tested according to the schedule depicted in fig. 2.
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Drug treatment
Male pups were randomly assigned to either the saline (SAL) or the dexamethasone 
(DEX) group using a within litter design. Pups in the DEX group were subcutaneously 
(SC) injected with dexamethasone-21-phosphate (Sigma Aldrich, Zwijndrecht, 
The Netherlands) on pnd 1 (0,5 µg/g body weight), pnd 2 (0,3 µg/g) and pnd 
3 (0,1 µg/g). Pups in the SAL group were injected with equivalent volumes of 
sterile and pyrogen free saline. In order to prevent bias for the dam to show 
enhanced attention for injected or non-injected offspring, all female littermates 
were injected with SAL on pnd 1, 2 and 3. All pups were daily marked using a non-
toxic, odourless marker in order to discriminate between littermates assigned to 
either the SAL or DEX group. 
Postnatal development
Postnatal development was monitored in SAL and DEX treated pups. Body 
weight, eye opening and fur development were recorded. For eye opening a 
scale from 0-9 was used indicating: 0 = closed, 3 = occasional/partial opening, 6 
= mostly open, 9 = fully open. For fur development a scale from 0-12 was used 
indicating: 0 = no fur, 3 = fine hairs, 6 = partial fur, 9 = mostly fur, 12 = full fur 
(adapted from (22)).
General procedure
Pnd 1-3: The daily procedure consisted of removing all pups from the nest followed 
by transfer to an adjacent room, where the holding cage was put on a heating pad. 
Body weights (BW), eye opening and status of fur development were recorded, 
followed by marking and injection of the pups. After the procedure (which took ~ 
10 minutes per litter) all pups were immediately returned to the home cage.
Pnd 4-21: The daily procedure consisted of removing all pups from the nest 
followed by transfer to an adjacent room, where the holding cage was put on 
a heating pad. Body weights, eye opening and status of fur development were 
recorded, followed by marking of the pups. After the procedure (which took ~ 6 
minutes per litter) all pups were immediately returned to the home cage. 
Besides these manipulations (which always took place between 9:00 and 
13:00h) litters were left undisturbed until weaning on pnd 22, except for a cage 
change on pnd 10.
adult Phenotype
Spatial learning: Circular hole board
Spatial learning was assessed between pnd 90 - 105. The Circular Hole Board 
consisted of a white circular platform (120 cm diameter) with 12 holes (10 cm 
diameter) equidistantly placed at 12 cm from the edge of the platform. An 
overhead camera allowed tracking of the behaviour of the animals during testing. 
Distal spatial cues were mounted on the walls of the testing room for orientation. 
The paradigm is based on the assumption that rodents are motivated to find a 
way to escape when being exposed to a light and unprotected place like the 
hole board. The animals were trained to locate the position of the exit hole that 
75
leads via an escape tunnel to the home cage. All other holes were closed with 
a lid placed 1 cm below the surface of the platform. This prevented the animal 
from seeing whether a hole is open or closed until it is in close proximity to the 
hole. The exit hole was always in the same spatial location; however, the platform 
was turned between trials to eliminate odour cues. All trials started by putting 
the animal in a start tube (diameter: 20 cm, height: 30 cm) that was positioned in 
the centre of the platform and removed to start the trial. If an animal did not find 
the exit hole within 120 seconds, it was gently guided there by the investigator. 
The platform was cleaned in between sessions using a 10% ethanol solution to 
eliminate odour cues. All testing took place between 10.00 and 13.00h.
General procedure
In the week prior to hole board training, animals were exposed to 3 sessions of 
tunnel training to practice manoeuvring through the escape tunnel that will lead 
to the home cage during hole board training. 
On day 1, to familiarize the animals with the platform and the existence of 
an exit hole plus escape tunnel, animals were allowed to explore the platform 
during a 3 min free exploration trial (FET) with all holes closed. At the end of the 
3 min period, the exit hole was opened and the animal was given another 2 min 
to locate the exit hole. 
On day 2, animals were trained during 6 trials with a 15 min inter-trial interval 
to find the location of the exit hole. 
On day 8, animals were retested to evaluate spatial memory during 2 memory 
trials, using similar conditions as during training on day 2.
Total distance moved, amount of time spend in different areas/quadrants 
of the platform, number of holes visited, latency to find exit hole and latency 
to escape were analyzed using EthoVision XT (Noldus Information Technology, 
Wageningen, The Netherlands).
Contextual fear Conditioning
Contextual fear memory was assessed between pnd 120-130. The shock box 
(40x40x50 cm) was made of black Plexiglas walls and a stainless steel rod floor, 
connected to a shock generator. The box was cleaned with a 10% ethanol solution 
between all sessions to eliminate odour cues. An overhead video camera recorded 
behaviour of the animals throughout all sessions. All testing took place between 
10.00 and 13.00h.
General procedure 
On day 1 the animal was transferred from the housing room to the adjacent test 
room where it was placed in the shock box. After 2 min it was exposed to a foot 
shock of 0.6 mA (duration 2 sec). After the shock the animal remained in the shock 
box for 2 minutes and was then removed from the box and transferred back to the 
home cage. 24 hours later (day 2), the animal was re-exposed to the shock box for 
4 min, however without receiving a foot shock. 
Behaviour of the animal was recorded both during training and re-exposure 
and analyzed by an observer unaware of treatment conditions using The Observer 
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9.0 XT (Noldus Information Technology, Wageningen, The Netherlands). The 
following behaviours were scored (1) freezing (lack of all body movement except 
those necessary for breathing), (2) scanning (lack of movements, except lateral 
head movements and movements necessary for breathing), (3) rearing, (4) walking, 
and (5) sitting. Behaviour was analyzed during 3 distinct time periods: (1) 2 min 
before shock, (2) 2 min after shock, (3) 4 min re-exposure.
endocrine response to restraint stress
On pnd 150, endocrine HPA axis activation in response to an acute restraint stressor 
was tested. One day prior to restraint stress a basal blood sample was taken from 
the tail vein. The next day animals were exposed to 10 min of restraint stress by 
placing them in a custom made restrainer, which restricts body movements. Blood 
samples were taken at 2, 5, 10 30, 60, and 120 min. 
hormone analysis
Blood samples were collected in EDTA coated tubes (Microvette CB 300 K2E, 
Sarstedt, Germany). Samples were kept on ice and centrifuged for 15 min at 13000 
rpm at 4°C. Plasma was transferred to Eppendorf tubes and stored at -20°C until 
further analysis. Plasma adrenocorticotropic hormone (ACTH) and corticosterone 
(CORT) concentration were measured using a commercially available radio 
immuno assay (RIA) kit containing 125Iodine labelled ACTH or CORT, respectively 
(MP Biomedicals Inc., USA). All samples were processed in the same assay to 
exclude inter-assay variability.
Prepulse inhibition
Prepulse inhibition was measured at 7 months of age. Three/four littermates 
were transferred together to the test room where they were allowed to habituate 
for 45 min. After habituation they were placed in a startle recording apparatus 
(SR-LAB, San Diego Instruments, CA, USA), containing a transparent Plexiglas 
tube (diameter 8.7 cm, length 20.5 cm) mounted on a Plexiglas base. Sounds 
were presented by a speaker and movement of the animals was detected by a 
piezoelectric accelerometer mounted below the Plexiglas tube and recorded by 
a computer. Testing started with a five min habituation session with background 
white noise of 70 dB[A]. Animals were first presented with six pulse alone trials 
(117 dB[A]) followed by 39 trials comprising different trial types according to a 
pseudo-randomized schedule with an inter-trial interval of 10-20 sec. Trial types: 
4x background white noise alone, 5x prepulse alone (16 dB[A] above background 
= 86 dB[A]), 20x prepulse–pulse trials using prepulse intensities of 2, 4, 8, 16 
dB[A] above background noise (i.e. 72, 74, 78 and 86 dB[A]), and 10x pulse alone 
(117 dB[A]). Finally, animals were again exposed to five pulse alone trials. The 
duration of the prepulses was 20 ms, duration of the pulses was 40 ms. Prepulse 
to pulse interval was 100 ms. Startle activity was measured during 100 ms after 
onset of the pulse. The percentage PPI at the different prepulse intensities was 
calculated as [100-(100 x startle amplitude at prepulse trial)/ (startle amplitude at 
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startle pulse-alone trial)]. Speakers were calibrated every day. Experiments were 
performed between 9:00 and 13:00 to minimize circadian influence. 
motor performance
At 14 months of age all animals were tested in a motor performance test battery. 
Testing took place over 4 different test sessions on 2 consecutive days. 
Balance beam
The animal was placed on a square metal bridge (2 cm x 2 cm x 40 cm, elevated 
about 40 cm above the surface) wrapped in anti slip tape. The duration the animal 
stayed on the bridge was measured to a maximum of 120 s. A pillow was placed 
beneath the bridge to cushion the animal’s fall. Rats were tested twice a day on 
2 consecutive days.
Rota-rod
Motor coordination was measured using the rota-rod test. In this test, the animal 
was placed on the rota-rod treadmill, attached to a rotating motor. The treadmill 
consisted of four rotating drums (7 cm diameter, 24 cm above ground), divided 
by flanges. The first day, rats were familiarized with the apparatus. During 2 
habituation trials - one in the morning and one in the afternoon - which lasted 2 
min each, the animals were placed on the constantly revolving drum (speed 13 
rpm). If a rat fell off during habituation it was placed back immediately. Number 
of falls during the 2 min habituation periods was recorded. On the second testing 
day, the animals were tested on an accelerating rota-rod (up to 40 rpm in max 3 
min). Latency to fall from the rotating rod was recorded. 
Foot-fault test
This test measures placement dysfunction of the paws and motor coordination. 
The animals were placed on an elevated wire grid (dimension 100 x 100 cm, grid 
size 4 x 9 cm) and allowed to explore the grid for 2 minutes. Number of steps and 
number of errors (foot-faults were counted when a paw fell completely through 
the bars of the grid) were recorded.
Water maze performance
At 22 months of age spatial learning in a water maze was tested. Animals were 
placed, without prior training, in a pool (150 cm diameter) filled with 30 cm of 
water (21°C) made opaque by adding 3 spoons of latex paint. A platform (10 cm 
diameter) was hidden 1 cm below the surface of the water and was positioned in 
the NE quadrant.
Animals were given 2 daily trials (inter-trial interval 15 min) to find the platform 
on day 1, 2 and 3. On day 4, one more training trial was given, followed by a 
probe trial without platform present. On day 5, animals were given 3 reversal trials 
with the platform located in the position opposite (SW) from where it was during 
training. Trials always started in one of the 3 quadrants where the platform was 
not located in a pseudo-randomized fashion, following the same order of start 
position for every animal. If an animal did not reach the platform within 2 minutes, 
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it was gently guided there by the investigator. Animals were allowed to stay on 
the platform for 15 sec after finding it or being guided there. 
Swim patterns were tracked by an overhead camera and later analysed using 
EthoVision XT (Noldus Information Technology, Wageningen, The Netherlands). 
Frequencies and time spent in target and other quadrants, or in close proximity 
to the platform (or the location where the platform used to be) were analyzed 
during training and reversal trials, as well as swim patterns during probe trials. 
After every swim trial, animals were dried with a towel and kept in a clean cage 
lined with clean dry tissues, placed on a heating pad. All trials took place between 
10.00 and 13.00h.
Survival
Survival of the animals was determined by recording the health span rather than 
the lifespan. If an animal died without showing signs of pathology, the age of 
natural death was recorded. However, if an animal did show signs of pathology 
(i.e. substantial weight loss, impaired locomotion, breathing problems) the animal 
was sacrificed and age of sacrifice was recorded. 
Data analysis
Data are presented as mean +/- SEM. All data were analysed using repeated 
measures ANOVA with time (age, trial, day or min) as within and drug treatment 
and handling as between subject factors, one-way ANOVA, or paired t-test with 
level of significance set at p < .05. Where appropriate main effects and interactions 
were further investigated using post-hoc analysis with appropriate correction for 
multiple testing. Corrections for violations of sphericity were conducted where 
needed. SAL H and DEX H animals were always initially included as separate 
groups in the analysis. If drug treatment did not significantly contribute to the 
outcome, data from SAL H and DEX H animals were pooled to investigate the 
impact of neonatal handling by comparing performance of these 2 groups to UNT 
NH animals.
reSultS exPeriment i
Postnatal development
Body weight gain is reduced in DEX treated animals during the postnatal 
period (fig. 3A) and remains lower throughout adult life (fig. 3B) (main effect of 
drug treatment F(1,18) = 26.01, p < .001). A significant time x drug treatment 
interaction was observed (F(36,648) = 5.62, p < .001). Post-hoc analysis per time 
point revealed a significant difference between SAL and DEX on all time points 
starting at pnd 2 (p < .001 until week 10, p < .01 until week 24, and p < .05 at 
week 26).
Neonatal DEX treatment results in accelerated eye opening (fig. 4A) and an 
altered pattern of postnatal fur development (fig. 4B). Besides a significant main 
effect of time (F(20,520) = 1382.18, p < .001) and drug treatment (F(1,26) = 168.12, 
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p < .001) a significant time x drug treatment interaction (F(20,520) = 56.81, p < 
.001) was observed for eye opening. Post-hoc analysis per time point revealed 
significant differences between SAL and DEX treated animals on pnd 10, 11, 12 
and 13 indicating that DEX treated animals open their eyes at an earlier age.
For fur development we observed, besides significant main effects of time 
(F(20,500) = 2059.70, p < .001) and drug treatment (F(1,25) = 27.70, p < .001), a 
significant time x drug treatment interaction (F(20,500) = 40.36, p < .001). Post-hoc 
analysis per time point revealed that DEX treated animals score significantly 
higher on pnd 6, 7 and 8, whereas SAL treated animals score significantly higher 
on pnd 11-20 (all < .01 and pnd 20 p = .044) leading to full fur development 4 
days earlier in SAL compared to DEX treated animals.
Spatial learning: Circular hole board
We analyzed behaviour during all 6 trials and performance during trial 1 and 2 
separately. For latency to first visit the exit hole (fig. 5A) and latency to escape 
Fig3.Body weight of SAL and DEX treated animals during the postnatal (A) and post-
weaning (B) period. DEX treated animals show significantly lower body weight compared to 
SAL treated animals at all time points starting on pnd 2. ** p < .01; * p < .05
Fig4.Timing of eye opening (A) and fur development (B) in SAL and DEX treated animals 
during the postnatal period. DEX treated animals show, compared to SAL treated animals, 
accelerated eye opening and a temporary advantage in fur development. However by pnd 
11 SAL treated animals catch up leading eventually to full fur development 4 days earlier 
compared to DEX treated animals. ** p < .01, * p < .05
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(fig. 5B), significant main effects of time were observed, (F(2.98,62.47) = 3.08, 
p = .034) and (F(3.62,76.09) = 6.60, p < .001) respectively. No effect of drug 
treatment was observed. For number of holes visited (before the first visit to exit 
hole, fig. 5C) performance tended to be different between SAL and DEX treated 
animals (F(1,21) = 3.28, p = .084). When trial 1 and 2 were analyzed separately, a 
significant main effect of drug treatment (F(1,21) = 4.64, p = .043) was observed 
indicating that DEX treated animals visit significantly fewer holes before going 
to the one that leads to the escape tunnel, compared to SAL treated animals. 
Additionally, when the percentage of animals visiting the correct quadrant of the 
platform during their first hole (any) visit was investigated, we observed that a 
slightly higher (although not statistically significant) percentage of DEX treated 
animals search for the exit hole in the correct quadrant compared to SAL treated 
animals in trial 1 (χ2 (1) 3.486, p = .062; fig. 5D). Behaviour during the memory trial 
was not different between SAL and DEX treated animals.
Fig5.Spatial learning on the Circular Hole Board. Latency to first visit the exit hole (A) and 
latency to leave the platform via exit hole (B) is not different between SAL and DEX treated 
animals. DEX treated animals visit fewer holes before finding the exit hole compared to 
SAL treated animals during the first 2 training trails (C). A higher percentage of DEX treated 
animals visits the correct quadrant of the hole board when visiting a hole for the first time 
compared to SAL treated animals, although this effect is not statistically significant (D). * 
p < .05.
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Contextual fear conditioning
Freezing, as well as other behaviours measured in the fear conditioning paradigm 
were not significantly affected by neonatal exposure to glucocorticoids (data not 
shown).
endocrine response to restraint stress
We did not observe DEX-induced changes in ACTH or CORT level under basal 
conditions or in response to acute restraint stress in adulthood (data not shown).
reSultS exPeriment ii
endocrine response to restraint stress
Since basal and restraint stress-induced ACTH and CORT levels were not different 
between SAL H and DEX H animals, data from these groups were pooled 
and analyzed as a handling (H) group. For ACTH a significant effect of time 
(F(2.76,63.46) = 62.59, p < .001) and a time x handling interaction (F(2.76,63.46) 
= 3.44, p = .025) were observed. The effect of handling did not reach statistical 
significance (F(1,23) = 4.06, p = .056). 
Post-hoc analysis per time point revealed a significantly lower ACTH level in H 
animals at t2 (p = .044), t5 (p = .002), t60 (p = .048) and t120 (p = .000), while peak 
level (t30) was not different (fig. 6A). Basal ACTH levels appeared to be higher H 
animals, although this effect was not statistically significant (p = .051).
For CORT level, a significant main effect of time (F(3.03,87.78) = 331.21, p < .001) 
and a time x handling interaction (F(3.03,87.78) = 10.32, p < .001) were observed. 
Post-hoc analysis per time point indicates that H animals have significantly higher 
CORT at t30 (p = .006) but lower CORT at t120 (p < .001) (fig. 6B).
Prepulse inhibition
Mean PPI is significantly different between UNT NH animals and animals from 
the two H groups (SAL H and DEX H) (F(2,23) = 22.01, p < .001) indicating that 
Fig6.Plasma ACTH (A) and CORT (B) levels before, during and after 10 min restraint stress 
(indicated with horizontal black bar). H animals displayed lower ACTH levels at t2, t5, t60 
and t120 compared to NH animals. H animals show higher CORT levels at t30 but lower 
CORT levels at t120. ** p < .01, * p < .05
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H animals show enhanced PPI compared to UNT NH animals. Post-hoc analysis 
revealed significant differences between UNT and SAL (p < .001) and between 
UNT and DEX (p < .001) (fig. 7).
Fig7.Prepulse Inhibition. H animals (SAL H 
and DEX H) show enhanced PPI compared 
to UNT NH animals. ** p < .01
motor performance
Balance beam
Performance (latency to fall) did not differ between treatment groups when 
analyzed per session. When performance was analyzed within groups to 
investigate improvement over test sessions, repeated measures ANOVA revealed 
no improvement in UNT NH animals (fig. 8A). Since SAL H and DEX H did not show 
differences in performance, data from these groups were pooled. A significant 
main effect of time was observed (F(1.67,35.07) = 4.35, p = .026) indicating that 
performance improved over the different test sessions in H animals (fig. 8B). 
Moreover a paired t-test showed that performance on day 2 was significantly 
higher compared to day 1 in H animals (t = -2.362 (21), p = .028), whereas there 
was no such effect in UNT NH animals.
Rota-rod
Overall one-way ANOVA revealed that performance during habituation session 1 
is comparable for all groups (fig. 9A). During habituation session 2 however, UNT 
NH animals fall significantly more compared to the two H groups (F(2,30) = 3.45, 
p = .045, fig. 9B). All groups fall less frequently during the 2nd compared to the 1st 
habituation session, however this finding indicates that improvement is stronger 
in H animals.
Performance on the accelerating rota-rod - on test day 2 - revealed that UNT 
NH appear to have a shorter latency to fall compared to H animals, although this 
effect was not statistically significant (F(2,30) = 3.23, p = .054; fig. 9C).
Foot-fault test
One-way ANOVA indicated that the total number of steps was somewhat lower 
(although not statistically significant) in DEX H compared to SAL H and UNT NH 
animals (F(2,29) = 2.97, p = .067, fig. 10). The error rate was not different between 
groups (26-27% in all groups).
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Fig8.Latency to fall from balance beam during 4 sessions over 2 test days. UNT NH (A) 
animals do not show improvement (increased latency to fall) in contrast to H animals (B) 
which improve significantly during the different sessions. * p < .05
Fig 9.Number of falls from the rota-rod 
during habituation session 1 (A) and 2 
(B) and latency to fall from accelerating 
rota-rod (C). H animals display significantly 
more improvement in habituation session 
2 compared to UNT NH animals. UNT NH 
animals have a shorter (ns) latency to fall 
from the accelerating rota-rod compared 
to H animals. * p < .05
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Water maze performance
Repeated measures ANOVA revealed a significant main effect of time (F(3,72) = 
14.69, p < .001) and handling (F(1,24) = 7.55, p = .011) indicating that UNT NH 
animals show higher latency to reach the platform compared to H animals during 
spatial learning (day 1-4). Performance during reversal learning on day 5 was not 
different between groups (fig. 11A). Additionally, on day 1 of spatial learning 65% 
of UNT NH animals did not reach the platform within 120 seconds and needed to 
be guided there, compared to only 25% of SAL H and 33% of DEX H animals (fig. 
11B). Chi-Square analysis revealed that H animals need significantly less guiding 
on day 1 compared to UNT NH (χ2 (1) 6.857, p = .009).
body Weight
Analysis of body weight of SAL H and DEX H animals shows a significant effect 
of time (F(15,240) = 118.89, p < .001) and a time x drug treatment interaction 
(F(15,240) = 2.08, p = .011). Post-hoc analysis per time point revealed that the 
weight of DEX-treated animals is significantly less up to week 44 (all p < .05). When 
age increases further, differences between SAL H and DEX H animals disappear. 
Fig10.Total number of steps and errors in foot 
fault test. DEX H animals tend to be overall 
less active compared to SAL H and UNT NH 
animals, however error rate is comparable 
between groups.
Fig 11. Spatial learning in the Morris Water Maze. Latency to reach the platform (A): 
performance per day (as average of 2 trials/day) on day 1-4 (spatial learning) and day 
5 (reversal learning). H animals reach the platform significantly faster compared to NH 
animals on days 1-4. Performance during reversal learning on day 5 is not different. On day 
1 a significantly higher percentage of UNT NH compared to H animals need to be guided 
to the platform (B). * p < .05 ** p < .01
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When UNT NH animals are included in the analysis, repeated measures ANOVA 
shows a main effect of time (F(2.96,71.04) = 199.62, p < .001), without effects of 
drug treatment or handling (fig. 12).
Survival
Although DEX H animals appear to die at a younger age and reach 50% survival 
several months before SAL H and UNT NH animals, Kaplan Meier analysis does 
not indicate significant differences in survival between treatment groups up to the 
age of 26 months (fig.13).
Fig12.Body weights of SAL H, DEX H 
and UNT NH animals from week 26 – 100. 
Up to 44 weeks of age, DEX H animals 
show lower body weight compared to 
SAL H. However with increasing age 
differences in body weight disappear. * 
p < .05 (SAL H vs DEX H)
Fig13.Survival curves of UNT NH, SAL 
H and DEX H animals up to 26 months 
of age. Although DEX H animals appear 
to have the steepest survival curve, 
differences between groups do not reach 
statistical significance.
DiSCuSSion
The goal of this study was to investigate the impact of neonatal glucocorticoid 
treatment on development, as well as on adult and aged phenotype in rats. We 
reported that neonatal DEX treatment resulted in developmental alterations in 
body weight, eye opening and fur development. However, we did not observe 
the frequently described alterations in cognitive performance and stress 
responsiveness in adulthood. Interestingly, the current experimental design 
consisted, besides manipulations necessary for injections on pnd 1, 2 and 3, 
of a substantial amount of neonatal handling during the full postnatal period 
(pnd 1-21) because of daily weighing and marking for discrimination between 
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individual pups receiving different treatments within the litter. Therefore, we 
included an untreated non-handled control group - originating from the same 
cohort of animals - in part II of the experiment to investigate the impact of 
neonatal handling. Indeed we observed on several parameters (endocrine and 
behavioural) throughout the lifespan a profound effect of neonatal handling 
without substantial differences between SAL and DEX-treated animals. Therefore 
we suggested that the impact of neonatal handling may have interacted with and 
potentially protected against DEX-induced alterations.
neonatal glucocorticoid treatment: impact on development
The impact of neonatal glucocorticoid treatment on development has been 
frequently reported. Reduced growth, similar to the findings in the current 
study, has been demonstrated in human as well as animal studies (21, 23-26). 
Although we have not investigated the underlying mechanism, others have 
suggested that DEX prevents adequate growth by inducing protein catabolism 
during a developmental period normally characterized by low levels of circulating 
glucocorticoids, thus promoting an anabolic state (27). 
Additionally, Vazquez and colleagues suggested that the reduction in weight 
gain could be attributed to an inability of DEX pups to get milk from the mother 
due to poor suckling. Their findings also demonstrate that DEX treated rat pups 
have lower post-weaning food intake (28). Human studies however demonstrate 
that the reduced growth seen in infants receiving DEX treatment cannot be 
explained by decreased energy intake or increased expenditure, but may be 
due to differences in the composition of newly accreted tissue due to a shift in 
intermediate metabolism (29).
Besides reduced growth, other developmental alterations are associated 
with neonatal glucocorticoid treatment. We report changes in eye opening 
and fur development which have also been reported in previous literature 
(23). The mechanism underlying these findings is still poorly understood. 
Neurodevelopmental delay following DEX treatment is frequently explained as 
being the result of inhibition of normal myelination processes (23). Peripherally, 
the impact of DEX has been often studied in the context of lung development. 
During normal development, glucocorticoids regulate the degree of proliferation 
and differentiation. Glucocorticoid-insufficient (CRH knock-out) animals, suffering 
perinatally from abnormal pulmonary development due to hyper-proliferation, 
can be rescued by exogenous glucocorticoid treatment (30). In premature 
infants, glucocorticoid treatment can enhance lung maturation (31) by stimulating 
differentiation of epithelial cells (32). Exogenous glucocorticoid administration 
during normal development leads to hypo-proliferation, as well as to pulmonary 
epithelial maturation (33). 
All together, it appears that glucocorticoid exposure enhances maturation and 
differentiation at the expense of growth and proliferation, as is reviewed by Bolt 
(34), which is either beneficial or detrimental depending on the developmental 
context. Similar alterations in other tissues might underlie the developmental 
alterations observed in the current study. 
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long-lasting effects on adult phenotype
Many studies have demonstrated long-lasting effects of neonatal DEX treatment 
on adult phenotype in terms of cognitive performance, hippocampal function, 
emotionality and stress responsiveness (19, 22, 28). Interestingly we did not 
observe such effects in the current study. Does this mean that DEX-induced 
alterations are not as adverse as suggested previously? There might be other 
factors playing a role in determining phenotypic outcome. Many of the previously 
mentioned studies have used Sprague-Dawley or Wistar rats as subjects, which 
might have a different sensitivity for neonatal glucocorticoid exposure, or early-life 
experiences in general, compared to Long-Evans rats. A comparable phenomenon 
has been reported in mice, in terms of sensitivity to the programming effects 
of maternal care on drug self-administration and depression-like behaviour (35). 
Additionally, besides the use of different strains, there is substantial variation in the 
treatment regimen among studies investigating the impact of neonatal exposure 
to glucocorticoids. Dosing and time of treatment varies greatly, as well as post 
weaning housing conditions. These factors are likely to contribute to determining 
treatment outcome.
Furthermore, the DEX-induced effects reported previously might be specific for 
certain behavioural paradigms. In contrast to many studies testing spatial learning 
using a water maze paradigm (19, 36), we initially used a circular hole board. It is 
known that the water maze, compared to the hole board results in substantially 
higher HPA axis activation (37). Altered expression of the glucocorticoid receptor 
(GR) after neonatal DEX treatment (38), might explain changes in water maze 
performance between SAL and DEX treated animals without differences on the 
hole board. 
Surprisingly, we observed slightly enhanced performance on certain aspects of 
circular hole board learning in DEX compared to SAL-treated animals. Moreover, 
when tested at 22 months of age in the water maze, DEX-treated animals overall 
do not show learning impairments, although SAL animals appear to continue to 
improve performance on the last learning day (day 4) in contrast to DEX animals 
who reach their maximum performance on day 2 without further improvement.
Additionally, the type of stressor appears to determine the DEX-induced effect 
on the endocrine response. Although DEX-treated animals have been reported 
to show a blunted CORT response to novelty stress; CORT levels did not differ 
from SAL-treated animals after experiencing conditioned fear (20). Immobilization 
stress (used in this study) can be considered a severe stressor; leading to a greater 
HPA axis activation compared to other stressors (39). This potentially reduced the 
likelihood to reveal differences between SAL and DEX-treated animals in stress 
responsiveness, due to a ceiling effect. 
However, Felszeghy and colleagues did report a suppressed elevation of both 
ACTH and CORT in response to restraint stress in adult rats that were neonatally 
exposed to DEX, but on pnd 1, 3 and 5 (40). Contrarily, other studies have 
reported a prolonged (rather than blunted) CORT response in DEX compared to 
SAL-treated animals after crowding stress (23), indicating that the DEX-induced 
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effect on the endocrine stress response is highly dependent on the type of stressor 
applied.
Hence, another factor potentially contributing to the somewhat surprising 
differences in outcome lies in the experimental design. As mentioned before, our 
design involved a substantial amount of neonatal handling. Besides manipulations 
necessary for injections on pnd 1, 2 and 3, SAL and DEX treated animals were 
daily weighed and marked during the full postnatal period in order to discriminate 
between animals receiving different treatments within the litter. Other studies 
investigating the long-term effects of neonatal DEX-treatment have used either 
a between-litter design (21) or a within-litter design with use of another type of 
marking (41) reducing the amount of daily handling. 
The within-litter design was chosen because it has the advantage of having 
both the genetic contribution as well as the shared maternal environment from 
a given litter represented in both treatment groups. Daily marking using a non-
permanent odourless marker was chosen since it is less invasive compared to a 
tattoo or toe clip. However, marking did lead to a substantial amount of daily 
handling of the neonate up to weaning age.
impact of neonatal handling
More than 6 decades ago, it was discovered that brief (3-15 min) daily separations 
between rodent mother and pup between pnd 1 and 21 had long-lasting impact 
on adult stress phenotype (42). Follow-up studies demonstrated that these 
manipulations resulted in HPA axis hypo-responsiveness (10, 43, 44) likely mediated 
by altered GR expression (45). Additionally, reduced emotionality (43), and increased 
cognitive performance (46) were reported in handled (H) rats compared to rats 
raised in undisturbed laboratory conditions, i.e. non-handled (NH). 
The data suggest that the effects of H might have potentially compensated for 
certain DEX-induced alterations. Regarding cognitive performance, H has been 
shown to improve spatial learning on the circular hole board (47) and in the water 
maze, an effect that lasts up to old age (48, 49) like we observed in the current 
study. These findings suggest that the effects of H might have overruled DEX-
induced adverse effects on spatial learning.
Interestingly, the effects of H and DEX treatment (20, 22, 44) on endocrine 
stress responsiveness are suggested to point in the same direction, i.e. they both 
result in a blunted response and enhanced feedback sensitivity (although likely 
via different mechanisms). In the current experiment, we observed the frequently 
described effect of H on the stress response without additional effect of DEX 
exposure. The effect of H might have overruled a potential HPA suppressing 
effect of DEX. If both of these individual effects are present, they apparently do 
not work synergistically, since DEX H animals do not differ from SAL H in their 
endocrine responsiveness.
Neonatal glucocorticoid treatment has resulted in inconsistent findings 
regarding PPI phenotype. Ferguson and colleagues report no effect of DEX 
treatment (50) whereas Hauser and colleagues report an increase in PPI after 
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prenatal DEX treatment, which was not replicated (51). Additionally, our data 
indicate no differences between SAL and DEX treated animals. In contrast to 
other studies demonstrating no effect of H on PPI (52), we report that H enhanced 
PPI substantially. 
Interestingly, other pre-weaning and post-weaning manipulations like maternal 
deprivation and social isolation (53, 54) have been reported to affect PPI. In this 
study - besides differences in postnatal experience - there is also a substantial 
difference in post-weaning manipulation between the H and UNT NH animals up to 
the age of 6 months (due to extensive behavioural testing of the H animals), which 
could explain differences in PPI between these groups. However, a study from our 
laboratory investigating this effect (post-weaning manipulation due to exposure to 
behavioural testing) indicates no differences between animals with a comparable 
postnatal experience which are either extensively tested or undisturbed during 
the post-weaning period (Claessens et al, unpublished data) suggesting that the 
differences in PPI in the current study can be attributed to early-life experiences. 
We did not report DEX induced alterations in motor performance in middle aged 
animals, in contrast to several human and animal studies showing DEX induced 
effects on neuro-motor development and performance (55, 56). Findings from 
human studies have suggested that these impairments cannot be fully attributed 
to DEX treatment, but that medical and socio-demographic factors other than GC 
treatment also contribute to the phenotype (57). Although others have suggested 
that motor performance in aged animals is not affected by H (49), we demonstrate 
beneficial effects of H on motor learning in middle aged rats, potentially interacting 
with or compensating for the effects of neonatal DEX exposure. 
Finally, we report that DEX treated animals appear to have a steeper survival 
curve, but in contrast with other rodent studies showing shortening of the lifespan 
after perinatal DEX treatment (21, 58, 59), this effect did not reach statistical 
significance. Whether a DEX effect might have interacted with potential beneficial 
effects of H remains to be investigated. However, we did not demonstrate an 
overall effect of H on lifespan.
The effects of H are suggested to be mediated via enhancing maternal care 
(60). It has to be noted that the postnatal manipulations in the current study 
are not identical to H as it is known in literature. Besides daily periods of brief 
separation, the offspring was exposed to the procedure of marking and weighing. 
Altogether, this can be considered a more abundant form of handling, which has 
been shown to interact with other developmental experiences (61). Unfortunately 
we have not studied maternal behaviour in the current experiment, but we 
did observe increased maternal licking and grooming directed at H compared 
to NH offspring under comparable experimental conditions (Claessens et al, 
unpublished data). Interestingly, Brabham and colleagues reported that certain 
(prenatal) DEX induced effects can be normalized by enhanced levels of maternal 
care during the postnatal period (36). In line with these findings we suggest that 
enhanced maternal care, as a result of H, is likely to contribute to ‘rescuing’ the 
DEX phenotype.
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ConCluDing remarkS
We did not observe the frequently reported programming effects of DEX 
treatment on adult phenotype, while DEX clearly affected the developmental 
trajectory and body weight. However, we did observe profound and long-lasting 
effects of H in both SAL and DEX treated animals. Since, to our knowledge, this 
treatment design (combining H and glucocorticoid treatment) has not been used 
before, we suggest that H might serve as a protective intervention, potentially 
compensating for the impact of neonatal DEX exposure. From these findings we 
cannot conclude that the effects of H have overruled DEX-induced alterations 
or that the current DEX-treatment would have resulted in a different outcome 
if administered in a NH context. Whether H can in fact compensate for DEX-
induced alterations in adult phenotype remains to be investigated in follow-up 
studies using appropriate control groups investigating the impact of DEX in a 
handing and non-handling context.
aCknoWleDgement
The support from EU funded LifeSpan Network of Excellence (FP6-036894), IRTG 
NWO DN-95-420, Royal Netherlands Academy of Arts and Sciences, Eurostress 
and TI Pharma T5-209 is gratefully acknowledged. The authors would like to thank 
J. Laboyrie, W. Meelis, M. van der Mark, L. Maas, M. Dubbelman and F. Izquierdo-
Moreno for technical assistance.
referenCeS
1. Champagne DL, de Kloet ER, Joels M. 
Fundamental aspects of the impact 
of glucocorticoids on the (immature) 
brain. Semin Fetal Neonatal Med. 2009 
Jun;14(3):136-42.
2. Oitzl MS, Champagne DL, van der Veen 
R, de Kloet ER. Brain development under 
stress: hypotheses of glucocorticoid 
actions revisited. Neurosci Biobehav 
Rev. 2010 May;34(6):853-66.
3. Heim C, Bradley B, Mletzko TC, Deveau 
TC, Musselman DL, Nemeroff CB, 
et al. Effect of Childhood Trauma on 
Adult Depression and Neuroendocrine 
Function: Sex-Specific Moderation by 
CRH Receptor 1 Gene. Front Behav 
Neurosci. 2009;3:41.
4. Heim C, Nater UM, Maloney E, Boneva R, 
Jones JF, Reeves WC. Childhood trauma 
and risk for chronic fatigue syndrome: 
association with neuroendocrine 
dysfunction. Arch Gen Psychiatry. 2009 
Jan;66(1):72-80.
5. Heim C, Nemeroff CB. The impact of 
early adverse experiences on brain 
systems involved in the pathophysiology 
of anxiety and affective disorders. Biol 
Psychiatry. 1999 Dec 1;46(11):1509-22.
6. Gunnar MR, Donzella B. Social 
regulation of the cortisol levels 
in early human development. 
Psychoneuroendocrinology. 2002 Jan-
Feb;27(1-2):199-220.
7. Heim C, Newport DJ, Mletzko T, Miller 
AH, Nemeroff CB. The link between 
childhood trauma and depression: 
insights from HPA axis studies in 
humans. Psychoneuroendocrinology. 
2008 Jul;33(6):693-710.
8. Gunnar MR, Frenn K, Wewerka SS, 
Van Ryzin MJ. Moderate versus severe 
early life stress: associations with stress 
reactivity and regulation in 10-12-year-
old children. Psychoneuroendocrinology. 
2009 Jan;34(1):62-75.
9. Levine S. The ontogeny of the 
hypothalamic-pituitary-adrenal axis. 
91
The influence of maternal factors. Ann 
N Y Acad Sci. 1994 Nov 30;746:275-88; 
discussion 89-93.
10. Levine S. Developmental determinants 
of sensitivity and resistance to stress. 
Psychoneuroendocrinology. 2005 
Nov;30(10):939-46.
11. Schmidt MV. Molecular mechanisms 
of early life stress--lessons from mouse 
models. Neurosci Biobehav Rev. 2010 
May;34(6):845-52.
12. Suchecki D, Rosenfeld P, Levine S. 
Maternal regulation of the hypothalamic-
pituitary-adrenal axis in the infant rat: the 
roles of feeding and stroking. Brain Res 
Dev Brain Res. 1993 Oct 15;75(2):185-
92.
13. Daskalakis NP, Claessens SE, Laboyrie 
JJ, Enthoven L, Oitzl MS, Champagne 
DL, et al. The newborn rat’s stress 
system readily habituates to repeated 
and prolonged maternal separation, 
while continuing to respond to stressors 
in context dependent fashion. Horm 
Behav. 2011 Jul;60(2):165-76.
14. Suchecki D, Nelson DY, Van Oers H, 
Levine S. Activation and inhibition of 
the hypothalamic-pituitary-adrenal axis 
of the neonatal rat: effects of maternal 
deprivation. Psychoneuroendocrinology. 
1995;20(2):169-82.
15. Rosenfeld P, Gutierrez YA, Martin AM, 
Mallett HA, Alleva E, Levine S. Maternal 
regulation of the adrenocortical 
response in preweanling rats. Physiol 
Behav. 1991 Oct;50(4):661-71.
16. Enthoven L, de Kloet ER, Oitzl MS. 
Differential development of stress 
system (re)activity at weaning dependent 
on time of disruption of maternal care. 
Brain Res. 2008 Jun 27;1217:62-9.
17. Mammel MC, Green TP, Johnson 
DE, Thompson TR. Controlled trial of 
dexamethasone therapy in infants with 
bronchopulmonary dysplasia. Lancet. 
1983 Jun 18;1(8338):1356-8.
18. Doyle LW, Ehrenkranz RA, Halliday HL. 
Postnatal hydrocortisone for preventing 
or treating bronchopulmonary dysplasia 
in preterm infants: a systematic review. 
Neonatology. 2010;98(2):111-7.
19. Kamphuis PJ, Gardoni F, Kamal A, 
Croiset G, Bakker JM, Cattabeni F, et 
al. Long-lasting effects of neonatal 
dexamethasone treatment on spatial 
learning and hippocampal synaptic 
plasticity: involvement of the NMDA 
receptor complex. FASEB J. 2003 
May;17(8):911-3.
20. Kamphuis PJ, Bakker JM, Broekhoven 
MH, Kunne C, Croiset G, Lentjes 
EG, et al. Enhanced glucocorticoid 
feedback inhibition of hypothalamo-
pituitary-adrenal responses to stress 
in adult rats neonatally treated with 
dexamethasone. Neuroendocrinology. 
2002 Sep;76(3):158-69.
21. Kamphuis PJ, de Vries WB, Bakker JM, 
Kavelaars A, van Dijk JE, Schipper ME, et 
al. Reduced life expectancy in rats after 
neonatal dexamethasone treatment. 
Pediatr Res. 2007 Jan;61(1):72-6.
22. Flagel SB, Vazquez DM, Watson SJ, 
Jr., Neal CR, Jr. Effects of tapering 
neonatal dexamethasone on rat growth, 
neurodevelopment, and stress response. 
Am J Physiol Regul Integr Comp Physiol. 
2002 Jan;282(1):R55-63.
23. Neal CR, Jr., Weidemann G, Kabbaj 
M, Vazquez DM. Effect of neonatal 
dexamethasone exposure on growth and 
neurological development in the adult 
rat. Am J Physiol Regul Integr Comp 
Physiol. 2004 Aug;287(2):R375-85.
24. Berry MA, Abrahamowicz M, Usher 
RH. Factors associated with growth of 
extremely premature infants during 
initial hospitalization. Pediatrics. 1997 
Oct;100(4):640-6.
25. Shrivastava A, Lyon A, McIntosh N. 
The effect of dexamethasone on 
growth, mineral balance and bone 
mineralisation in preterm infants with 
chronic lung disease. Eur J Pediatr. 2000 
May;159(5):380-4.
26. Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh 
WS, Lin CH, et al. Outcomes at school age 
after postnatal dexamethasone therapy 
for lung disease of prematurity. N Engl J 
Med. 2004 Mar 25;350(13):1304-13.
27. Weiler HA, Wang Z, Atkinson SA. 
Whole body lean mass is altered by 
dexamethasone treatment through 
reductions in protein and energy 
utilization in piglets. Biol Neonate. 
1997;71(1):53-9.
28. Vazquez DM, Neal CR, Jr., Patel PD, 
Kaciroti N, Lopez JF. Regulation of 
corticoid and serotonin receptor brain 
system following early life exposure of 
glucocorticoids: Long term implications 
for the neurobiology of mood. 
Psychoneuroendocrinology. 2011 Aug 
18.
29. Leitch CA, Ahlrichs J, Karn C, Denne SC. 
Energy expenditure and energy intake 
during dexamethasone therapy for 
92
developmental and long-lastIng effects
4
chronic lung disease. Pediatr Res. 1999 
Jul;46(1):109-13.
30. Muglia LJ, Bae DS, Brown TT, Vogt SK, 
Alvarez JG, Sunday ME, et al. Proliferation 
and differentiation defects during lung 
development in corticotropin-releasing 
hormone-deficient mice. Am J Respir 
Cell Mol Biol. 1999 Feb;20(2):181-8.
31. Massaro D, Teich N, Maxwell S, Massaro 
GD, Whitney P. Postnatal development 
of alveoli. Regulation and evidence for a 
critical period in rats. J Clin Invest. 1985 
Oct;76(4):1297-305.
32. Olson EB, Jr. Role of glucocorticoids 
in lung maturation. J Anim Sci. 1979 
Jul;49(1):225-38.
33. Carson SH, Taeusch HW, Jr., Avery 
ME. Inhibition of lung cell division 
after hydrocortisone injection into 
fetal rabbits. J Appl Physiol. 1973 
May;34(5):660-3.
34. Bolt RJ, van Weissenbruch MM, Lafeber 
HN, Delemarre-van de Waal HA. 
Glucocorticoids and lung development 
in the fetus and preterm infant. Pediatr 
Pulmonol. 2001 Jul;32(1):76-91.
35. van der Veen R, Koehl M, Abrous 
DN, de Kloet ER, Piazza PV, Deroche-
Gamonet V. Maternal environment 
influences cocaine intake in adulthood 
in a genotype-dependent manner. PLoS 
One. 2008;3(5):e2245.
36. Brabham T, Phelka A, Zimmer C, Nash 
A, Lopez JF, Vazquez DM. Effects of 
prenatal dexamethasone on spatial 
learning and response to stress is 
influenced by maternal factors. Am J 
Physiol Regul Integr Comp Physiol. 2000 
Nov;279(5):R1899-909.
37. Harrison FE, Hosseini AH, McDonald 
MP. Endogenous anxiety and stress 
responses in water maze and Barnes 
maze spatial memory tasks. Behav Brain 
Res. 2009 Mar 2;198(1):247-51.
38. Felszeghy K, Gaspar E, Nyakas C. Long-
term selective down-regulation of brain 
glucocorticoid receptors after neonatal 
dexamethasone treatment in rats. J 
Neuroendocrinol. 1996 Jul;8(7):493-9.
39. Pacak K, Palkovits M, Kvetnansky 
R, Yadid G, Kopin IJ, Goldstein DS. 
Effects of various stressors on in 
vivo norepinephrine release in the 
hypothalamic paraventricular nucleus 
and on the pituitary-adrenocortical axis. 
Ann N Y Acad Sci. 1995 Dec 29;771:115-
30.
40. Felszeghy K, Bagdy G, Nyakas C. 
Blunted pituitary-adrenocortical 
stress response in adult rats 
following neonatal dexamethasone 
treatment. J Neuroendocrinol. 2000 
Oct;12(10):1014-21.
41. Neal CR, Jr., VanderBeek BL, Vazquez 
DM, Watson SJ, Jr. Dexamethasone 
exposure during the neonatal period 
alters ORL1 mRNA expression in the 
hypothalamic paraventricular nucleus 
and hippocampus of the adult rat. Brain 
Res Dev Brain Res. 2003 Dec 19;146(1-
2):15-24.
42. Levine S. Infantile experience and 
resistance to physiological stress. 
Science. 1957 Aug 30;126(3270):405.
43. Meerlo P, Horvath KM, Nagy GM, 
Bohus B, Koolhaas JM. The influence 
of postnatal handling on adult 
neuroendocrine and behavioural stress 
reactivity. J Neuroendocrinol. 1999 
Dec;11(12):925-33.
44. Meaney MJ, Aitken DH, Bodnoff SR, 
Iny LJ, Sapolsky RM. The effects of 
postnatal handling on the development 
of the glucocorticoid receptor systems 
and stress recovery in the rat. Prog 
Neuropsychopharmacol Biol Psychiatry. 
1985;9(5-6):731-4.
45. Meaney MJ, Diorio J, Francis D, 
Widdowson J, LaPlante P, Caldji C, 
et al. Early environmental regulation 
of forebrain glucocorticoid receptor 
gene expression: implications for 
adrenocortical responses to stress. Dev 
Neurosci. 1996;18(1-2):49-72.
46. Kosten TA, Lee HJ, Kim JJ. Neonatal 
handling alters learning in adult male 
and female rats in a task-specific manner. 
Brain Res. 2007 Jun 18;1154:144-53.
47. Bredy TW, Lee AW, Meaney MJ, Brown RE. 
Effect of neonatal handling and paternal 
care on offspring cognitive development 
in the monogamous California mouse 
(Peromyscus californicus). Horm Behav. 
2004 Jun;46(1):30-8.
48. Lehmann J, Pryce CR, Jongen-Relo 
AL, Stohr T, Pothuizen HH, Feldon J. 
Comparison of maternal separation 
and early handling in terms of their 
neurobehavioral effects in aged 
rats. Neurobiol Aging. 2002 May-
Jun;23(3):457-66.
49. Meaney MJ, Aitken DH, van Berkel 
C, Bhatnagar S, Sapolsky RM. Effect 
of neonatal handling on age-related 
impairments associated with the 
93
hippocampus. Science. 1988 Feb 
12;239(4841 Pt 1):766-8.
50. Ferguson SA, Paule MG, Holson RR. 
Neonatal dexamethasone on day 7 in rats 
causes behavioral alterations reflective 
of hippocampal, but not cerebellar, 
deficits. Neurotoxicol Teratol. 2001 Jan-
Feb;23(1):57-69.
51. Hauser J, Feldon J, Pryce CR. Prenatal 
dexamethasone exposure, postnatal 
development, and adulthood prepulse 
inhibition and latent inhibition in 
Wistar rats. Behav Brain Res. 2006 Nov 
25;175(1):51-61.
52. Pryce CR, Bettschen D, Bahr NI, Feldon 
J. Comparison of the effects of infant 
handling, isolation, and nonhandling 
on acoustic startle, prepulse inhibition, 
locomotion, and HPA activity in the adult 
rat. Behav Neurosci. 2001 Feb;115(1):71-
83.
53. Domeney A, Feldon J. The disruption 
of prepulse inhibition by social isolation 
in the Wistar rat: how robust is the 
effect? Pharmacol Biochem Behav. 1998 
Apr;59(4):883-90.
54. Ellenbroek BA, van den Kroonenberg PT, 
Cools AR. The effects of an early stressful 
life event on sensorimotor gating in 
adult rats. Schizophr Res. 1998 Apr 
10;30(3):251-60.
55. Karemaker R, Heijnen CJ, Veen S, 
Baerts W, Samsom J, Visser GH, et al. 
Differences in behavioral outcome and 
motor development at school age after 
neonatal treatment for chronic lung 
disease with dexamethasone versus 
hydrocortisone. Pediatr Res. 2006 
Dec;60(6):745-50.
56. Hauser J, Knapman A, Zurcher NR, 
Pilloud S, Maier C, Diaz-Heijtz R, et al. 
Effects of prenatal dexamethasone 
treatment on physical growth, pituitary-
adrenal hormones, and performance of 
motor, motivational, and cognitive tasks 
in juvenile and adolescent common 
marmoset monkeys. Endocrinology. 
2008 Dec;149(12):6343-55.
57. Crotty KC, Ahronovich MD, Baron 
IS, Baker R, Erickson K, Litman FR. 
Neuropsychological and behavioral 
effects of postnatal dexamethasone 
in extremely low birth weight preterm 
children at early school age. J Perinatol. 
2011 May 5.
58. Noorlander CW, Visser GH, Ramakers 
GM, Nikkels PG, de Graan PN. Prenatal 
corticosteroid exposure affects 
hippocampal plasticity and reduces 
lifespan. Dev Neurobiol. 2008 Feb 
1;68(2):237-46.
59. Liu Y, Van Der Leij FR. Long-term 
effects of neonatal treatment with 
dexamethasone, L-carnitine, and 
combinations thereof in rats. Pediatr 
Res. 2011 Feb;69(2):148-53.
60. Smotherman WP, Bell RW. Maternal 
mediation of experiences. In: 
Smotherman, W.P., Bell, R.W. (Eds.), 
Maternal Influences and Early behavior. 
Spectrum Publications, New York. 
1980:201–10.
61. Daskalakis NP, Kaperoni M, Koros C, 
de Kloet ER, Kitraki E. Environmental 
and tactile stimulation modulates the 
neonatal handling effect on adult rat 
spatial memory. Int J Dev Neurosci. 2009 
Dec;27(8):747-55.
94


Early handling modulates outcome of neonatal 
glucocorticoid exposure
Sanne E.F. Claessens, Nikolaos P. Daskalakis,  
Melly S. Oitzl and E. Ronald de Kloet
Division of Medical Pharmacology, LACDR/LUMC, Leiden University, The Netherlands
Submitted
CHAPTER 5
abStraCt
Synthetic glucocorticoids are frequently used to prevent respiratory disorders in 
prematurely born infants. Besides the short-term benefit on lung function, numerous 
human and animal follow-up studies have reported adverse neurodevelopmental 
side effects. In contrast to these reports we recently showed a relatively mild 
outcome after neonatal dexamethasone treatment using a rat model. The aim 
of the current study was to investigate whether neonatal handling, which was an 
inevitable component of our experimental design, might serve as an intervention 
strategy modulating the adverse effects of dexamethasone treatment. 
Rat pups were injected with dexamethasone or saline on postnatal days 1, 2 
and 3, and additionally daily handled or left undisturbed until postnatal day 21. 
Maternal care was observed during the first week of life and was enhanced in 
response to handling. Eye opening was accelerated and body weight reduced 
in dexamethasone treated animals. In adulthood, we report that although 
dexamethasone treatment and handling yielded comparable effects on stress-
induced CORT response and startle reactivity, acquisition of fear was only affected 
by handling. Dexamethasone treatment reduced the sensitivity for beneficial 
effects of handling on pre-pulse inhibition. Non-handled animals appeared more 
susceptible to the impact of dexamethasone treatment compared to handled 
animals, as was demonstrated for spatial learning in the water maze. Moreover, 
dexamethasone treatment only impaired spatial orientation in the T-maze in non-
handled animals. 
These findings emphasize that the outcome of neonatal glucocorticoid 
exposure is not deterministic and strongly interacts with other components of the 
postnatal environment.
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introDuCtion
Synthetic glucocorticoids such as dexamethasone (DEX) are frequently used to 
enhance lung function in prematurely born infants. Although some studies indeed 
showed beneficial effects of glucocorticoid treatment (1) leading to a decreased 
incidence and severity of bronchopulmonary dysplasia, others however failed 
to do so or showed only modest effects (2). Moreover, follow-up studies of 
prematurely born infants treated with glucocorticoids have shown pervasive 
adverse neurodevelopmental effects (3, 4). Randomized placebo-controlled 
trials reported that glucocorticoid treatment led to an increased incidence of 
neurodevelopmental impairment (3), and resulted in poor motor skills as well as 
lower IQ scores compared to untreated controls (5). Therefore there has been 
growing concern whether the short-term benefits of glucocorticoid treatment 
outweigh the adverse side effects leading to neurodevelopmental impairment (6). 
In line with evidence from human studies, rodent studies demonstrated that 
perinatal glucocorticoid treatment resulted in long-lasting alterations in cognitive 
performance and hippocampal function (7-10), stress responsiveness (11, 12), 
social behaviour (13) and to a significantly shortened lifespan (10, 14). Previous 
rodent studies in our laboratory did show developmental alterations after neonatal 
DEX treatment in terms of brain development, body weight and eye opening. 
However, the long term consequences for behavioural phenotype were relatively 
mild and in some cases even beneficial (chapter 4 of this thesis). 
Interestingly, our experimental design consisted, besides manipulations 
necessary for drug treatment, of a substantial amount of neonatal handling during 
the full postnatal period. This was the result of daily weighing and marking for 
discrimination between individual pups receiving different treatments according 
to a within-litter design. Other studies investigating the long-term effects of 
neonatal DEX-treatment have used either a between-litter design (14) or a within-
litter design with use of another type of marking (15) reducing the amount of daily 
handling. 
It is well known that daily handling during the postnatal period attenuates 
stress-induced activation of the hypothalamic-pituitary-adrenal (HPA) axis (16-19), 
reduces emotionality (18), and enhances cognitive performance (20). Moreover, we 
have previously reported the long-lasting impact of neonatal handling - inherent 
to the dexamethasone-treatment design - throughout the lifespan, suggesting an 
interaction with the effects of DEX treatment (chapter 4 of this thesis). Therefore, 
it is hypothesized that the effects of handling might have potentially compensated 
for certain DEX-induced alterations. To investigate whether handling of the 
neonate can indeed reverse neonatal DEX-induced alterations in adult phenotype 
we have studied the effects of glucocorticoid treatment in a handling vs a non 
handling context.
99
material anD methoDS
animals
Adult female and male Long Evans rats from our breeding population (originally 
obtained from Janvier, France) were used as breeders. Two females were mated 
with one male for 10 days in type IV polycarbonate cages (59x38x20cm) containing 
sawdust bedding and tissues. Food (RM3, Special Diet Services, Witham, Essex, 
UK) and water (8 ml 25% HCl /10 L tap water) were provided ad libitum. Animals 
were maintained on a 11-h light : 13-h dark cycle with lights on at 08.30h, in a 
temperature (21± 2°C) and humidity (55 ± 5%) controlled room. After breeding, 
pregnant females were individually housed. Females were checked daily for 
presence of pups. If pups were present, the day of birth for that particular litter 
was defined as postnatal day 0 (pnd 0). On pnd 1, litters were culled to 8 pups (4 
male and 4 female) and randomly assigned to the Handling (H) or Non Handling 
(NH) group. Cages were cleaned once on pnd 10 and after weaning once weekly. 
After weaning (pnd 22) animals were group housed with same sex littermates. 
Animal experiments were approved by the Local Committee for Animal Health, 
Ethics and Research of Leiden University and carried out in accordance with 
European Communities Council Directive (86/609/EEC). 
Drug treatment
Male pups were randomly assigned to either the saline (SAL) or the dexamethasone 
(DEX) group using a within litter design. Pups in the DEX group were subcutaneously 
(SC) injected with dexamethasone-21-phosphate (Sigma Aldrich, Zwijndrecht, 
The Netherlands) on pnd 1 (0,5 µg/g body weight), pnd 2 (0,3 µg/g) and pnd 
3 (0,1 µg/g). Pups in the SAL groups were injected with equivalent volumes of 
sterile and pyrogen free saline (SAL). In order to prevent bias for the dam to show 
enhanced attention for injected or non-injected offspring, all female littermates 
were injected with SAL on pnd 1, 2 and 3. Pups were marked for identification 
with a toe clip on pnd 1. Drug treatment always took place between 9:00 and 
11:00.
handling
From pnd 1-21 H pups underwent daily 15 min separations from the dam. At the 
onset of each separation, pups were removed altogether from the home cage, 
and placed in a type IIL polycarbonate cage (36,5x20,5x14cm) that was brought 
to an adjacent room, where it was placed on a heating pad. Following 15 min of 
separation, all pups were returned to the housing room and reunited with the 
dam in the home cage. Handling always took place between 12:00 and 13:00. NH 
pups were left undisturbed from pnd 1-21 except for a cage change on pnd 10.
maternal Care
The maternal behaviour of each dam was observed and scored for five 60 minute 
periods per day during the first 7 days postpartum using a procedure as described 
by Champagne et al (2003) (21). Observations were performed at three periods 
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during the light phase (13:00, 15.30, 18:00) and two periods during the dark 
phase (07:00 and 20:00) of the light cycle. Within each observation period the 
behaviour of each mother was scored every 3 minutes (20 observations per period, 
100 observations per day, 700 observations for the first 7 days postpartum). The 
following maternal behaviours were scored: a) Licking and grooming (LG) of the 
pups, b) Arched back nursing/blanket nursing/passive nursing, c) Mother away 
from nest/no maternal contact. The data were analyzed as the percentage of 
observations in which dams displayed one of the behaviours described above.
Postnatal development
Postnatal development (body weight and eye opening) was monitored in H pups 
during H procedure. For eye opening a scale from 0-2 was used indicating: 0 = 
closed, 1 = partial opening, 2 = fully open (adapted from Flagel, Vazquez, 2001).
adult Phenotype
Animals were tested according to the schedule depicted in figure 1.
Fig 1. Timeline experiments. Pnd: postnatal day; ASR: acoustic startle reactivity; PPI: 
prepulse inhibition; FC: fear conditioning; Stress: endocrine response to restraint stress; 
MWM: morris water maze.
acoustic Startle reactivity and Prepulse inhibition
Prepulse inhibition was measured at 3 months of age. Animals were brought to 
the testing room and allowed to habituate for 45 min. After habituation they 
were placed in a startle recording apparatus (SR-LAB, San Diego Instruments, CA, 
USA) containing a transparent Plexiglas tube (diameter 8.7 cm, length 20.5 cm) 
mounted on a Plexiglas base. Sounds were presented by a speaker and movement 
of the animals was detected by a piezoelectric accelerometer mounted below 
the Plexiglas tube and recorded by a computer. Testing started with a 5 min 
habituation session with background white noise of 70 dB[A]. Animals were first 
presented with six pulse alone trials (117 dB[A]) followed by 39 trials comprising 
different trial types according to a pseudo-randomized schedule with an inter-trial 
interval of 10-20 sec. Trial types: background white noise alone, prepulse alone 
using intensities of 2, 4, 8, 16 dB[A] above background noise (i.e. 72, 74, 78 and 
86 dB[A]), pulse alone (117 dB[A]) or a combination of one of the four prepulses 
plus pulse. Finally, animals were again exposed to five pulse alone trials. The 
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duration of the prepulses was 20 ms, duration of the pulses was 40 ms. Prepulse 
to pulse interval was 100 ms. Startle activity was measured during 100 ms after 
onset of the pulse. The percentage of PPI at the different prepulse intensities was 
calculated as [100-(100 x startle amplitude at prepulse trial)/ (startle amplitude 
at startle pulse-alone trial)]. Speakers were calibrated every day, and boxes were 
cleaned with a 10% ethanol solution after every session to eliminate odour cues. 
Experiments were performed between 09:00 and 13:00 to minimize circadian 
influence. 
t-maze
Spatial orientation in the T-maze was investigated at 4 months of age. The T-maze 
consisted of three unequally sized arms made of Plexiglas. The length of the start 
arm was 75 cm, whereas the other arms were both 32 cm in length. The width 
and height of the arms were 12 and 20 cm respectively. During training, rats were 
placed in the start arm facing the outer wall and were allowed to explore the 
start arm and one of the two other arms for 10 minutes. Half of the animals were 
allowed to visit the left and the other half the right arm to reduce the influence of 
a preference of the rats for one side. After a delay of 2.5 hours, rats were placed 
back in the T-maze and were allowed to explore all three arms for 5 minutes. The 
duration and frequency of visiting the familiar or new arm during re-exposure were 
measured using EthoVision XT (Noldus Information Technology, Wageningen, 
The Netherlands). T-maze experiments were performed between 09:00 and 13:30 
to minimize circadian influence. The experimental apparatus was cleaned with a 
10% ethanol solution between all sessions to eliminate odour cues.  To reduce 
the effect of stress due to testing order within the cage, one animal per litter was 
tested per day. 
Contextual fear Conditioning
Contextual fear memory was assessed at 4,5 months of age. The shock box 
(40x40x50 cm) consisted of black Plexiglas walls and a stainless steel rod floor, 
connected to a shock generator. On day 1 the animal was transferred from the 
housing room to the adjacent test room where it was placed in the shock box. 
After a 2 min delay it was exposed to a foot shock of 0.6 mA (duration 2 sec). After 
the shock the animal remained in the shock box for 2 minutes, after which it was 
removed from the box and transferred back to the home cage. 
24 hours later (day 2), the animal was re-exposed to the shock box for 4 min, 
however without receiving a foot shock.  An overhead video camera recorded 
behaviour of the animals throughout all sessions. Behaviour was analyzed 
by an observer unaware of treatment conditions using The Observer 9.0 XT 
(Noldus Information Technology, Wageningen, The Netherlands). The following 
behaviours were scored (1) freezing (lack of all body movement except those 
necessary for breathing), (2) scanning (lack of movements, except lateral head 
movements and movements necessary for breathing), (3) rearing, (4) walking, and 
(5) sitting. Behaviour was analyzed during 3 distinct time periods: (1) 2 min before 
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shock, (2) 2 min after shock, (3) 4 min re-exposure. All testing took place between 
10:00 and 13:00 to minimize circadian influence. The shock box was cleaned with 
a 10% ethanol solution between all sessions to eliminate odour cues. To reduce 
the effect of stress due to testing order within the cage, one animal per litter was 
tested per day.
endocrine response to restraint stress
At 5,5 months of age, endocrine response to an acute restraint stressor was 
tested. One day prior to restraint stress a basal blood sample was taken from the 
tail vein. The next day animals were exposed to 10 min restraint stress by placing 
them in a custom made restrainer restricting body movement. Blood samples 
were taken at 2, 5, 10, 30, 60, and 120 min. 
hormone analysis
Blood samples were collected in EDTA coated tubes (Microvette CB 300 K2E, 
Sarstedt, Germany). Samples were kept on ice and centrifuged for 15 min at 
13000 rpm at 4°C. Plasma was transferred to Eppendorf tubes and stored at 
-20°C until further analysis. Plasma and corticosterone (CORT) concentration was 
measured using a commercially available radio immuno assay (RIA) kit containing 
125Iodine labelled CORT (MP Biomedicals Inc., USA). All samples were processed 
in the same assay to exclude inter-assay variability. 
Water maze performance
At 10 months of age spatial learning in a water maze was tested. Animals were put, 
without prior training in a pool (150 cm diameter) filled with 30 cm of water (21°C) 
made opaque by adding 3 spoons of latex paint. A platform (10 cm diameter) 
was hidden 1 cm below the surface of the water and was positioned in the NE 
quadrant. Animals were given 3 daily trials (inter-trial interval 15 min) to find the 
platform on day 1, 2 and 3. On day 4, two more training trials were given, followed 
by a probe trial without platform present. On day 5, animals were given 3 reversal 
trials with the platform located in the position opposite (SW quadrant) from where 
it was during training. Trials always started in one of the 3 quadrants where the 
platform was not located in a pseudo-randomized fashion, following the same 
order of start position for every animal. If an animal did not reach the platform 
within 2 minutes, it was gently guided there by the experimenter. Animals were 
allowed to stay on the platform for 15 sec after finding it or being guided there. 
Swim patterns were tracked by an overhead camera and later analysed using 
EthoVision XT (Noldus Information Technology, Wageningen, The Netherlands). 
Latency and distance to platform as well as latency, frequency and duration in 
target and other quadrants, or in close proximity to the platform (or the location 
where the platform in previous trials) were analyzed during training and reversal 
trials, as well as swim patterns during probe trials. After every swim trial, animals 
were dried with a towel and kept in a clean cage lined with clean dry tissue paper 
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that was placed on a heating pad. All trials took place between 10:00 and 13:00 
to minimize circadian influence.
Data analysis
Statistical analysis was performed using SPSS 17.0. Data are presented as mean 
+/- SEM. Data were analysed using two-way repeated measures ANOVA with 
time (age, trial, day or min) as within and drug treatment and handling as between 
subject factors, one-way ANOVA to compare H to NH animals (in case of maternal 
LG data), or two-way ANOVA to measure a main effect of drug treatment (SAL, DEX) 
and handling (NH, H), or an interaction between drug treatment and handling. If 
an interaction was observed, post-hoc pair-wise comparisons were performed. 
For the T-maze experiments, differences within each group were tested using a 
paired t-test. Level of significance was set at p < .05. Where needed corrections 
for multiple testing and violation of sphericity were conducted. Graphs were 
made using GraphPad Prism®.
reSultS
maternal care
H pups received significantly higher levels of maternal LG compared to NH pups 
directly following exposure to the handling procedure (F(1,39) = 12.72, p = .001, 
fig 2A). However, overall level of LG did not differ significantly between NH and 
H litters (fig 2B).
body weight and postnatal development
DEX treated animals weighted significantly less throughout the postnatal period 
(F(1,20) = 90.25, p < .001, fig 3A). For obvious reasons this was monitored only 
in H animals. During the post-weaning period (fig 3B), NH animals tended to 
Fig2.Maternal licking and grooming (LG) directly following the handling procedure (A) and 
overall (B). Displayed are mean +/- SEM. ** p < .01
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have a lower body weight than H animals, although this effect was not statistically 
significant (F(1,32) = 4.12, p = .051).
 For eye opening we observed a significant main effect of drug treatment 
(F(1,19) = 40.66, p < .001, fig 4) indicating that DEX treated animals show an 
acceleration in eye opening. For obvious reasons this was monitored only in 
H animals. We also observed a significant time x drug treatment interaction 
(F(20,380) = 17.29, p < .001). Post-hoc analysis per time point revealed that DEX 
treated animals showed enhanced levels of eye opening compared to SAL treated 
animals on pnd 8 (p = .019), 9, 10, 11, 12 (p < .01).
adult phenotype
acoustic Startle reactivity
Acoustic startle reactivity (ASR) to the first five pulses revealed a main effect of 
handling (F(1,37) = 9.047, p = .005) and a drug treatment x handling interaction 
(F(1,37) = 13,497, p < .001; fig 5A, black bars). Post-hoc pair-wise comparisons 
revealed higher ASR in SAL NH animals compared to SAL H (p = .011) and DEX 
NH (p = .023), indicating that both H and DEX treatment reduced initial startle 
reactivity. No main effect of handling, drug treatment or an interaction effect was 
Fig3.DEX treatment significantly reduced body weight throughout the postnatal period 
(A). In adulthood, no effect of DEX treatment was observed. H however tended (ns) to result 
in higher body weight (B). Data represent mean ± SEM. ** p < .01
Fig 4. DEX treatment resulted in 
accelerated eye opening, on pnd 8-12 
DEX treated animals show enhanced 
levels of eye opening compared to SAL 
treated animals. Data represent mean ± 
SEM. * p < .05, ** p < .01
105
observed for the last five pulses where all groups showed similar startle reactivity 
(fig 5A, white bars).
Habituation of ASR was calculated based on the difference in ASR to the first 
and the last five pulses. Main effects for handling (F(1,33) = 8.478, p = .006) and 
drug treatment (F(1,33) = 10.901, p = .002) were observed, indicating that both 
H and DEX treatment reduced habituation of the acoustic startle response (fig 
5B), an effect that appears to be mostly driven by the high initial ASR in SAL NH 
animals.
Fig5.Acoustic startle reactivity (ASR) to the first five (black bars) and last five (white bars) 
pulses (A) and habituation of ASR (B). Data represent mean ± SEM. $ main effect of handling 
p < .01, # main effect of drug treatment p < .01, ^ drug treatment x handling interaction p 
< .01. Results of post-hoc pair-wise comparisons: * p < 0.05.
Prepulse inhibition (PPi)
Analysis of PPI data showed a significant drug treatment x handling interaction 
(F(1,35) = 4.81, p = .035, fig 6) for PP2 (prepulse 2 dB[A] above background). 
Post-hoc pair-wise comparisons revealed significantly lower PPI in SAL NH 
animals as compared to SAL H animals (p = .021) indicating that H enhanced PPI 
in SAL treated but did not affect DEX treated animals. We did not observe main 
effects of drug treatment or handling on PPI. Effects were comparable for PP4 
(4 dB[A] above background), however post-hoc testing showed a trend towards 
significance. No effects of DEX treatment or H were observed for PP8 and PP16.
Spatial orientation in the t-maze
Since exploratory behaviour was reduced after the first minute of re-exposure to 
the T-maze, we focused on behaviour during the first minute. All animals, except 
DEX NH, showed the expected preference for the new versus the familiar arm of 
the T-maze, indicating that this DEX-induced effect on hippocampal performance 
can be reversed by handling. Paired T-tests showed that all groups except for DEX 
NH spent significantly more time in the new compared to the familiar arm (SAL 
NH: p = .028, SAL H: p = .002, DEX H: p < .001, fig 7).
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Contextual fear Conditioning
No significant differences in behaviour were observed between groups prior to 
shock administration.Directly after shock exposure, a main effect of handling 
was observed for freezing (F(1,36) = 14,731, p < .001, fig 8A) indicating that H 
animals showed less freezing compared to NH animals. During re-exposure (24h 
later), a main effect of handling was observed for freezing (F(1,36) = 8.892, p = 
.005, fig 8B) indicating that again, H animals showed less freezing compared to 
NH animals. Three animals did not receive a shock and were therefore excluded 
from the analysis. 
endocrine stress responsiveness
Repeated measures ANOVA revealed a main effect of time (F(2.39, 69.20) = 
184.73, p < .001) and a time x drug treatment x handling interaction (F(2.39,69.20) 
= 4.56, p = .010). Post-hoc analysis per time point indicated at t = 120 min a 
significant drug treatment x handling interaction (F(3,42) = 3.55, p = .023). At 
t = 120 SAL NH animals showed significantly higher CORT levels compared to 
DEX NH (p = .005) and SAL H (p = .009). The difference compared to DEX H was 
not statistically significant (p = .071). This indicates that both handling and DEX 
treatment resulted in enhanced negative feedback of the HPA axis in response to 
acute restraint stress (fig 9).
Fig 6. Prepulse inhibition for PP2 (2 
dB[A] above background). Handling 
significantly enhanced PPI in SAL treated 
animals without affecting DEX treated 
animals. Data represent mean ± SEM. 
^ drug treatment x handling interaction 
p < .05. Results of post-hoc pair-wise 
comparisons: * p < .05.
Fig7.Spatial orientation in the T-Maze. 
All groups except DEX NH spent 
significantly more time in the new 
compared to the familiar arm during 
re-exposure to T-maze. Data represent 
mean ± SEM. * p < .05, ** p  < .01.
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Spatial learning in the morris Water maze
Repeated measures ANOVA of spatial learning revealed a main effect of time 
(F(2.09,77.35) = 127.62, p < .001) and a main effect of drug treatment (F(1,37) = 
5.41, p = .026), indicating that SAL treated animals show overall a longer latency 
to find the platform compared to DEX treated animals during spatial learning on 
days 1 to 4. There was a trend towards a drug treatment x handling interaction 
(F(1,37) = 4.07, p = .051). Post-hoc analysis showed that overall SAL NH animals 
need more time to find the platform compared to DEX NH (p = .026), an effect 
that is mostly driven by performance on day 1 (fig 10A). When day 1 is analysed 
into more detail (per trial, see fig 10B) we observed a main effect of time (F(2,74) 
= 26.71, p < .001), and drug treatment (F(1,37) = 8.74, p = .005) and a drug 
treatment x handling interaction (F(1,37) = 6.80, p = .013). Post-hoc analysis shows 
that SAL NH animals need significantly more time to find the platform compared 
to DEX NH animals (p = .003) whereas the other groups do not differ significantly. 
This indicates that DEX treatment affects mostly NH animals. However, although 
Fig8.Freezing behaviour directly following shock exposure (A) and during re-exposure to 
shock context (B). Data represent mean ± SEM. Handled animals display significantly lower 
levels of freezing both directly after shock exposure and during re-exposure to the shock 
context. **: main effect of handling, p < .01
Fig 9. Corticosterone (CORT) levels 
before, during and following exposure 
to 10 min restraint stress (indicated 
with horizontal black bar). Both 
handling and DEX treatment result in 
enhanced negative feedback of the 
HPA axis at t = 120 min. Data represent 
mean ± SEM. ** time x drug treatment 
x handling interaction p = .01, * drug 
treatment x handling interaction at t = 
120, p < .05
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DEX NH animals are significantly faster compared to SAL NH, the slope of the 
learning curves is highly comparable.
Fig 10.Spatial learning in the water maze. Overall, DEX treated animals had a shorter 
latency to find the platform compared to SAL treated animals. This effect was mostly driven 
by a difference between SAL NH and DEX NH on training day 1 (A). When day 1 was 
analysed per trial we observed that DEX treatment affected NH animals, without affecting 
H animals. DEX NH animals are faster on all trials, including trial 1 (B). ^ main effect of time 
p < .01, # main effect of drug treatment p < .05, $ main effect of drug treatment p < .01 * 
drug treatment x handling interaction p < .05.
DiSCuSSion
The aim of this study was to investigate the impact of neonatal glucocorticoid 
treatment in an H vs NH context, in order to answer the question if H compensates for 
the effects of neonatal DEX treatment. We observed DEX-induced developmental 
alterations, in terms of reduced body weight and accelerated eye opening, which 
were comparable to previous findings from our laboratory. For adult and middle 
aged behavioural and endocrine phenotype we observed that the outcome was 
determined by various interactions between neonatal DEX treatment and H. 
effects of dexamethasone treatment and handling work in same direction
For some characteristics of the animal’s phenotype the effects of DEX treatment 
and H point in the same direction. SAL NH animals show an extremely high initial 
ASR which is substantially lower in both DEX-treated and H animals. Interestingly, 
startle reactivity in SAL NH animals is reduced to levels comparable to the other 
groups towards the end of the startle protocol, resulting in a high degree of 
habituation in these animals. All groups show startle habituation, but since initial 
startle was lower in DEX-treated and H animals, the degree of habituation is also 
lower in these groups. Overall, both DEX and H appear to reduce acoustic startle 
reactivity. A similar phenomenon has been shown in previous studies from our 
group (Claessens et al, unpublished), however different control groups were used. 
Others have also reported that H animals show reduced ASR compared to NH 
individuals (22). The effects of neonatal glucocorticoid treatment on ASR have not 
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been frequently studied, but Ferguson and colleagues showed no effect of DEX 
treatment on postnatal day 7 on adult ASR (23).
The impact of DEX treatment and H on CORT responsiveness follows a 
comparable pattern: both DEX treatment and H enhance negative feedback 
of the HPA axis, leaving SAL NH animals with a significantly prolonged CORT 
response. A suppressed CORT response following acute restraint - and other 
types of - stress in adult rats that were neonatally exposed to DEX has been 
reported before (12, 24), as well as the impact of H leading to enhanced stress 
recovery (19, 25). Although functional outcome is similar, the effects of DEX 
treatment and H are likely to be mediated via different mechanisms. H animals 
show increased expression of GR compared to NH animals (26), whereas such an 
effect has never been shown in response to postnatal DEX treatment. However, 
prenatal DEX treatment has been reported to result in an increase in hippocampal 
GR density (27).
Overall it can be concluded that SAL NH animals display a ‘reactive’ phenotype. 
As expected, the experience of H reduces this reactivity. Interestingly, neonatal 
exposure to glucocorticoids has a comparable effect.
Dexamethasone treatment interacts with handling
H enhanced PPI in SAL treated animals, but did not affect DEX treated animals. 
Although Pryce and colleagues did not report differences in PPI after neonatal H 
(22), the current PPI enhancing effect of H is in line with previous findings from our 
laboratory (chapter 4 of this thesis), although in that study the interaction with DEX 
treatment was not investigated. Zhang and colleagues have reported enhanced 
PPI in animals receiving high compared to low levels of maternal care during 
infancy (28). This is in line with our observation that maternal care is enhanced 
upon reunion following H. Neonatal glucocorticoid treatment has resulted in 
inconsistent findings regarding PPI phenotype. Ferguson and colleagues report 
no effect of DEX treatment (23) whereas Hauser and colleagues report an increase 
in PPI after prenatal DEX, which was not replicated (29). Our data indicate no 
overall effect of DEX treatment on PPI. However, DEX treatment appears to 
reduce the susceptibility to H effects.
A comparable type of interaction was observed for spatial learning in the water 
maze at middle age: DEX treatment altered performance of NH animals, whereas 
in H animals no effect of DEX treatment was observed. Several studies have 
shown the adverse effects of neonatal DEX treatment on water maze performance 
(8). We observed that DEX NH animals need significantly less time to find the 
platform compared to SAL NH animals, especially on the first day of training. 
Brabham and colleagues also showed that animals exposed prenatally to DEX 
(although raised by a non DEX-treated foster mother) perform better than other 
(SAL-treated) groups in the water maze (27). These findings were unexpected and 
the authors have suggested an important role for postnatal maternal care which 
might be different in mothers exposed to DEX or vehicle during pregnancy. 
Similarly, there might have been differences in maternal care directed towards 
DEX vs SAL offspring in our current study. Since we observed maternal care 
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directed towards the entire litter containing both SAL and DEX treated offspring, 
we cannot be sure whether treatment-specific differences exist and/or contribute 
to the adult phenotype. Although H decreases the impact of DEX treatment, we 
did not find an overall effect of H on water maze performance. While H has been 
shown to improve spatial learning in the water maze, an effect that lasts up to old 
age (20, 30), our data are in line with those from several other studies which do 
not indicate improved circular maze performance in H compared to NH animals 
(25, 31, 32).
Neonatal glucocorticoid exposure reduced the sensitivity to the beneficial 
effects of H on PPI, whereas H reduced the sensitivity to the beneficial effects of 
DEX treatment on spatial learning.
handling compensates for dexamethasone-induced effects
A different interaction between DEX treatment and H was observed for spatial 
orientation in the T-maze. DEX NH animals do not discriminate between the new 
and familiar arm upon re-exposure to the same extent as other groups do, in 
favour of the new arm. This DEX-induced effect can be reversed by H. The impact 
of neonatal H on T-maze performance has been reported before (33) and appears 
to result in a higher discrimination rate compared to NH animals, especially with 
increasing age (25). The impact of neonatal DEX treatment on T-maze learning 
has, to our knowledge, not been described. 
Spatial orientation with a long-term memory component is affected by DEX 
treatment and can be fully restored by neonatal H.
handling effect – no dexamethasone effect
Not all behaviours are affected by both DEX treatment and H. For the behavioural 
phenotype observed in the fear conditioning paradigm, we found that immediate 
reactivity, in terms of freezing, to the foot shock was higher in NH compared to 
H animals. NH animals continue to show more freezing during re-exposure to the 
shock context 24h later. Although H has been reported to enhance contextual fear 
conditioning (34), our findings cannot be interpreted as a difference in contextual 
fear learning or memory, due to differences in responsiveness directly following 
shock exposure, and are more likely to indicate a difference in coping style (35). 
We do not report a main effect of, or an interaction with DEX treatment, which is 
in line with findings from Kamphuis and colleagues (12).
ConCluSionS
We report that the outcome of neonatal DEX treatment was determined by 
interactions with the effects of H. Overall, SAL NH animals appear to be ‘challenged’ 
the most during behavioural testing in adulthood. They show: (1) extreme startle 
reactivity, (2) low PPI, (3) high freezing in response to a foot shock (although 
similar to DEX NH), (4) low negative feedback of the HPA axis in response to acute 
stress, and (5) impaired spatial learning in the water maze. As expected, neonatal 
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H reduced startle reactivity and enhanced glucocorticoid feedback of the HPA 
axis. Neonatal DEX treatment, although expected to have detrimental effects on 
phenotype, resulted in effects comparable to H for several of the parameters 
studied. DEX treatment led to reduced ASR, enhanced feedback of the HPA axis 
and improved performance in the water maze. Whereas H reduced the impact of 
DEX in the T-maze and the water maze, DEX treatment reduced the sensitivity for 
H effects as observed for PPI.
These findings clearly show that the outcome of neonatal DEX-treatment: 1) 
is not deterministic, 2) highly depends on other characteristics of the postnatal 
environment, and 3) is potentially mediated by alterations in mother-pup 
interaction. Moreover, they highlight the importance of interaction between 
individual components of the early postnatal environment.
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The aim of the research described in this thesis was to explore, using a rat model, 
the short- and long-term consequences of 1) very subtle differences in early-life 
experience, induced by within-litter variation in individual pup-directed maternal 
care, and 2) pharmacological manipulation of the neonate’s brain and HPA axis 
development by early synthetic glucocorticoid exposure. The latter treatment, 
used clinically to treat respiratory distress syndrome in prematurely born infants, 
has been reported to result in adverse neurodevelopmental outcomes. Therefore, 
we investigated the possibility to reverse these frequently reported detrimental 
effects using both pharmacological and behavioural interventions.
In this chapter, the experimental findings described in this thesis will first be 
summarized and evaluated. Then, the implications of the findings for the field of 
developmental programming will be discussed, as well as the impact of potential 
intervention strategies to prevent the adverse effects of dexamethasone treatment 
on the developing brain. The chapter is concluded with an adjustment of our 
initial hypothesis on the intensity of individual components of the early postnatal 
environment, and their potential to program later-life phenotypes.
Summary of finDingS
Within-litter differences in maternal care
To investigate the existence of subtle individual differences in maternal 
environment we used an adapted version of a frequently used model of naturally 
occurring variations in maternal care (1). This allowed the study of within-litter 
differences in single pup-directed maternal licking and grooming in Wistar rats 
to test the hypothesis that maternal care is equally distributed across littermates.
We reported that maternal care is not homogeneously distributed across 
littermates. Thus, besides differences in maternal care between litters, also 
variation within the litter exists. 
Next, the endocrine response to an acute novelty stressor was investigated during 
adolescence and adulthood to test the hypothesis that within-litter differences in 
maternal care have long-lasting impact on stress phenotype.
We reported that these very subtle differences in early-life experience have long-
lasting impact on the offspring’s later-life endocrine stress phenotype, although 
these findings were biased by a gender-preference displayed by the majority of 
dams.
neonatal glucocorticoid exposure
To investigate the impact of neonatal exposure to synthetic glucocorticoids, 
Long Evans rat pups were injected with dexamethasone according to a protocol 
based on the treatment regimen for premature infants used in clinical settings. 
Preterm infants are mostly treated with glucocorticoids between week 26 and 
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32 of gestation. Therefore, we aimed to expose rats to dexamethasone during a 
period in which the stage of brain development is comparable to that of a human 
fetus during the last trimester of pregnancy (2). 
We first investigated: 
1. the acute consequences of this treatment on cell proliferation and glial activity 
in the developing brain
2. the possibility to prevent these alterations by pharmacological intervention 
using local GR antagonist administration
We reported that, as expected, neonatal glucocorticoid exposure acutely affects 
hippocampal cell proliferation and number of glial cells in the developing brain. 
These short-term alterations can be partially prevented by central GR antagonist 
pre-treatment, which was suggested as a potential intervention strategy to protect 
the developing brain against the detrimental effects of glucocorticoid exposure.
Then, we investigated the consequences for postnatal development, as well as 
the adult, middle aged and aging endocrine and behavioural phenotype.
We reported that although neonatal dexamethasone treatment leads to 
developmental alterations, the frequently reported adverse effects on adult 
endocrine and behavioural phenotype were not observed. Based on the data it 
was suggested that – contrary to our expectations - daily handling of the neonate 
during the postnatal period modulates - and potentially overrides - the outcome 
of neonatal dexamethasone exposure. 
Finally, we tested the hypothesis that brief daily separations from the nest, leading 
to an ‘enriched’ postnatal environment due to enhanced maternal care upon 
reunion with the dam, modulate the negative programming effects of neonatal 
glucocorticoid exposure.
We reported that the effects of neonatal dexamethasone treatment interact 
with those of neonatal handling in shaping the adult endocrine and behavioural 
phenotype (see table 1). We observed that non-handled animals appear to be 
more susceptible to the impact of neonatal dexamethasone treatment, compared 
to handled animals. These findings emphasize that the outcome of neonatal 
glucocorticoid exposure is not deterministic and strongly interacts with other 
components of the postnatal environment.
gluCoCortiCoiDS During DeveloPment
In chapter3 the acute effects of neonatal dexamethasone treatment on markers for 
brain development are described. Our findings, a reduction in growth, hippocampal 
cell proliferation and number of GFAP-positive cells in the hilus and corpus callosum, 
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followed our expectations based on numerous studies investigating the impact of 
early glucocorticoid exposure on neuronal and glial proliferation.
The role of glucocorticoids during brain development has been studied 
for decades, starting long before their use in treating respiratory disease of 
premature infants (3). Appropriate levels of glucocorticoids are necessary for 
normal development (4-6). Absence of glucocorticoids threatens survival as 
has been demonstrated in glucocorticoid-insufficient and GR-deficient animals, 
which die of respiratory failure due to abnormal lung development (7, 8). During 
normal pregnancy the activity of the maternal HPA axis changes dramatically, 
leading to increased circulating glucocorticoid levels in late gestation (9). This 
rise in glucocorticoids is essential for maturation of various tissues (10). Therefore, 
premature infants, or pregnant women at risk of giving premature birth, are 
treated with synthetic glucocorticoids to stimulate lung maturation. 
However, not only absence of glucocorticoids, but also elevated levels can 
disturb normal development. This happens in case of exaggerated levels of 
endogenous glucocorticoids, due to maternal stress during pregnancy. Exposure 
to synthetic glucocorticoids such as dexamethasone is considered even more 
dangerous since those are not converted by placental 11β HSD2 (11, 12), 
making them more likely to cross the placenta and enter the fetal circulation (13). 
Additionally, synthetic corticosteroids show little affinity for corticosteroid binding 
globulin and can readily enter the brain, since the blood-brain barrier is not fully 
developed in neonates (14, 15).
neonatal glucocorticoid exposure suppresses growth and proliferation
Growth retardation, like we observed in dexamethasone-treated animals, is 
one of the frequently reported side effects of exposure to increased levels of 
glucocorticoids in early-life. This phenomenon is probably the consequence of a 
glucocorticoid-induced (transient) catabolic state and suppression of insulin-like 
growth factor (IGF)-axis activity (16, 17). 
Besides somatic growth, brain growth is also retarded in response to 
excessive glucocorticoid exposure. Exogenous glucocorticoid treatment results 
in reduced cerebral weight, DNA content and cell proliferation (18-21). Especially 
Table 1. Overview of dexamethasone- and handling-induced effects on adult 
endocrine and behavioural phenotype.
PPI ASR CHB T-maze FA MWM HPA
DEX = ↓ ↑ ↓ = ↑ ↓
H ↑ ↓ ? ↑ ↓ ↑ ↓
DEX x H + + ? + - + +
DEX: dexamethasone, H: handling, DEX x H: dexamethasone x handling interaction. PPI: 
Pre-pulse inhibition, ASR: acoustic startle reactivity, CHB: circular hole board, FA: fear acquisition 
(freezing response to foot shock), HPA: CORT response to restraint stress, MWM: morris water 
maze. ↑: increase, ↓: decrease, =: no increase/decrease, ?: not studied, +: interaction, -: no 
interaction.
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hippocampal cell proliferation has been shown to be sensitive to the effects of 
neonatal glucocorticoid exposure, likely because it is one of the areas undergoing 
substantial postnatal growth (4). Whereas proliferation in this area is suppressed 
during exposure, a rebound effect is observed upon cessation of treatment leading 
to ‘normal’ dentate gyrus volume in adulthood (18). This early finding in rodents 
was later confirmed by studies in the marmoset (22, 23) and also matches the 
findings reported in chapter3 of this thesis. These findings indicate the amazing 
plasticity and capacity for recovery of the neonatal brain.
long-lasting implications of acute transient effect
Glucocorticoid exposure enhances overall maturation and differentiation at 
the expense of growth and proliferation (10). This effect is either beneficial or 
detrimental depending on the developmental context. A premature system 
might benefit from a cue that stops growth and enhances differentiation, since 
tissue maturation rather than growth is necessary for survival in the extra-uterine 
environment. Thus, the acute benefits for survival are obvious. And although 
rebound effects, normalizing the acute proliferation-inhibiting effect, have been 
reported in various studies, it is likely that there will be consequences for later-life 
functioning. 
In rodents, the development of the hippocampus, especially the dentate gyrus, 
happens largely postnatally (24-27). It is believed that the extensive plasticity that 
characterizes normal early development is necessary for proper adult functioning 
of the hippocampus (27-29). Even a transient reduction in proliferation during a 
developmental stage that is normally characterized by high levels of proliferation, 
can influence adult functioning of the hippocampus and connected structures. 
These alterations may contribute to the frequently reported cognitive impairments 
observed after neonatal glucocorticoid exposure (30, 31).
effects on different cell populations
Besides a reduction in cell proliferation on postnatal day 4, we observed a 
substantial reduction in the number of astrocytes on postnatal day 10. Because 
the timing of glucocorticoid treatment in the preterm infant (and also in our animal 
model) coincides with a period of substantial glial proliferation, it is not surprising 
that gliogenesis is affected. Indeed, studies performed in the 1980’s showed 
reductions in myelination in postnatally treated rats, likely due to reduction in 
oligodendrocytes number (32). This effect was later supported by evidence in 
other species (33, 34). Interestingly, Bohn and Friedrich reported - similar to their 
neuronal observations - a rebound effect with significantly enhanced genesis 
of oligodendrocytes after termination of glucocorticoid treatment. We did not 
report such a rebound effect for the number of GFAP-labelled cells, at least not 
after a 1 week recovery period. Tsuneishi and colleagues also reported that GFAP 
levels were still reduced 10 days post-treatment, but normalized to control levels 
20 days post-treatment (35), indicating that the glial rebound process needs more 
time and likely proceeds between postnatal days 10 and 20.
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Protecting the brain
The acute effects after neonatal dexamethasone treatment described in chapter
3 of this thesis can be partially prevented by centrally blocking the GR prior 
to treatment. Beneficial effects of systemic GR blockade prior to neonatal 
dexamethasone treatment on hippocampal functioning have been reported 
previously (36). Additionally, the effects of chronic corticosterone treatment and 
of chronic stress in adulthood on hippocampal structure and function appear 
reversible upon a short course of GR antagonist treatment (37, 38).
The findings described in chapter3 of this thesis are to our knowledge the 
first report of beneficial effects of brain-specific GR blockade, which is more 
clinically relevant given the beneficial peripheral effects of dexamethasone 
treatment on lung development in prematurely born infants. Therefore, central 
GR blockade might serve as a potential pharmacological intervention strategy for 
adverse dexamethasone-induced effects. However, the invasive way of antagonist 
administration might have functional consequences as a result of astrogliosis 
induced by the intracerebroventricular injection as observed in our studies. 
Therefore, future studies using another, less invasive, route of administration, 
such as intrathecal injection, are needed to investigate the clinical potential of 
this intervention strategy.
Window of vulnerability
The specific developmental outcome of neonatal glucocorticoid exposure, 
including the potential for recovery, depends on numerous factors such as dose 
and timing of exposure, as well as the specific brain area studied. The impact is 
probably most considerable in brain areas undergoing growth and development 
at the time of exposure, such as the cerebellum and hippocampus in the postnatal 
rodent brain (4, 21). However, these brain areas still display a distinct postnatal 
developmental trajectory.
The growth spurt of the external granular layer of the cerebellum occurs 
slightly later compared to that of the granule layer in the dentate gyrus. Therefore, 
glucocorticoid treatment on postnatal days 7-18 has a more severe impact on 
cerebellar development compared to treatment on days 1-4, which has a large 
impact on dentate gyrus development (19). The decrease in cerebellar granule 
cell proliferation never fully recovers after glucocorticoid treatment, in contrast to 
the dentate population. These findings show that even small variations in timing 
of glucocorticoid exposure can result in targeting different areas and functions, 
and that certain areas are apparently more resilient to the growth suppressing 
effects of glucocorticoids.
Although, timing of treatment in the clinical situation is - and should be - 
mostly driven by severity of prematurity-associated pathology, research on the 
mechanism underlying the adverse neurodevelopmental effects using animal 
models should consider the sequence of events during brain development and 
choose time of treatment accordingly.
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ConSequenCeS of neonatal gluCoCortiCoiD 
exPoSure for aDult PhenotyPe
Besides studies on the acute effects, numerous reports have been published on 
the long-lasting impact of neonatal dexamethasone treatment in rats. 
health- and lifespan
Probably the most striking finding is that neonatal dexamethasone treatment results 
in a significant shortening of the lifespan (39-41). Liu and colleagues reported 
survival rates of 79% and 83% at 50 weeks of age after neonatal dexamethasone 
treatment, compared to 100% survival in saline-treated controls at the same age. 
A 50% reduction in the dexamethasone dose leads to survival rates comparable 
to those of saline-treated animals. This shortening of the lifespan was suggested 
to be the result of renal failure, since the surviving dexamethasone-treated 
animals displayed increased blood pressure, kidney damage and urinary protein 
content. These effects might be related to an early inflammatory response in the 
kidney. The authors observed that on postnatal day 2, TNF-α gene expression 
was suppressed in the kidney, followed by a significant increase on day 7 (41).
Additionally, Kamphuis and colleagues reported an overall shortening of 
lifespan of 25% in male rats neonatally treated with dexamethasone, with a mean 
survival of 21 months in dexamethasone- vs 29 months in saline-treated animals 
(39). These findings were associated with cardiac and renal failure already present 
at 15 months of age. Moreover, dexamethasone-treated animals already showed 
hypertension in young adulthood. The effects on the heart were in line with earlier 
findings of progressive hypertrophic cardiomyopathy (42) which might be the 
result of acute suppression of cardiomyocyte proliferation observed in the rat pup 
in response to glucocorticoid treatment (43). Additionally, an acute reduction in 
mitotic activity in the renal cortex after dexamethasone treatment results in lower 
nephron numbers and renal damage in later-life (44).
Neonatal dexamethasone treatment also alters adult immune function. 
An increase in severity and incidence of inflammatory autoimmune disease in 
adulthood has been shown in adult animals, treated as infants with dexamethasone. 
These animals also showed a reduced corticosterone response to LPS challenge. 
Additionally, LPS-stimulated macrophages of these animals showed an 
altered immune profile in terms of reduced TNF-α and IL-1β production (45). 
Dexamethasone-treated animals also displayed differential long-term effects on 
the expression of Vβ genes in CD4 and CD8 splenocytes which were preceded 
by changes in intrathymic corticosterone production and in CD4/CD8 thymocyte 
ratio (46).
As also extensively discussed in chapter4and5of this thesis, there are reports 
on impaired spatial learning (30) and hippocampal synaptic plasticity (30, 47) in 
adulthood which appear to be in line with the acute effects of dexamethasone 
treatment on hippocampal cell proliferation. Moreover, many studies have 
demonstrated alterations in endocrine responsiveness to stress (48-50).
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As described in chapters4and5, the adult phenotype of animals neonatally 
exposed to dexamethasone observed in our studies did not follow the 
expectations based on this substantial amount of data showing a severely affected 
adult phenotype. For instance, we did not report such dramatic effects of early 
glucocorticoid treatment on survival, although the steroid was administered in the 
same dose and during the same postnatal days as in the studies of Kamphuis and 
Liu. Although our dexamethasone-treated animals appeared to show a steeper 
survival curve, this effect did not reach statistical significance at 25 months, an 
age at which effects were detectable in the studies mentioned above.
Our findings indicate that the outcome of early glucocorticoid exposure 
is not deterministic and might depend on interactions with multiple internal 
(genetic, developmental stage) and external (environmental) factors, which might 
contribute to this apparent inconsistency.
genetic factors                
Opposing effects, in terms of body weight, motor performance and social 
interaction, after early hydrocortisone treatment, have been reported in closely 
related species (pine and meadow voles) (51). Following these findings, it can 
be suggested that also more subtle genetic differences might contribute to 
variation in the outcome. The majority of rat studies are performed in Wistar and 
Sprague-Dawley rats, in contrast to Long-Evans rats used in our experiments. 
In studies using mice it has been shown that certain strains are more sensitive 
compared to others, to the programming effects of maternal care received in 
infancy, with consequences for later-life drug self-administration and depression-
related behaviours (52). Additionally, there are substantial inter-strain differences 
in expression of corticosteroid receptors and sensitivity of these receptors to their 
ligands (53, 54), which makes certain strains react differently to programming 
effects of glucocorticoids compared to others.
timing of exposure
As reported before regarding acute effects on brain development, slight 
differences in the timing of treatment can have major impact on later-life 
phenotypes as well. Variation of only days can result in targeting either mostly 
cognition-related functions in the dentate gyrus or motor-related circuits in 
cerebellum. More specifically, Meaney and colleagues reported that there is a 
critical period for glucocorticoid-induced disruption of play-fighting behaviour, 
with substantial effects after corticosterone treatment on postnatal days 1-4, but 
not after treatment on days 9-10 (55). 
Interestingly, our treatment protocol is identical to that used by Kamphuis and 
colleagues, who have described a broad spectrum of molecular and behavioural 
alterations after neonatal dexamethasone treatment on postnatal days 1-3 (30, 39, 
50, 56). Although our dose and timing of dexamethasone treatment is identical to 
theirs, substantial differences exist in functional outcome in adulthood. 
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impact of experimental design
An important difference between these protocols lies in the litter composition, 
meaning the use of either a ‘split-litter’, with dexamethasone and control (saline) 
treated animals within one litter, or a ‘whole-litter’ design, in which all pups in the 
litter are subjected to the same treatment. We have chosen the split-litter design 
because we aimed to distribute equally over the different treatment groups: 1) 
genetic differences between litters, and 2) differences in maternal care between 
dams. 
Kamphuis and colleagues however report that the use of a split-litter design 
might enhance the effects of neonatal dexamethasone treatment on various 
developmental parameters (57). The authors show that maternal care is not 
different towards dexamethasone-treated compared to saline-treated offspring, 
as investigated using a whole-litter approach. They suggest that the amount of 
maternal care will be lower towards dexamethasone- compared to saline-treated 
pups when they are reared together in the same litter, due to competition of 
the pups for maternal care, leading to the enlargement of the dexamethasone 
effect. This within-litter effect was unfortunately not investigated. However, as we 
described in chapter2 of this thesis, these within-litter differences in maternal 
care can be substantial.
maternal mediation
Interestingly, rather than more substantial differences, we observed less differences 
between saline and dexamethasone-treated animals using a split-litter design 
(chapter4), compared to Kamphuis’ whole-litter reared animals. We suggested 
this to be the result of the brief daily periods of separation from the nest, necessary 
to mark the pups for identification between saline- and dexamethasone-treated 
littermates. This neonatal handling is known to result in alterations in HPA axis 
responsiveness (58-61) and cognitive performance (62) in adulthood. The effects 
of handling are suggested to be mediated via enhancing maternal care (63). 
Therefore, we suggested that the absence rather than enlargement of differences 
between saline and dexamethasone-treated offspring (chapter4) are the result of 
enhanced maternal care directed towards all handled pups.
Indeed, we showed in chapter5 that maternal care was enhanced in handled 
compared to non-handled animals, a finding that supports our hypothesis. 
Unfortunately, in this study we only observed whole-litter oriented maternal 
care since we aimed to compare maternal care levels towards handled vs non-
handled animals. The study of differences in individual pup-directed maternal 
care requires marking of individual pups for identification (like we did in chapters
2 and 4), which would have interfered with the undisturbed environment of the 
non-handled animals in chapter5. Therefore, future studies using a different type 
of marking are needed to investigate the presence of within-litter differences in 
maternal care directed towards dexamethasone- and saline-treated pups.
If there is competition between pups in favour of saline-treated offspring, to 
such an extent that a lack of maternal care enhances the dexamethasone-induced 
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phenotype (as suggested by Kamphuis and colleagues), this effect is apparently 
blunted when pups are daily handled and maternal care levels are increased to 
such an extent, that they override differences induced by neonatal dexamethasone 
treatment, as was observed in chapter4. We did observe in chapter5 for several 
cognitive functions (T-maze and water maze) that indeed the impact of neonatal 
dexamethasone treatment is more substantial in non-handled, compared to 
handled animals. These findings further support the idea that enhanced maternal 
care following handling, results in blunting of the dexamethasone effect.
implications for the clinic
These observations clearly demonstrate that neonatal dexamethasone treatment 
does not override all other environmental factors, as initially expected. The 
developmental impact of early glucocorticoid exposure is not deterministic 
and strongly interacts with other environmental factors. Although the effects of 
handling did not prevent all dexamethasone-induced effects and the findings 
cannot be directly extrapolated to the human situation, the observations described 
in this thesis might be valuable for the clinic. They could create awareness for 
the important contribution of environmental influences mediating glucocorticoid-
induced effects. They emphasize, for instance, the risk of a lack of maternal contact 
in incubator care preterm infants. Additionally, they contribute to evidence from 
studies investigating the beneficial effects of massage therapy (64-66) as well as 
other protocols directed at enhancing maturation in the preterm infant. 
It would be interesting and important to investigate whether variation in the 
degree of care or contact to a caregiver can be an additional factor (besides dose 
and time of exposure) explaining variation observed in the degree of adversity of 
the outcome of dexamethasone treatment in human preterm infants. Overall, the 
findings described in this thesis seem promising for the human situation since they 
show that besides pharmacological intervention; also behavioural intervention can 
be effective in mediating the development of certain dexamethasone-induced 
alterations. 
inDiviDual DifferenCeS in maternal Care 
As suggested before, within-litter competition for maternal care between pups - 
potentially induced by pup treatment (67, 68) - might modulate (enhance) the direct 
impact of such a treatment. Although we did not investigate treatment-specific 
within-litter effects on maternal care, we did observe that naturally-occurring 
within-litter differences in maternal care exist (chapter 2). It was already known 
that variation in maternal care has profound and long-lasting impact on adult stress 
phenotypes (69). This association was however based on differences in maternal 
care between litters, and the assumption that care is equally distributed across 
littermates, rather than on what is experienced by individual pups within the nest.
Previous studies have suggested that pups from the same litter display 
substantial variation in behavioural phenotype later in life (70). Moreover, it was 
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previously reported that a 24 hour maternal deprivation results in the amplification 
of individual differences in stress responsiveness, rather than having a generalized 
outcome (71). Variation in individual mother-infant interactions during early-life 
might contribute to the development of this dichotomy and enhance either 
vulnerability or resilience to the impairing effects of the deprivation.
Here, we reported that within-litter differences that are up to 10-fold smaller 
than those used previously to characterise dams, appear to have predictive value 
for later-life stress phenotype. Since these effects interacted with gender, the 
gender-specific effects of within-litter differences in maternal care require further 
investigation. Additionally, it has been recently shown that hippocampal synaptic 
plasticity and glucocorticoid receptor mRNA expression are affected by within-
litter differences in maternal care (72) to a similar extent as has been shown for 
between-litter variation in care (73).
Interestingly, in order to investigate individual pup-directed levels of maternal 
care, it was necessary to daily mark the pups for identification. This procedure 
obviously resulted in a substantial amount of neonatal handling, the impact of 
which has been described extensively in chapters 1, 4 and 5. The impact of 
handling is considered substantial and long-lasting. Intriguingly, the extremely 
subtle within-litter differences in maternal care were apparently not overruled by 
the supposedly strong overall effect of handling. Although all pups were exposed 
to handling, differences in endocrine stress responsiveness were still observed in 
adolescence and adulthood, although in a gender-specific manner.
imPaCt of inDiviDual ComPonentS of the early-
life environment anD their interaCtion
This finding showing the impact of very subtle differences in early maternal 
environment potentially overriding the effects of handling, together with the 
observation that the consequences of dexamethasone exposure can be strongly 
mediated by the effects of handling, or handling-induced variation in maternal 
care, changed our hypothesis about the intensity of the impact of individual 
aspects of the early-life environment. Thus, although we initially expected that 
the order of magnitude of the programming effect would be:
Dexamethasone > Handling > Maternal Care
the findings reported in this thesis suggest that the programming impact of early-
life experiences more closely resembles:
Maternal Care > Handling > Dexamethasone 
Obviously, other components should be taken into consideration, such as 
(interaction with) genetic background and timing of exposure as described above, 
as well as the environmental context in which the animal is tested, the impact of 
which will be discussed below.
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Context matterS
We have reported that the outcome of early-life experiences highly depends 
on the context in which they take place, such as in an undisturbed environment 
with continuous maternal presence or in a more challenging environment with 
transient separations from the mother or exposure to novel situations. These 
factors determine the outcome (and degree of adversity) of for instance neonatal 
synthetic glucocorticoid exposure.
The environmental context in later-life also mediates the impact of early 
experiences. The ‘predictive adaptation plasticity hypothesis’ (74-78) is based on 
the concept that a developing organism responds to cues (e.g. maternal care, 
glucocorticoids) in its environment by changing certain aspects of its homeostatic 
regulation (e.g. HPA axis) in order to produce a phenotype that is highly adapted 
to its current environment, assuming that this environment is comparable to 
its future environment. Following this reasoning, a high degree of ‘mismatch’ 
between the early- and later-life environments might account for an increased risk 
to develop diseases in adulthood (75-78). 
More specifically, the outcome of early maternal environment on later cognitive 
performance seems dependent on later-life environmental context (73, 79), with 
adult offspring exposed as neonates to low levels (or temporary deprivation) of 
maternal care showing poor cognitive performance in a low-stress context (80). 
However, in a high-stress context their performance was better as compared to 
that of animals that received high levels of maternal care, which were actually 
impaired under these stressful conditions (73, 79). These findings suggest that 
the influence of environmental experiences during development might serve as a 
basis for resilience to stressful challenges in later-life. 
Although the concept of ‘matching environments’ was not explicitly investigated 
in the studies described in this thesis, the potential beneficial long-term outcome 
after neonatal dexamethasone exposure, preparing the organism for better 
coping with stressful events in adult life, should be taken into consideration in the 
design of future studies.
ConCluDing remarkS
We investigated the impact of neonatal dexamethasone exposure, which we 
expected to overrule any other environmental effect. Interestingly we observed that 
dexamethasone-induced effects interact strongly with other environmental factors 
during development and are therefore susceptible to intervention strategies. 
We have indications that extremely subtle within-litter differences in maternal 
care have long-lasting impact on later-life stress phenotypes, potentially 
overriding the supposedly robust effects of handling. These findings indicate that 
all components of the postnatal environment, no matter how subtle, interact in 
shaping the adult phenotype. 
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SummARy 
Summary
It is well documented that early-life experiences are involved in shaping later-life 
phenotypes. Both human and animal studies have reported the impact of (adverse) 
early experiences on the development of the stress system, and its consequences 
for the development of stress-related disorders. The aim of the research described 
in this thesis was to explore the acute and long-lasting consequences of two distinct 
types of postnatal experience, varying substantially in nature and severity. In one 
study, the outcome of very subtle differences in maternal environment was examined. 
In another series of experiments, exposure to synthetic glucocorticoids during the 
early postnatal period was investigated. Furthermore, two potential intervention 
strategies to prevent the frequently reported adverse effects of glucocorticoid-
induced disruption of normal development and brain maturation were evaluated.
In chapter 1 an overview was given of important concepts for the study 
of developmental programming. Additionally, several animal models used in 
experiments described in this thesis were introduced.
In chapter2 we tested the hypothesis that maternal care is equally distributed 
across littermates and results in the development of a uniform stress phenotype 
with the litter. To investigate the distribution of maternal care across individual 
pups within the litter, we used an adapted version of a frequently used model 
of naturally-occurring variations in maternal care (Champagne et al. 2003). This 
allowed the study of within-litter differences in single pup-directed maternal 
licking and grooming. We reported that maternal care is not homogeneously 
distributed across littermates. Thus, besides differences in maternal care between 
litters, also variation within the litter exists. Next, the endocrine response to an 
acute novelty stressor was investigated at adolescence and adulthood in pups 
receiving low versus high levels of maternal care within the litter. We reported that 
these very subtle differences in early-life experience have long-lasting impact on 
the offspring’s later-life endocrine stress phenotype. Interestingly, we observed 
that rat mothers show a preference for male over female pups, resulting in a bias 
in the distribution of males and females over the low and high maternal care 
group. Therefore, future studies are needed to investigate the gender-specific 
impact of within-litter differences in maternal care on later-life stress phenotype.
In chapter3 we investigated the acute consequences of neonatal glucocorticoid 
treatment on cell proliferation and glial activity in the developing brain. To 
investigate the impact of neonatal exposure to synthetic glucocorticoids, Long 
Evans rat pups were injected with dexamethasone on postnatal day 1, 2 and 3, 
according to a protocol based on the treatment regimen for premature infants 
used in clinical settings. We reported that neonatal glucocorticoid exposure 
acutely, but transiently reduced hippocampal cell proliferation. Additionally, the 
number of glial cells in the corpus callosum and hippocampus was reduced in 
dexamethasone-treated animals one week post-treatment. These short-term 
alterations in the developing brain might contribute to the frequently reported 
detrimental impact of neonatal dexamethasone treatment on adult phenotype. 
Next, we tested the possibility to prevent these alterations by pharmacological 
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intervention using central GR antagonist administration prior to dexamethasone 
treatment. We reported that although central mifepristone administration did 
not prevent the reduction in hippocampal cell proliferation, the dexamethasone-
induced reduction in number of glial cells was fully normalized by central 
mifepristone pre-treatment, which was suggested as a potential intervention 
strategy to protect the developing brain against certain detrimental effects of 
glucocorticoid exposure.
Then, we investigated in chapter 4 the consequences of this treatment for 
postnatal development, as well as the young adult, middle aged and senescent 
endocrine and behavioural phenotype, in order to test the hypothesis that 
neonatal glucocorticoid exposure results in long-lasting alterations in endocrine 
and behavioural reactivity as well as in a shortening of the lifespan. We reported 
that neonatal dexamethasone treatment leads to developmental alterations, 
such as growth retardation and accelerated eye opening. The frequently 
reported adverse effects on adult endocrine and behavioural phenotype were 
however not observed. Neonatal dexamethasone treatment did not result in 
spatial learning impairments, nor did it result in altered stress-induced HPA axis 
activation and acquisition of fear. Additionally, we did not report a shorter lifespan 
in dexamethasone- compared to saline-treated animals. It was suggested that 
- contrary to our expectations - postnatal handling of the neonate, as a result 
of our within-litter treatment design, modulates - and potentially overrides - 
the outcome of neonatal dexamethasone exposure. Indeed, additional studies 
showing reduced pre-pulse inhibition, motor performance and spatial learning, as 
well as prolonged stress-induced HPA axis activation in animals that experienced 
a totally undisturbed postnatal environment compared to handled animals (both 
saline and dexamethasone treated), strengthen this hypothesis, which was finally 
tested in chapter5. 
In chapter 5 we investigated whether neonatal handling could serve as a 
second - behavioural - intervention strategy to rescue the dexamethasone-
induced phenotype. We reported that neonatal handling enhanced maternal 
care upon reunion, and that the effects of handling indeed interacted with 
those of neonatal dexamethasone treatment in shaping the adult endocrine 
and behavioural phenotype. Although dexamethasone treatment and handling 
yielded comparable effects on the restraint stress-induced CORT response and 
acoustic startle reactivity, acquisition of fear was only affected by handling without 
an effect of dexamethasone exposure. Interestingly, it could be concluded that 
dexamethasone treatment reduced the sensitivity for beneficial effects of handling, 
as was observed for pre-pulse inhibition. Additionally, non-handled animals 
appeared to be more susceptible to the impact of neonatal dexamethasone 
treatment compared to handled animals, as was demonstrated for spatial learning 
in the water maze. Moreover, the impairing effects of dexamethasone treatment 
in spatial orientation in the T-maze were only observed in non-handled animals. 
Overall it appears that dexamethasone-treatment mostly affects non-handled 
animals, specifically for tasks with a cognitive component.
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These findings emphasize that the outcome of neonatal glucocorticoid 
exposure is not deterministic and strongly interacts with other components of the 
postnatal environment.
In chapter6, the experimental findings described in this thesis were summarized 
and evaluated, and the implications for the field of developmental programming 
were discussed. We concluded that dexamethasone-induced effects interact 
strongly with other environmental factors during development and are therefore 
susceptible to intervention strategies, contrary to our expectations that the impact 
of neonatal dexamethasone exposure would overrule any other environmental 
effect. These observations might be valuable for the clinic, creating awareness 
for the important contribution of environmental influences, such as the degree of 
contact to the caregiver, in mediating glucocorticoid-induced effects.
Additionally, the finding that very subtle within-litter differences in maternal 
care have long-lasting impact on later-life stress phenotypes, highlights the 
important contribution of all components of the postnatal environment, no matter 
how subtle, in shaping the adult phenotype.
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SAmEnvATTing 
Samenvatting
Vroege levenservaringen dragen bij aan verschillende aspecten van de ontwikkeling 
van een individu. Er zijn veel gegevens van studies in dier en mens die aangeven dat 
stressvolle gebeurtenissen vroeg in het leven invloed hebben op de ontwikkeling 
van het stress syteem en daardoor mogelijk bijdragen aan het ontstaan van 
stress-gerelateerde aandoeningen. Het doel van het onderzoek beschreven in dit 
proefschrift was de korte en lange termijn effecten te beschrijven van twee soorten 
vroege levenservaringen die van elkaar verschillen in type en intensiteit. Door 
middel van diermodellen onderzochten we de consequenties van: 1) zeer subtiele 
verschillen in moederzorg tijdens de eerste week van het leven (hoofdstuk 2), 
en 2) blootstelling aan een synthetisch glucocorticoïde tijdens de eerste 3 dagen 
van het leven (hoofdstukken 3, 4 en 5). Aangezien deze laatste ervaring, een 
veelgebruikte behandeling voor respiratoire aandoeningen in prematuren, 
negatieve gevolgen lijkt te hebben voor de neurologische ontwikkeling, hebben 
we tevens de mogelijkheid onderzocht om deze negatieve effecten tegen te gaan 
danwel te verminderen door toepassing van twee interventie strategiën.
In hoofdstuk1 werden verschillende concepten geïntroduceerd die belangrijk 
zijn voor onderzoek op het gebied van ‘developmental programming’. Daarnaast 
hebben we enkele relevante diermodellen besproken, waarvan sommige ook 
gebruikt werden in de experimenten beschreven in dit proefschrift.
In hoofdstuk2 hebben we allereerst de hypothese getest dat moedergedrag 
gelijk verdeeld wordt over individuele pups binnen het nest. Om deze hypothese 
te toetsen hebben we een aangepaste versie van een bestaand model gebruikt 
om moedergedrag in ratten te bestuderen. In tegenstelling tot het originele 
model, was het in het aangepaste model mogelijk om individuele moeder-pup 
interacties te bestuderen en scoren. We concludeerden dat moedergedrag niet 
homogeen is verdeeld over de verschillende pups in het nest. Naast eerder 
aangetoonde verschillen tussen nesten (en dus moeders) blijkt er ook variatie 
te bestaan in de hoeveelheid moedergedrag ontvangen door individuele pups 
binnen een nest. Vervolgens hebben we de hormonale stress reactie gemeten in 
de adolescentie evenals op volwassen leeftijd in dieren die veel danwel weinig 
moedergedrag hadden gekregen in vergelijking met hun broers en zussen. We 
lieten zien dat subtiele verschillen in moederzorg, ontvangen tijdens de eerste 
week van het leven, leiden tot variatie in stressgevoeligheid later in het leven. 
Opvallend was dat de moeders een voorkeur leken te hebben voor de mannelijke 
in vergelijking met de vrouwelijke pups. Dit zorgde voor een ongelijke verdeling 
van mannelijke en vrouwelijk dieren over de ‘veel’ en ‘weinig’ moedergedrag 
groepen. Vervolgonderzoek naar de precieze, sexe-specifieke, effecten van 
moedergedrag op latere stress gevoeligheid, is dus nodig.
In hoofdstuk 3 hebben we de korte termijn effecten van blootstelling aan 
het synthetische glucocorticoïd dexamethason bestudeerd op de ontwikkeling 
van de hersenen. Meer specifiek hebben we gekeken naar celproliferatie en de 
hoeveelheid en activiteit van gliacellen. Om de invloed van blootstelling aan 
glucocorticoïden vroeg in het leven te onderzoeken hebben we Long Evans 
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ratten geinjecteerd met dexamethason op dag 1, 2 en 3 na de geboorte. Dit is 
gebaseerd op het behandelingsschema dat in medische centra gebruikt wordt om 
longrijping te stimuleren na vroeggeboorte. We zagen dat celproliferatie acuut, 
maar tijdelijk, was afgenomen in de hippocampus van dieren behandeld met 
dexamethason. Daarnaast bleek het aantal gliacellen in het corpus callosum en de 
hippocampus significant te zijn verminderd 1 week na de laatste dexamethason 
injectie. Deze korte termijn effecten op de ontwikkelende hersenen zouden 
kunnen bijdragen aan de negatieve bijwerkingen van dexamethason-behandeling 
op de cognitieve vaardigheden later in het leven, die vaak zijn beschreven in de 
literatuur. Vervolgens hebben we de mogelijkheid onderzocht om deze effecten 
op de hersenen te blokkeren door een glucocorticoïd receptorantagonist lokaal 
in de hersenen toe te dienen vlak voor dexamethason-behandeling. We zagen 
dat, hoewel de effecten op celproliferatie niet werden beïnvloed, behandeling 
met de antagonist de afname in aantal gliacellen tegenging. Op basis hiervan zou 
deze voorbehandeling als potentiele interventie strategie kunnen dienen om de 
effecten van dexamethason op de hersenen (gedeeltelijk) tegen te gaan.
In hoofdstuk 4 hebben we de lange termijn effecten van dexamethason-
behandeling onderzocht. We hebben gekeken naar de postnatale ontwikkeling, 
en naar het functioneren van de dieren op jongvolwassen, middelbare en hoge 
leeftijd om de hypothese te toetsen dat behandeling met dexamethason vroeg 
in het leven resulteert in lange termijn effecten op cognitieve vaardigheden 
en stressgevoeligheid, en daarnaast in een kortere levensduur. We zagen dat 
dexamethason-behandeling, zoals verwacht, resulteerde in een verstoorde 
postnatale ontwikkeling. Behandelde dieren vertoonden een groeiachterstand en 
juist een versnelde opening van de ogen. De veel beschreven negatieve lange 
termijn effecten op het cognitieve en endocriene functioneren op volwassen 
leeftijd, zagen we echter niet in onze dieren. Dexamethason-behandelde dieren 
vertoonden geen leerproblemen en hadden ook een normale stressreactie. Ook 
het effect op de levensduur werd niet waargenomen: wij zagen geen significante 
verkorting van de levensduur. 
We hebben toen onderzocht of het hanteren van de dieren tijdens de 
postnatale periode (dagelijks 15 minuten scheiden van de moeder, noodzakelijk 
om individuele dieren te kunnen markeren voor identificatie), de effecten van 
dexamethason-behandeling zou hebben kunnen beïnvloeden. We hadden 
verwacht dat het effect van dexamethason-behandeling elke andere manipulatie 
tijdens de postnatale periode zou overtreffen. Naar aanleiding van de bevindingen 
in hoofdstuk4 hebben we deze hypothese echter herzien. Aanvullende studies in 
hoofdstuk4 laten zien dat dieren die tijdens de postnatale periode volledig met 
rust gelaten werden verminderde pre-puls inhibitie, motorische en cognitieve 
vaardigheden hadden, en daarnaast een minder goede negatieve feedback van 
de endocriene stressreactie lieten zien in vergelijking met de gehanteerde dieren 
(zowel dexamethason-behandeld als de controles die een injectie kregen met 
fysiologisch zout). Deze bevindingen versterkten onze hypothese dat het hanteren 
van dieren tijdens de postnatale periode als een tweede interventiestrategie zou 
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kunnen dienen, en als zodanig de negatieve bijwerkingen van dexamethason-
behandeling zou kunnen tegengaan.
Deze hypothese werd vervolgens getest in hoofdstuk5. We onderzochten 
de interactie tussen dexamethason-behandeling en het hanteren door dieren 
met en zonder dexamethason-behandeling al dan niet 3 weken lang dagelijks te 
hanteren. We zagen dat het hanteren resulteerde in een toename in moedergedrag 
wanneer de dieren na het hanteren werden teruggeplaatst bij de moeder. Het 
effect van dexamethason-behandeling op moedergedrag kon in dit design niet 
worden bestudeerd. 
De lange termijn effecten van dexamethason-behandeling werden in 
grote mate bepaald door het wel of niet hanteren van de dieren. We zagen 
verschillende typen interacties tussen de effecten van dexamethason en hanteren. 
Enerzijds werkten de twee effecten in dezelfde richting voor wat de endocriene 
stressreactie en de startle reactiviteit betrof. Anderzijds werd het aanleren van 
angstgedrag alleen beïnvloed door het hanteren en niet door dexamethason-
behandeling. Daarnaast konden we concluderen dat dexamethason-behandeling 
de dieren minder ontvankelijk maakte voor de positieve effecten van hanteren 
op de pre-puls inhibitie en dat niet-gehanteerde dieren gevoeliger zijn voor de 
effecten van dexamethason-behandeling zoals we zagen bij het ruimtelijk leren. 
Bovendien zagen we dat de negatieve effecten van dexamethason-behandeling 
op de ruimtelijke orientatie alleen zichtbaar waren in niet-gehanteerde dieren. 
Samenvattend lijkt het erop dat de effecten van dexamethason-behandeling het 
sterkst zijn in niet-gehanteerde dieren, met name in taken met een cognitieve 
component. Deze bevindingen benadrukken dat de uitkomst van dexamethason-
behandeling niet eenduidig is en sterk beïnvloed wordt door andere 
omgevingsfactoren tijdens het vroege leven.
In  hoofdstuk 6 werden de bevindingen, beschreven in de verschillende 
hoofdstukken van dit proefschrift samengevat en de implicaties voor het veld 
van ‘developmental programming’ werden bediscussieerd. We concludeerden 
dat - in tegenstelling tot onze verwachting dat het effect van dexamethason-
behandeling sterker zou zijn dan dat van andere omgevingsfactoren - de 
uitkomst van dexamethason-behandeling juist sterk afhankelijk is van andere 
omgevingsfactoren, en dat deze dus gevoelig is voor interventiestrategieën. 
Deze bevindingen hebben mogelijk klinische implicaties en benadrukken dat 
aandacht moet worden besteed aan de invloed van omgevingsfactoren, zoals 
contact tussen (couveuse) prematuren en de ouders, op het effect van vroege 
dexamethason-behandeling.
Daarnaast concludeerden we dat zeer subtiele verschillen in moedergedrag 
invloed hebben op de stressgevoeligheid later in het leven. Deze bevinding 
benadrukt dat alle omgevingsfactoren tijdens het vroege leven, hoe subtiel ook, 
bijdragen aan de ontwikkeling van het latere fenotype.
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